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SUMMARY 
Clostridium difficile, a Gram positive, anaerobic, spore-forming bacterium is the 
commonest cause of hospital acquired infection in the UK. The organism initiates 
infection through spore formation and attachment, germination in the gut and then the 
production of two potent cytotoxins; toxins A and B. While the contribution of toxins A 
and B to infection is beyond dispute the relative importance of each toxin is a subject of 
debate. Thus diagnostic assays capable of rapidly detecting the presence of both toxins are 
needed. 
To develop such an assay we first characterised the structure of C. difficile spores to better 
understand their role in pathogenicity and adherence to organic and inorganic surfaces. 
Following attachment the spore germinates and the resulting vegetative bacteria express 
toxins. To facilitate the development of an assay capable of detecting both toxins, we 
employed a bioinformatics based approach which identified highly conserved nucleotide 
sequences within regions of each toxin which we hypothesised were under strict selective 
pressure.    
The specificity of the probes identified was confirmed using a panel of 58 clinical C. 
difficile isolates, related Clostridium isolates, non-related species and human gut 
metagenomic DNA samples. Selected probes were incorporated into a metal enhanced 
fluorescent assay platform and their ability to detect the organism in various organic 
backgrounds was determined. We were able to detect as few as 10 bacteria in 500 μl of 
human faecal material within 40 seconds, suggesting that this approach has the potential to 
be developed into a commercial assay. 
To support the development of this assay we sought to develop an insect infection model 
using the worm Manduca sexta. Our inability to initiate infection, inspite of the fact that 
bioinformatic analysis revealed the presence of genes with homology to known insect 
virulence factors, suggests that C. difficile may have potential evolutionary association to 
invertebrates. 
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1.1. HISTORY OF CLOSTRIDIUM DIFFICILE 
First isolated from neonates in 1935 by Hall and O’Toole, Clostridium difficile was 
originally known as Bacillus difficilis due to its difficulty to isolate from human faeces. 
Hall and O’Toole established the toxigenic nature of C. difficile when experimenting with 
rabbits and guinea pigs, finding that when broth culture of the organism was injected in 
the animals, lesions, respiratory arrest and occasionally death occurred. At the time the 
toxin was thought to be a type of neurotoxin (Lyerly et al., 1988). The only knowledge 
available on B. difficilis was a few papers between 1934 and 1962, which were 
documented by Willis in his book “Clostridia of wound infection” in 1969 (Duerden et al., 
1992).  
 
It was not until 1978 that Bacillus difficilis- renamed Clostridium difficile - was identified 
as the causative agent of pseudomembranous colitis (PMC). Prior to this, clinicians were 
aware that antibiotic therapies induced PMC and associated diarrhoea. Antibiotics such as 
clindamycin and lincomycin were implicated in causing disease (Small et al., 1968). 
Meanwhile in the USA, Green (1974) had described a cytotoxin present in the stool of 
guinea pigs after penicillin treatment, and Tedesco et al. (1974) found a significant 
association between PMC development in patients receiving clindamycin treatment.  
 
Even so the correlation between C. difficile and the toxic effects observed by Green and 
Tedesco et al. (1974) were not established until a few years later. Bartlett et al. (1978), 
with their letter pertinently titled “Will the real Clostridium species responsible for 
antibiotic-associated colitis please step forward?”, were the first to contest the conclusions 
from two previous papers naming Clostridium sordellii as the cause of PMC (Rifkin et al., 
1977; George et al., 1978). Rifkin et al. (1977) described a heat labile cytotoxin capable of 
killing hamsters and causing vascular permeability in the skin of rabbits. The cytotoxin 
was neutralised by the C. sordellii antitoxin but not by other clostridial antitoxins, or 
antitoxins to Escherichia coli or Vibrio cholerae toxins, thus leading to the conclusion that 
C. sordellii caused PMC (George et al., 1978).  
 
Interestingly Bartlett et al. (1978) were reluctant to ascribe C. sordellii with a pathogenic 
role in the disease as they had not isolated the bacterium from stool cultures. PMC 
sufferers were known to have intestinal lesions and although injections of C. sordellii into 
the caecum of hamsters resulted in death, the autopsies did not produce evidence of 
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lesions or cell cytotoxicity. Bartlett et al. (1978) had in fact isolated C. difficile from 
infected patients. Broth cultures of C. difficile were injected into the caecum of healthy 
hamsters and gave rise to colitis symptoms seen in humans. Additionally the toxin was 
found to be cytopathic and was neutralised when mixed with the gas gangrene producing 
C. perfringens antitoxin and C. sordellii antitoxin. Thus as more reports showed 
correlations between C. difficile infection and PMC, C. difficile was fully implicated with 
a role in PMC (Burdon & George, 1978; Keighley et al., 1978; Larson et al., 1978). 
  
Early literature on C. difficile can be confusing as the cytotoxin was considered to be the 
only toxin produced from the organism. Taylor et al. (1981) actually found that another 
enterotoxin existed which elicited a positive response in biological assays and degraded on 
polyacrylamide electrophoresis into two molecules- one of which appeared to migrate 
with the purified cytotoxin band. This toxin was designated toxin A and was thought to 
play an important role in C. difficile associated disease (CDAD). This was indeed 
confirmed by further research (Banno et al., 1981; Sullivan et al., 1981). It was then 
firmly established that C. difficile produced two distinct toxins. 
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1.2. CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHOEA 
1.2.1. Pathogenesis & Infection 
C. difficile manifests in varying severity from mild diarrhoea to fatal colitis in antibiotic-
treated patients (Voth & Ballard, 2005). The gut microbiota of antibiotic-treated patients is 
disrupted allowing C. difficile, which may be exogenously acquired or endogenous to the 
colon, to proliferate. Carriage of C. difficile can be asymptomatic and occurs in 40-60% of 
neonates and 1-3% of healthy adults (Kuijpers & Surawicz, 2008). In the hospital 
environment the organism is primarily acquired exogenously through the faecal-oral route 
(Figure 1.1; Salyers & Whitt, 2002).  
 
 
 
Figure 1.1: Clostridium difficile Infection Cycle 
The transmission of Clostridium difficile from faeces to infection can be seen. 
 
Following uptake spores pass through the stomach, are thought to germinate in response to 
bile salts and other environmental factors in the gut, and attach to the gut wall to colonise 
this environment (Panessa-Warren et al., 2007; Sorg & Sonenshein, 2008). Disease arises 
when there are enough clostridia present to produce copious amounts of toxin. 
 
Toxin A causes necrosis of cells, inducing tumour necrosis factor alpha (TNF-α), 
interleukins IL-1β, IL-6 and IL-8 and toll-like receptors (TLR-2) to be produced which 
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signals for transcription factor NFкB (Poutanen & Simor, 2004; Giannasca et al., 2004; 
Janeway et al., 2005). The human immune system also produces high levels of 
immunoglobin G (IgG) in response to toxin A post colonisation, suggesting that a robust 
antibody response contributes to protecting the host from CDAD (Voth & Ballard, 2005). 
The toxins activate intestinal nerves to release neuropeptides and a calcitonin gene-related 
peptide (CGRP), thought to have proinflammatory properties.  
 
Neutrophil response and polymorphonuclear leucocytes are stimulated by the release of 
inflammatory mediators such as macrophage inflammatory protein 2 (MIP-2) identified in 
rats, from the macrophage and resident mast cells. Mast cells are degranulated post 
exposure to toxin A. These factors all contribute to the associated inflammatory response 
and pseudomembrane formation, increased intestinal permeability, causing electrolyte 
imbalance and inhibition of protein synthesis (Figure 1.2). This may result in damage to 
the intestinal mucosa, villi and mast cells, thus causing a bloody, viscous fluid to be 
released- i.e. diarrhoea and pseudomembranous colitis (PMC). This inflammatory 
response has been demonstrated in vivo using rabbit or rat ileal loop models (Voth & 
Ballard, 2005). 
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Figure 1.2: Pathophysiology of C. difficile infected gut 
(a) Healthy gut epithelial cells with normal microbiota. (b) Microbiota disrupted by antibiotic treatment. C 
difficile spores and vegetative cells start to proliferate. (c) Toxins A and B are released from vegetative cells. 
Immune response is initiated and M cells are damaged. Electrolyte imbalance occurs. (d) Inflammation 
results in CDAD and pseudomembranous colitis.  
 
 
Toxin B is known as a cytotoxin and does not elicit fluid release however in vitro it has 
been shown to be lethal to cells (Genth et al., 2008). Polymorphonuclear leucocytes 
migrate between mucosal cells promoting damage and perforation, thus allowing toxin B 
to diffuse across the mucosal membrane and cause further damage to the intestinal wall. 
This pore formation has been found to be cell-specific and dependent on cholesterol 
(Giesemann et al., 2006). If the damage to the intestinal wall becomes too extensive 
bacteria can enter the blood stream to cause septicaemia. In an endoscopy, yellow-white 
raised plaques are seen on the pseudomembranes, with inflamed mucosa (Kuijpers & 
Surawicz, 2008). These yellow plaques (Figure 1.3) are accumulations of fibrin, mucin 
and dead host cells, initially forming a few lesions, and progressing to form spreading 
pseudomembranes, which have been found to form a sheath over the entire colonic 
mucosa in some cases (Lyerly et al., 1988). This is what distinguishes the severity of the 
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disease from colitis (Salyers & Whitt, 2002; Poutanen & Simor, 2004). Ultimately PMC 
can lead to toxic mega colon and even death- as the disease rapidly increases in severity 
within the space of two weeks (Wren et al., 2009). Thus rapid detection methods are 
needed to elucidate the presence of C. difficile and diagnose the infected patient. 
 
 
 
Figure 1.3: Pseudomembrane formation in a patient infected with C. difficile 
Pseudomembrane formation can be seen in the form of raised yellow plaques on the lining of the gut wall. 
These are accumulations of fibrin, mucin and dead host cells. Taken from Kuijpers & Surawicz (2008). 
 
Indeed the role of toxins A and B in CDAD have been debated. A study by Lyras et al. 
(2009) suggested that C. difficile strains producing only toxin A did not elicit CDAD, and 
that only toxin B production was essential for disease. The impact of this study was the 
move within the healthcare industry to produce diagnostics which focused only on toxin B 
detection. A more recent study by Kuehne et al. (2010) however re-established that a 
mutated strain of C. difficile which produced only toxin A could in fact elicit disease, 
meaning that both toxins A and B have a role in CDI. Thus it is important to develop 
diagnostics able to accurately detect both toxins A and B of C. difficile. 
 
1.2.2. Prevention and treatment of CDAD  
In order to prevent C. difficile infection control measures need to be employed within the 
hospital environment (Gerding et al., 1995). These measures include strict practices such 
as hand washing rather than using alcohol hand rubs as C. difficile spores are resistant to 
alcohol (Bartlett, 2006). Furthermore use of gloves and disinfection with sodium 
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hypochlorite has resulted in decreased incidence of CDAD (Department of Health & 
Health Protection Agency, 2008). An increased level of surveillance to detect new cases 
and isolate patients with CDAD can also help limit spread of the bacteria (McFarland, 
2005).  
 
The most important risk factor for C. difficile infection is antibiotic use. Broad spectrum 
antibiotics including clindamycin, aminopenicillins, cephalosporins (cefoxitins) and 
fluoroquinolones are used to treat pathogens which infect patients (Pepin et al., 2005). 
Simultaneously, however, they disrupt human colonic microbiota and the host can become 
susceptible to opportunistic pathogens such as C. difficile (Mulligan et al., 1984; Deneve 
et al., 2008). Fluoroquinolones such as moxifloxacin were found to increase CDAD when 
North American epidemic strain (NAP1) PCR ribotype 027 emerged (Biller et al., 2006; 
Deneve et al., 2008).  
 
To successfully treat CDAD broad spectrum antibiotic usage must be discontinued and 
replaced with a narrow spectrum antibiotic (McFarland, 2005).The primary antibiotics 
used to manage CDAD are vancomycin and metronidazole which are bactericidal to C. 
difficile; although this treatment is associated with relapse (Hinkson et al., 2008). 
Vancomycin is given orally at 125 mg four times daily for 10-14 days while 
metronidazole is given orally at a dosage of 250 mg respectively four times daily (or 500 
mg three times daily) for 10-14 days depending on severity of disease (Kuipers & 
Surawicz, 2008). Original studies have recommended metronidazole as first-line treatment 
of CDAD, as it is significantly less expensive than vancomycin, and reduces selective 
pressure for the emergence of vancomycin- resistant Enterococci (VRE). Guidelines set 
out by the UK Department of Health recommend that metronidazole be used in mild cases 
of disease, and vancomycin be used in severe incidences (Department of Health & Health 
Protection Agency, 2008). 
 
Ramoplanin is a glycolipodepsipeptide used to treat VRE infections and is currently being 
evaluated as another measure to combat CDAD (Freeman et al., 2005). Recently 
tolevamer, a novel toxin-binding anionic polymer, has been found to improve CDAD 
without affecting normal guy microbiota. Tolevamer works by binding to toxins A and B 
via a styrene sulphonate polymer (Miller, 2007). Phase 2 clinical trials with tolevamer 
demonstrated a trend for reduced re-occurrence of C. difficile infection (Hinkson et al., 
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2008). Low risk of C. difficile infection has also been found with use of tigecycline 
(Wilcox, 2007).  
 
Faecal transplants and bowel irrigations are currently being used to replace the original 
microbiota of the gut (Macconnachie et al., 2009). Studies have shown that patients who 
have had this treatment do not have any reoccurrence of infection (McFarland, 2005). In 
cases of toxic mega colon where the patient develops severe PMC, a total colectomy is a 
last resort, as hemi-colectomies have a 100% mortality rate (Miller, 2007).  
 
Probiotics are increasingly being used as a means of restoring normal gut microbiota 
following antibiotic treatment to prevent C. difficile proliferation (Miller & Fraser, 2009). 
Probiotics are not as yet widely accepted as an effective means for prevention and is the 
subject of much debate. Even so, some scientists recommend probiotics use in CDAD 
prevention to attempt to restore normal colonic microbiota. In 1989 Surawicz et al. found 
that Saccharomyces boulardii, a non-pathogenic yeast, prevented infection and relapses in 
clindamycin treated animals. It is normally given twice a day to infected patients, but is 
not given to immuno-suppressed patients as fungaemia can occur (Kuipers & Surawicz, 
2008). Other probiotics include Lactobacillus rhamnosus GG, Lactobacillus acidophilus, 
Lactobacillus bulgaricus and Lactobacillus plantarum 299v (Miller, 2007).  
 
Immunomodulation via active and passive immunity is being considered to prevent CDI. 
Active immunity involves vaccination with toxin gene-derived vaccines; however there is 
currently no direct evidence to demonstrate the efficacy of this approach (Miller, 2007). 
Even so, the company Acambis (based in Cambridge) is developing the world’s first 
vaccine against CDAD which commenced clinical trials in 2008. Passive immunity 
involves the administration of preformed antibodies capable of neutralising the activity of 
toxin A and B (Miller, 2007).   
 
New therapies for CDAD and recurrence of CDAD include the production of human 
monoclonal antibodies against the two toxins of C. difficile. Lowy et al. (2010) have 
recently performed a randomised, double blind placebo controlled study of two 
neutralising, fully human monoclonal antibodies against toxins A and B. The antibodies 
were administered in an established hamster model of C. difficile infection, as well as in 
phase 1 with human healthy volunteers, and significant efficacy of these antibodies was 
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found. A phase 2 randomised trial involving 200 patients with CDAD who were treated 
intravenously with the antibodies, along with standard antibiotics, reduced the 
reoccurrence rate of infection by 70% (Lowy et al., 2010). However the cost of IV 
antibody therapy is likely to be high. This antibody combination is currently in the process 
of being licensed to Merck. 
 
1.2.3. Epidemiology 
The number of death certificates (Figure 1.4) in England and Wales which mentioned the 
bacterium C. difficile in 2007 was 8,324 - an increase of 28% from 2006 (Office of 
National Statistics, 2010). Most deaths occurred in the elderly with mortality rates in 
patients over the age of 85 between 3,429 and 3,396 per million populations (Office of 
National Statistics, 2010). Importantly approximately 80% of reported cases of C. difficile 
were in patients 65 years of age or older. Before the emergence of the BA/NAP1 027 
strain in 2003, the cases of CDAD were not deemed significant across North America or 
Europe (Figure 1.5; Kuijpers et al., 2008). However between October 2003 and June 2004 
an outbreak caused by the ribotype 027 strains at Stoke Mandeville Hospital involved 174 
cases and 19 deaths due to C. difficile (Freeman et al., 2010). A second outbreak occurred 
in October 2004 again at Stoke Mandeville involved 160 and another 19 deaths occurred. 
An investigation afterwards concluded that the outbreaks were the result of poor patient 
environments and infection control practice (Freeman et al., 2010). 
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Figure 1.4: National Statistics of C. difficile 
Graph from National Statistics data depicting the number of death certificates mentioning Clostridium 
difficile as the cause of deaths in England and Wales 2006-2010. (Data taken from Office of National 
Statistics online). After 2007 there is a steady decrease in mentions of C. difficile. There are fewer mentions 
in 2010 compared to 2007, attributed to better implementation of cleaning practice. 
 
 
Currently in England there is a C. difficile PCR Ribotyping Network (CDRN) which 
allows for rapid ribotyping of samples (HPA, 2010). Indeed in 2008- 2009 the CDRN 
processed 4682 samples in England, the most prevalent being 027 (36%), 106 (13%) and 
001 (7%)  (Freeman et al., 2010). The costs of C. difficile infection are estimated by the 
European Centre for Disease Prevention and Control (ECDPC) to be between €5.000-
15.000 per case in England and $1.1 billion per year in the USA. Across Canada and the 
USA the incidences of C. difficile infection (CDI) have changed radically, increasing from 
36.5 cases per 100 000 population in 1991 to 156.3 cases per 100 000 population in 2003 
(Office of National Statistics, 2010). A similar epidemiological increase occurred from 2.7 
cases per 1000 in 1997 to 6.8 per 1000 discharges in 2001. 
 
6480
8324
5931
3933
2704
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
2006 2007 2008 2009 2010
INTRODUCTION 
 
12 
 
 
 
Figure 1.5: Distribution of Clostridium difficile type 027 strain in Europe by country 
This image shows the areas across Europe where outbreaks of 027 ribotype occurred and the sporadic cases 
of C. difficile. (Taken from Eurosurveillance, June 2008: Kuijpers et al., 2008.) 
 
 
1.2.4. Incidence in Animals 
There have been many documented cases of CDI in a range of livestock and domestic 
animals. C. difficile has been suggested to be an enteric pathogen of horses, associated 
with acute colitis post antibiotic treatment- usually with erythromycin (Baverud, 2002; 
Taha et al., 2007). The organism has also been identified as a cause of enteritis in calves, 
with toxins A and B found to be in 25.3% and 22.9%, respectively, of diarrhoeic calves 
(Hammit et al., 2008). The dominant isolate in the calf was found to be of ribotype 078. 
Ribotype 078 has been implicated as a cause of enteritis in piglets. Further genetic 
evaluation via multiple locus variable number tandem repeat analysis (MLVA) revealed 
porcine 078 strains and human 078 strains are genetically related (Debast et al., 2009). 
Therefore there is a high degree of similarity between human toxinotype V strains and 
animal toxinotype V strains (Jhung et al., 2008; Alvafrez-Perez et al., 2009). 
INTRODUCTION 
 
13 
 
C. difficile has been found to cause enteritis in captive ostriches. In other species enteritis 
occurs in stressed neonates or antibiotic treated animals, however in ostriches C. difficile 
is presumed to be an important commensal (Frazier et al., 1993). In this particular case 
described by Frazier, the presence of an antibiotic compound called sulfamerazine in feed 
could have induced clinical symptoms. Replacement of sulfamerazine with oral penicillin 
was shown to reduce mortality by 50% in the ostriches, but it seems that CDAD is a 
common problem in captive ostriches. Another interesting incidence of C. difficile is in 
desert locust Schistocerca gregaria Forskål, where it was found to be a commensal of the 
gut flora. C. difficile has also been found in retail meat and salads, indicating food could 
be involved in transmission from animals to humans (Bakri et al., 2009). C. difficile has 
also been found in the environment. Studies of the distribution of C. difficile within the 
environment of South Wales have found its presence in river water at a percentage of 
87.5%, sea water (44%) and in 46.7% of lake samples taken throughout South Wales (Al 
Saif & Brazier, 1996). C. difficile was also recovered from soil samples and 50% of 
swimming pools examined in the same study (Al Saif & Brazier, 1996).  
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1.3. GENERAL MICROBIOLOGY 
1.3.1 Clostridium difficile 
C. difficile is a member of the Firmicutes phylum, and the family Clostridiaceae. The 
bacteria grow optimally at 37
o
C and are heterotrophic. C. difficile is an anaerobic spore 
forming bacillus, possessing subterminal spores and peritrichous flagella conferring its 
motility (Hafiz & Oakely, 1976). Bacilli have dimensions of 0.5-1.9 μm by 3.0-16.9 μm 
(Hatheway, 1990). Bacteria also stain Gram positive; however older colonies sometime do 
exhibit Gram stain variability (Aktories & Wilkins, 2000). C. difficile is known to have a 
pleomorphic nature, and varying morphologies have been observed with strains (Reynolds 
et al., 2010; Siani et al., 2010). Indeed dwarf colonies have been documented in culture, 
representing colonies from inoculated spores which have subsequently germinated 
(Wilkins, 2000; J. S. Brazier: personal observation). 
 
Colonies have a ground glass appearance on agar with an irregular lobate edge. Typically 
on blood agar media the diameter of colonies ranges from 3-5 mm (Figure 1.6; Aktories & 
Wilkins, 2000). Colonies change form with age and sporulation is noticeable on cultures 
>72 hours post incubation. This is when the colonies have reached stationary or decline 
phase of growth. Interestingly these colonies have been described to have a “fried egg” 
appearance at 48-72 hours of incubation due to the raised whitish- grey centre spot visible 
in the colony.  
 
On selective agar media colonies appear to have a bluish/ green tinge due to an alpha- type 
haemolysis (Aktories & Wilkins, 2000). The most common selective agar used for C. 
difficile isolation from stool specimens is cycloserine cefoxitin fructose agar (CCFA). 
Under ultraviolet light colonies can characteristically exhibit a yellow-green fluorescence 
(chartreuse) and exude a pungent horse manure-like odour (Delmee, 2001). The distinct 
odour is attributed to C. difficile’s ability to produce isovaleric acid, isocaproic acid and p-
cresol (Levett, 1984). Indeed C. difficile can withstand a concentration of 0.5% p-cresol, 
unlike other anaerobic bacteria which are inhibited at this concentration (Dawson et al., 
2008). 
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Figure 1.6: Clostridium difficile active cultures.  
A: C. difficile grown on CCFA under white light. B: C. difficile grown on CCFA under UV light. Chartreuse 
colour visible. (Images courtesy of Daniel Phillips) C. Individual colonies of C. difficile showing 
characteristic lobate edges. (Image courtesy of Sciencephoto.com). 
 
 
1.3.2. Vegetative cells 
Vegetative C. difficile cells have complex structures, some of which serve as potential 
virulence factors (Figure 1.7). Certain strains C. difficile possess flagella which confer 
motility. Flagella are thought to be involved in gut colonisation and have been shown to 
play a role in cell adherence (Tasteyre et al., 2000; 2001). Tasteyre et al. (2001) found that 
crude flagella were able to adhere 10x more strongly to mouse caecum tissue compared to 
a non-flagellated strain of the same serogroup.  
 
C. difficile vegetative cells also possess fimbriae. Fimbriae are 4 - 9 nm in diameter and 6 
nm in length and are thought to be involved in adhesion; however as yet no association 
between fimbriae and adherence ability of strains has been determined (Borriello, 1998). 
Some strains of C. difficile produce a polysaccharide capsule (glycocalyx), which is 
A B
C
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thought to protect the bacterium from phagocytosis by polymorphonuclear leucocytes 
(PMN) i.e. it is an antiphagocytic factor. It has been suggested that toxigenic strains which 
produce more fimbriae and capsular material may cause more severe cases of disease; 
however this is still the subject of some debate (Bongaerts & Lyerly, 1997).  
 
 
 
Figure 1.7: Vegetative cells of Clostridium difficile.  
False-coloured SEM image of vegetative cells of C. difficile strain DS1748.  Characteristic bacilli rods 
(purple) are visible. Scale bar represents 5 μm. 
 
 
1.3.3. Vegetative cell proteins 
The surface layer (S-layer) of C. difficile is a proteinaceous para-crystalline structure 
surrounding the vegetative cell (Fagan et al., 2009). The S-layer has been implicated in 
adhesion and colonisation of cells within the gut and as a protector of the cell against 
parasitic attack by bacteriophages. The S-layer consists of S-layer proteins (SLP) (which 
act as a molecular sieve) and cell wall proteins (Cwp) (Waligora et al., 2001). Eleven cwp 
genes are found to be clustered around the slp locus, and those downstream of slpA (cwp2- 
cwp7) are conserved between strains (Calabi et al., 2001; Sebaihia et al., 2006). Of all the 
Cwp, CwpV is the largest and is known to promote C. difficile aggregation (Reynolds et 
al., 2011).  
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The S-layer comprises of two peptide subunits encoded by the single slpA gene and is the 
major surface antigen to which the immune system is exposed (Ni Eidhin et al., 2008). 
The pre-protein of slpA contains a signal peptide which guides translocation across the cell 
membrane and production of mature SLP post cleavage (Fagan et al., 2009). Mature SLP 
are high molecular weight (HMW) and low molecular weight proteins (LMW), ~40 kDa 
and ~35 kDa respectively, which facilitate adhesion to cell culture lines (Calabi et al., 
2001). The LMW protein is an immunodominant antigen (i.e. this protein is most easily 
recognised by the immune system, and thus influences the specificity of the induced 
antibody) and so antibodies against this protein are most common in sera from patients 
with CDAD. 
 
Interestingly there are differences in sequence homology between strains of C. difficile 
particularly in the LMW protein which has been found to induce very limited 
immunological cross reactivity. Indeed the LMW antigen is the main basis of serotyping 
of C. difficile, which comprises of 21 main serogroups. The HMW sequences do not show 
any sequence identity to the LMW sequences, are highly conserved between strains and 
are immunologically cross reactive (Fagan et al., 2009). The HMW sequences are 70-71% 
identical, whereas the LMW proteins possess 34-40% identity. The reason for sequence 
conservation in the HMW proteins has yet to be elucidated, although it has been noted that 
the variable regions of the LMW proteins appear to resemble those of flagellin sequences, 
which possess highly variable central sequence segments (Calebi et al., 2002). 
Alternatively, this lack of sequence identity may prevent the host mounting a protective 
immune response and enable reinfection, thus conferring an evolutionary advantage 
(Calebi et al., 2002). Hence as the S-layer surrounds the cell almost completely there is 
potential for it to be used as a vaccine, and an antibody response may also be used to 
eliminate carriage of C. difficile (Ni Eidhin et al., 2008).   
 
1.3.4. Spores 
C. difficile produces spores in times of stress, such as nutrient depletion and in aerobic 
environments. Spores are highly resistant to desiccation, extreme temperatures and 
chemicals and contaminate the environment through faecal soiling from infected patients, 
often surviving in the environment for months (Gerding et al., 2008). The spores 
themselves appear to be composed of a number of concentric layers as can be see in 
Figure 1.8. These layers consist of an inner core surrounded by an outer coat layer and a 
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cortex peptidoglycan layer. Indeed not all spores exhibit the same structure, with some 
spores possessing an outer exosporium layer hypothesised to play a role in spore 
adherence (Figure 1.8; Joshi et al., Unpub.). 
 
 
 
Figure 1.8: TEM images of Clostridium difficile spores. 
A. TEM image of a spore of strain DS1748. Concentric layers of the spores can bee seen. B. TEM image of 
a spore of DS1813 with exosporium visible. The layers of the spore coat are visible. Scale bar represents 100 
nm. Both images are of clinical isolates examined during this study. 
 
 
1.3.4.1. Sporulation 
Sporulation is induced by limitations in certain key nutrients in a population of cells 
(Durre, 2005). In Bacillus and Clostridium species the mechanism of sporulation is quite 
similar; however C. difficile sporulation has not been extensively studied. In times of 
nutrient depletion, vegetative cells generate spores. Initially the vegetative cells split 
asymmetrically producing two septa which both contain a copy of the chromosome (Sorg 
& Sonenshein, 2008). The mother cell subsequently engulfs the smaller forespore, 
assisting it with maturation, and addition of layers such as the peptidoglycan cortex and 
coat proteins (Figure 1.8) allows formation of the endospore. The mother cell lyses 
releasing the spore into the environment, where it lays dormant until conditions are 
adequate for germination to ensue (Durre, 2005).  
 
Recently proteins expressed in the outer spore coat layer of strain CD630 have been 
identified as carrying catalase, peroxiredoxin and chitinase activity. These coat proteins 
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are CotCB, CotD and CotE respectively (Permpoonpattana et al., 2011). CotCB and CotD 
proteins express putative manganese catalases and CotE act as a bi-functional protein with 
peroxiredoxin and chitinase activity (studied in Chapter 4), which is hypothesised to play 
a role in assembly of the spore coat via protein monomer polymerisation. However the 
exact functional activity of these proteins has yet to be fully elucidated. 
 
1.3.4.2. Sporulation genetics 
C. difficile lacks the genes present in most bacilli which govern the phosphor-relay system 
triggering sporulation. As C. difficile sporulation mechanisms are not yet clear, B. subtilis 
is used as a model organism for sporulation. In B. subtilis there are 5 sigma factors 
associated with sporulation working in a series to direct RNA polymerase to transcribe 
genes in varying stages (Figure 1.9; Piggot & Losick, 2002; Piggot & Hilbert, 2004). An 
early event in sporulation is the synthesis and activation of sigma factor H (σH), which 
joins the core polymerases and directs them to promoter sites: the Spo0A- genes.  
 
Spo0A products negatively or positively regulate the genes and are transcription factors 
(Durre, 2005). These products allow for formation of the septa and forespore as described 
earlier (Section 1.3.4.1). In C. perfringens Spo0A assists in both toxin production and 
sporulation; however in C. difficile the role of Spo0A has been debated. Indeed 
Underwood et al. (2009) generated Spo0A mutants by inactivating genes encoding Spo0A 
and associated sensor kinases to understand their contribution to sporulation, revealing 
links between toxin production and the sporulation pathway. Sigma factors E and F are 
active in forespore development and are later replaced by sigma factors G and K. In B. 
subtilis the sigG gene region downstream shares synteny with C. difficile but has different 
genes inserted into this area (Durre, 2005). Interestingly, the genome of C. difficile 
possesses a prophage-like element known as skin inserted in the sigma-factor K (σK) gene. 
This 14.6 kb skin insertion encodes a RNA polymerase sigma factor required for efficient 
sporulation (Haraldsen & Sonenshein, 2003).  
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Figure 1.9: Sporulation Initiation Spo0A Pathway (Adapted from Piggot & Hilbert, 2004) 
Kinases (KinA - KinE) phosphorylate the Spo0 genes: Spo0F- the sporulation initiation phosphotransferase. 
Spo0B the response regulator and the phosphoryl group is then passed onto the master regulator Spo0A 
(Paredes et al., 2005). Spo0A is subsequently phosphorylated on an aspartate active site, resulting in binding 
to a target sequence known as the “0A box” near the promoters of genes controlled by Spo0A, leading to 
gene activation or repression (Underwood et al., 2009). Some spore-forming bacteria have evolved to utilise 
Spo0A to adapt their virulence and ability to survive. 
 
1.3.4.3. Spore germination 
Germination occurs when there is change in optical density caused by spore rehydration 
and calcium dipicolinate (CaDPA) release (Sorg & Sonenshein, 2008). The stimulus of 
spore germination has yet to be established in C. difficile; however the primary bile salts 
cholate, taurocholate and glycolate have been shown in vivo to cause spore germination 
(Giel et al., 2010). Indeed early experiments involved supplementing selective agar with 
sodium taurocholate and other bile salts such as deoxycholate (Wilson et al., 1982; 
Wilson, 1983; Buggy et al., 1985). The normal physiological concentration of sodium 
taurocholate in the duodenum is approximately 6.9 mmol l
-1 
and 1.2 mmol l
-1 
in the 
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jejunum (Leverrier et al., 2003) which, interestingly, corresponds with the optimal range 
for germination of C. difficile previously found by Sorg & Sonenshein (2008) and 
Wheeldon et al. (2008). Glycine has also been found to be a potent co-germinant of C. 
difficile spores (Sorg & Sonenshein, 2008; Wheeldon et al., 2008). 
 
Conversely, chenodeoxycholate has been found to inhibit germination in the presence of 
taurocholate and cholate (Sorg & Sonenshein, 2009). Another inhibitor of spore 
germination in vivo is cholestyramine- a bile salt sequestrant, responsible for the removal 
of excess bile salts from the lower digestive tract (Giel et al., 2010). Cholestyramine is 
used as a treatment for CDAD, but the efficacy of cholestyramine has been debated as bile 
acid synthesis increases 42-46 fold once cholestyramine is ingested. In addition 
cholestyramine is able to bind to the antibiotic vancomycin potentially competing with its 
activity (Giel et al., 2010).  
 
Spore germination is initiated in the presence of germinants, such as nutrients, surfactants, 
lysozyme, peptidoglycan and dipicolinic acid. There are no known germination receptors 
in C. difficile, and as such Bacillus spp are used as study examples. In B. subtilis, 
germination occurs in response to asparagine, glucose, fructose and potassium (Setlow, 
2003). Three sensory receptors are located within the B. subtilis spore inner membrane 
which activates the germination process; gerA, gerB and gerK (Durre, 2005). Once 
germination is initiated there is no way of stopping the spore from converting into a 
vegetative cell, even if the germinants are removed. After this, there is cation (H
+
, Na
+
, 
K
+
) and CaDPA release leading to hydrolysis of the spore peptidoglycan layer (Figure 
1.8). At this point the water content of the spore increases, the core of the spore expands 
and enzymatic activity, metabolism and spore outgrowth is able to occur (Setlow, 2003).  
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Figure 1.10: Main events in Spore germination (Adapted from Setlow, 2003) 
The cycle of spore germination has distinct stages. The first is activation; the mechanisms of which have yet 
to be elucidated. Secondly Stage 1 involves core hydration and ion release, leading to stage 2 where there is 
total core hydration, expansion and loss of characteristic spore resistance. At the outgrowth stage there is 
degradation of small acid soluble proteins (SASP), degradation of spore coats and finally emergence of a 
vegetative cell capable of metabolism. 
 
 
1.3.4.4. Enzymes necessary for spore germination 
Spore germination enzymes have been well studied in C. perfringens. The enzymes 
associated with spore hydrolysis are SleB and CwlJ, known specifically as spore cortex-
lytic enzymes (SCLEs). CwlJ breaks down the peptidoglycan layers leading to outgrowth, 
however the mechanisms of activation for SleB remains unknown. CwlJ is thought to be 
activated by CaDPA from the spore coat. Another enzyme –SleC- is essential for complete 
hydrolysis to occur, and enzyme SleM is able to degrade peptidoglycan in the spore 
cortex, but is not essential for spore germination (Burns et al., 2010).  
 
Sebaihia et al. (2006) found genes homologous to the CwlJ and SleB genes of B. subtilis 
(CD3563), and the SleC genes of C. perfringens (CD0551), within the genome of C. 
difficile CD630 (Sebaihia et al., 2006). In fact, in a recent paper Burns et al. (2010) found 
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SleC mutants in C. difficile R20191 were unable to germinate and form colonies, even in 
the presence of germinants such as taurocholate, whereas the parent strains were capable 
of producing colonies. This suggests that SleC is in fact necessary for germination of C. 
difficile spores (Burns et al., 2010). 
 
1.3.4.5. Exosporium- a role in germination? 
An exosporium layer has been found to surround spores of the highly plastic genome 
sequenced C. difficile strain 630 (Sebaihia et al., 2006; Lawley et al., 2009). Other 
investigations into the exosporium of C. difficile ATCC 9689 and 43594 have revealed 
that during early germination endospores produce strain-specific exosporial projections 
which appear to facilitate attachment of the spore to agar or to other spores (Panessa-
Warren et al., 1997). In a later paper (2007) Panessa-Warren also reported bumps and 
knobs covering the spore at the initial stages of attachment, which later developed into 
more pronounced protrusions. Interestingly the visualization of spore structure during 
germination and the structural role of the exosporium have not yet been defined. However 
it is clear that bile salts, spore structure and the function of certain spore layers must all 
play a part in germination of the spore in the gut.  
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1.4. MOLECULAR BIOLOGY OF TOXINS 
1.4.1. Large clostridial toxins  
Pathogenic isolates of C. difficile usually produce two toxins: toxin A (TcdA- enterotoxin) 
and toxin B (TcdB- cytotoxin). These toxins are part of the large clostridial toxin (LCT) 
family which target the rho-GTPases and the Ras-GTPases (guanosine triphosphases) 
responsible for regulation of actin cytoskeleton dependent cell functions. Furthermore 
these GTPases are also involved in cell apoptosis, transcription and transformation (Table 
1.1; Aktories & Just, 2005; Alouf & Popoff, 2006). These single chained toxins are 
composed of three distinctive functional domains and are characterised by their cytopathic 
effects on cell culture (Von Eichel-Streiber et al., 1996). Other classification properties 
include: (a) high molecular weight (ranging from 250-308 kDa); (b) an amino- terminal 
enzymatic domain with characteristic repeats; (c) a central hydrophobic region; and (d) a 
carboxy-terminal domain with carbohydrate recognition sequence repeats (CROPs) 
(Rupnik et al., 2009).  
 
Table 1.1: Properties of large clostridial toxins 
The main properties of toxins from species within the family of LCTs are shown and compared.  
 
 
 Clostridium 
species 
Toxin Size 
(kDa) 
Homology (%) 
(No. 
oligonucleotide 
repeats) 
Cytopathic 
effect 
typical for: 
Cellular 
target 
proteins 
Position of 
glucosylation 
Enzymatic 
Activity 
 
C. difficile 
 
TcdA 
 
308 
 
48/15 
 
TcdB 
 
Rho, Rac, 
Cdc42 
 
Thr37 (Rho) 
 
UDP- 
glucosylation 
 
TcdB 270 100 TcdB Rho, Rac, 
Cdc42 
Thr37 (Rho) UDP-N-acetyl-
glucosylation 
TcdB-
1470 
270 93/2 TcsL  -  
 
C. sordellii 
 
TcsH 
 
300 
 
- 
 
- 
 
Rac, Ras, 
Rap, Ral 
 
  
TcsL 270 76/14 TcsL Rac, Ras, 
Rap1, Rap2 
Thr35 (Rho) UDP- 
glucosylation 
 
C. novyi 
 
Tcnα 
 
250 
 
32/16 
 
TcdB 
 
Rho, Rac, 
Cdc42 
 
- 
 
UDP-N-acetyl-
glucosylation 
 
C. 
perfringens 
TcpL 
 
TpeL 
- 
 
- 
- 
 
- 
- 
 
TcdB, TcsL 
Ha- Ras, 
Rap1B, Ras1 
- 
 
Thr35 (Rho) 
UDP- 
glucosylation 
UDP-N-acetyl-
glucosylation 
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Toxins from other species classed within this family include Clostridium novyi’s alpha 
toxin (TcnA), Clostridium sordellii’s haemorrhagic (TcsH) and lethal toxins (TcsL), and 
Clostridium perfringens (types B and C) toxin TcpL, due to their structural and functional 
relatedness (Figure 1.11; Rupnik et al., 2009). Recently C. perfringens has been shown to 
possess another LCT, TpeL (Nagahama et al., 2011). This has implications in terms of C. 
difficile toxin evolution, as it was previously thought that C. difficile toxins were only 
related to two other species of clostridia; C. novyi and C. sordellii (Amimoto et al., 2007). 
It is well documented that C. difficile’s two toxins share high similarity with C. sordellii’s 
toxins. Indeed, C. difficile TcdA is a functional homolog of TcsH, and TcdB is a homolog 
of TcsL (Figure 1.11).  
 
 
 
Figure 1.11: Phylogenetic tree demonstrating relatedness of large clostridial toxins.  
Genetic relatedness is determined from nucleotide sequences of the toxins using average percentage distance 
(%). Tree constructed using the Jalview
TM
 programme for multiple sequence alignments. Interestingly TcdA 
of C. difficile appears to be more closely related to the TpeL toxin of C. perfringens. TcdB is more closely 
related to the TcsL toxin of C. sordellii, and C. novyi appears to have diverged from the main toxin family, 
and thus has its own separate lineage. 
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1.4.2. Structure of the large clostridial toxins  
The N- terminus of tcdA and tcdB is 543 aa and harbours the glucosyltransferase (GT) 
domain which is responsible for the glucosylation of Rho proteins. The central 
translocation domain is characterised by a hydrophobic region (956-1128 aa) which is 
thought to have a role in membrane penetration during the infective process by 
translocation of proteins across cellular membranes (Von Eichel-Streiber et al., 1992; 
Aktories & Barbieri, 2005). The cysteine protease domain is also in this region. The 
combined translocation and receptor binding domains are classed as the delivery domain 
(Figure 1.12; Genth et al., 2008).  
 
The C- terminus harbours the receptor binding domain of tcdA and tcdB and a putative 
transmembrane domain which controls receptor- binding and pore formation. This region 
consists of short homologous aa residues known as CROPS- combined repetitive 
oligopeptides and exhibits homology to the carbohydrate-binding regions of GTs from 
Streptococcus mutans (Just & Gerhard, 2004).  
 
CROPs within TcdA are 21 to 50 residues long and can be repeated throughout the 
protein. These repeats are isolate-specific, giving rise to the theory that this region of the 
toxin may have been generated from multiple duplication and recombination events in the 
gene (Rupnik et al., 2005). The increased repetitiveness of sequence could also explain the 
agglutination activity of TcdA in the infective process (Voth & Ballard, 2005). 
Interestingly these repeats are only conserved at nucleotide level within tcdA, resulting in 
frequent homologous recombinations such as deletions and insertions (Alouf & Popoff, 
2006). The tcdB encodes CROPs that are homologous to four of the CROPs of tcdA (Voth 
& Ballard, 2005).  
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Figure 1.12: Detailed domain structure of large clostridial toxin of Toxin B. 
Tripartite Structure of TcdB: (a) Three functional domains are visible. (b) Putative Functions of regions 
within domains given:  
1. Trp: Binding site for phosphatidylserine 
2. DXD Motif Glucosyltransferase Domain: Short conserved motif is found in many families of 
glycosyltransferases and is expected to play a carbohydrate binding role in sugar-nucleoside diphosphate and 
manganese dependent glycosyltransferases. 
3. GTPase Substrate specificity: Catalytic domain harbours enzymatic activity 
4. Cysteine Protease: Homology to RTX toxins of Vibrio Cholerae 
5. Hydrophobic Region: Possible involvement in pore formation and delivery of the catalytic domain into 
the cytosol of the cell 
6. DXG Aspartate Protease: DXG (1665aa) motif is suggested to be part of an aspartate protease domain, 
possibly involved in processing of the toxins. 
7. CROPs: clostridial Repetitive Oligopeptides- repeating units. 
 
 
1.4.3. Mechanism of action of the large clostridial toxins 
LCT are glucosyltransferases that modify the host cell membrane G proteins which 
control cell processes- mainly targeting actin polymerisation, resulting in host cell death 
(apoptosis) (Poxton et al., 2001; Salyers & Whitt, 2002; Voth & Ballard, 2005). The 
toxins glucosylate the Rho, Rac and Cdc42 GTPases at the threonine residue (Thr35/37) 
which is essential for the switch function of the GTPases (Giesemann et al., 2008). This 
renders them inactive (Salyers & Whitt, 2002). The G proteins cycle between two states; 
the GDP (guanosine diphosphate) binding state and the GTP (guanosine triphosphate) 
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binding state (Salyers & Whitt, 2002). Toxins A and B act upon the GDP-bound state, as 
this configuration allows the threonine to be uncovered, thus allowing easier glucosylation 
by the toxins. This reduces the activity of the GTPase in the G protein, resulting in an 
imbalance of cellular function (Figure 1.13; Salyers & Whitt, 2002).  
 
 
 
Figure 1.13: Toxin Mode of Action:  
(a) The normal GTP cycle with the threonine residues being glucosylated. (b) The effect of glucosylation on 
the G proteins by toxins A and B. The glucosylated GTP bound form residue has a lower affinity for GTP, 
disrupting the normal functions of the G protein causing changes to host cells. 
 
 
1.4.4. Mode of action of toxins A and B 
The mode of action of the toxins is specific. Toxins A and B are both cytotoxic; however 
toxin B is more potent than toxin A. Both cause severe vascular permeability by disrupting 
junctions between cells and causing haemorrhaging (Poutanen & Simor, 2004). The toxins 
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bind to specific receptors. The receptor for toxin A in animals is the trisaccharide Gal-β1-
4GlcNAc and Gal-α1-3GlcNAc which is not present in humans. In humans the co-receptor 
for toxin A is glycoprotein 96 (gp96), binding to the apical membrane of the host cell 
(Rupnik et al., 2009). Toxin B binds to an unknown receptor on the baso-lateral 
membrane of the host cell (Rupnik et al., 2009). 
 
Upon binding both toxins are endocytosed by low pH endosomes. This in turn induces 
structural changes leading to pore-formation. Qa’Dan et al. (2000) established this by 
using bafilomycin- a macrolide antibiotic derived from Streptomyces griseus, finding that 
endosomes with a low pH may cause a conformational change in the protein regions in the 
toxins. The toxin N termini are translocated into the cytosol across the membrane by the 
translocation domain and then transferred into the cytosol through pores (Poxton et al., 
2001). The glucosyltransferase domain in the cytosol is released by autoproteolysis and 
targets GTPases (Rho, Rac). The delivery domain is then cleaved by autoproteolysis 
triggered by inositol hexakisphosphate (InsP6) (Davies et al., 2011; Reinike et al., 2007).  
 
The cysteine protease domain is also thought to play a part in the auto-proteolytic 
cleavage, as it is located adjacent to this site (Ergerer et al., 2007). This cysteine protease 
is linked to the RTX toxin of Vibrio cholerae, which possesses a catalytic triad comprising 
an aspartate-1665 residue (also present in tcdB), a cysteine 698 residue and a histidine 653 
residue. Hence it has been suggested that the clostridial glucosylating toxins belong to a 
new family of cysteine proteases. The catalytic domain of the toxin is translocated into the 
cytosol of target cells, which supports the theory of toxin autocatalytic cleavage (Egerer et 
al., 2010). Dithiothreitol (DTT) induces cysteine protease activity by increasing the 
synergistic effect of InsP6, which in turn activates the cysteine protease domain (Reineke 
et al., 2007).   
 
1.4.5. Pathogenicity Locus  
Toxin production is encoded by the tcdA and tcdB genes located on a 19.6 kb 
pathogenicity locus (PaLoc) that encompasses three additional small open reading frames 
(ORFs): tcdR, tcdE and tcdC (Figure 1.14; Cohen et al., 2000; Spigaglia & Mastrantonio, 
2002). Toxin A is 8.1 kb in length and is 308 kDa consisting of 2710 aa residues and toxin 
B is 7 kb in length and is 270 kDa consisting of 2366 aa residues (Bongaerts et al., 1994; 
Faust et al., 1998).  
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The PaLoc is located between two insertion sequences- cdu 2/2 and cdd 2-3 located 
upstream and downstream respectively of the PaLoc (Cohen et al., 2000). The locus also 
contains ORFs for insertion sequence cdu-4 (Spigaglia & Mastrantonio, 2002). In every 
toxigenic C. difficile strain the PaLoc has been found to be present at the same 
chromosomal integration site, and in non-toxigenic strains this site is replaced by a 115 bp 
non-coding sequence (Rupnik et al., 2009; Stare & Rupnik, 2010). This gene organisation 
is not conserved in all strains, and usually C. difficile strains are compared to reference 
strain VPI10463 (Figure 1.14) via a system known as toxinotyping, as described in 
Section 1.5.2. 
 
 
 
Figure 1.14: Pathogenicity Locus of C. difficile 
PaLoc of C. difficile strain VPI 10643 (toxinotype 0). The PaLoc includes two large toxin genes (tcdA, 
tcdB) and three accessory genes involved in various regulatory and transportation functions. The PaLoc is 
located between the Open Reading Frames (ORFs) of insertion sequences cdu 2/2 and cdd 2-3 and cdu-4 in 
non-toxigenic strains (Adapted from Bruggeman & Gottschalk, 2009). 
 
 
The toxins genes tcdA and tcdB have ~66% sequence homology, functional homology and 
a low GC content. They are also similar in their biological functional activity, using their 
highly conserved N-terminal region to glucosylate substrates (Voth & Ballard, 2005). Due 
to this it has been proposed by Von Eichel-Streiber et al. (1992) and others that the genes 
arose from a duplication event.  
 
Other genes located in the PaLoc include tcdR (formerly known as tcdD and as TxeR), 
tcdE and tcdC genes (Braun et al., 1996). Gene tcdR encodes an alternative sigma factor 
involved in positive transcriptional regulation of toxin expression. Indeed tcdR was first 
found to be an unconventional positive regulator in expression experiments using E. coli, 
(Moncreif et al., 1997). These results were confirmed by experiments using C. perfringens 
and then C. difficile (Mani & Dupuy, 2001). These experiments assessed tcdR’s ability to 
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act as a sigma factor, and established that a combination mixture of core RNA polymerase 
and tcdR is able to bind to the tcdA, tcdB and tcdR promoter regions (Mani, 2002).  
 
Hence tcdR functions as an RNA polymerase sigma factor for toxins A and B and 
activates its own expression in a similar manner to its effect on the toxin promoters (Mani 
& Dupuy, 2001; Dupuy et al., 2008). The tcdR gene is also homologous to the cntR gene 
(previously known as the TetR and BotR genes) regulator of the toxin cntABCDE genes 
of C. botulinum and cntA gene of C. tetani respectively (Sebaihia et al., 2007). These 
proteins act as alternative sigma factors and are so different in their structure and function 
that they have been classed into their own subgroup of sigma-
70
 family (Dupuy et al., 
2008). This family includes the UviA gene of C. perfringens, which regulates an UV-
induced bacteriocin (Bruggeman, 2005).  
 
The negative regulator is encoded by the tcdC gene and is responsible for down regulation 
of toxin A and B production (Hinkson et al., 2008). Gene tcdC is a 231 aa and 693 bp 
(Govind et al., 2006). The tcdC gene is not similar to any regulatory protein known as it is 
highly variable. Some strains possess deletions in tcdC of 18 bp and/or 39 bp which are 
associated with toxin overproduction. This is evident in toxinotype III, of which the 
hypervirulent 027 strain B1/NAP1 of C. difficile is part (Spigaglia & Mastrantonio, 2002; 
Loo et al., 2005; McDonald et al., 2005).  
 
Transcription of tcdC occurs early in the growth phase of C. difficile (Cohen et al., 2000). 
tcdC has been studied by Matamouros et al. (2007), who found that tcdC, when co-
expressed with tcdR, caused less activity of the toxins, resulting in  reduced expression of 
tcdA. This occurred as tcdR activated expression from the tcdA promoter, giving the first 
direct evidence that tcdC negatively regulates tcdA transcription by interfering with the 
tcdR- containing RNA polymerase (Figure 1.15; Dupuy et al., 2008). Indeed the putative 
transmembrane domain located with the tcdC region has been proven by Govind et al. 
(2006) to be a membrane associated protein. 
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Figure 1.15: Schematic representation of C. difficile toxin gene regulation by tcdC 
The tcdC gene represses transcription of tcdA and tcdB via inhibition of tcdR RNA polymerase interaction or 
the ability of tcdR to recognise the toxin promoters. When tcdC is absent, and there is presence of positive 
stimuli, tcdR transcribes toxin production (Matamouros et al., 2007). Adapted from Dupuy et al.  2008.  
 
 
The tcdE gene is a 501 bp ORF between tcdA and tcdB, which encodes for a 170 aa 
hydrophobic protein. Gene tcdE appears to have high homology with a phage holin-like 
pore forming protein thought to contribute to release of the toxin from bacterial cells 
(Bartlett, 2006; Jank et al., 2007; Rupnik et al., 2009). Holins themselves are cytolytic 
proteins which cause lysis of the bacterial host in order to release progeny phage. Indeed 
expression of tcdE in E. coli caused bacterial cell death, which suggests that tcdE in some 
way functions as a lytic protein, potentially facilitating release of toxins A and B into the 
extracellular environment (Tan et al., 2001).  
 
tcdR tcdB tcdE tcdA tcdC
?
SIGNAL
+/- +/- +/- +/-
CARBON 
SOURCES
BIOTIN
AMINO 
ACIDS
BUTANOL
TEMPERATURE
ANTIBIOTICS
SIGNAL PROCESSING
RNA Polymerase
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There is high homology between PaLoc genes and phage genes. The most notable is 
tcdE’s phage – like holin. Interestingly tcdA also shares homology with phage gene ϕ CT2 
in Clostridium tetani strain E88, 55% sequence identity with Lactobacillus casei phage ϕ 
A2 (ORF 22) and homology with a 103 aa section of tcdC in strain VPI 10463 (Canchaya 
et al., 2003; Goh et al., 2005). This suggests that the origins of the PaLoc may have been 
an ancient prophage (Fortier & Moineau, 2007). 
 
 
1.4.5.1. Evolutionary origins of the PaLoc  
The PaLoc is a genetic element hypothesised to have been incorporated into the C. difficile 
genome from an unrelated strain via a process called horizontal gene transfer (HGT). This 
hypothesis has yet to be proven and thus the genetic element is still designated a 
“pathogenicity locus” (Rupnik et al., 2005). The locus was defined by Braun et al. (1996) 
as a distinct genetic element incapable of mobility. Braun et al. also proposed that the 
PaLoc may be a self-governing part of a larger genetic element linked with virulence.  
 
Thus there is no surprise that many scientists are reluctant to speculate upon the origins of 
the PaLoc. Indeed there is a distinct possibility that at some point in the organism’s 
evolution that the PaLoc may have originally been a pathogenicity island (PAI) acquired 
via HGT into the C. difficile genome, but has lost its mobility over time. Interestingly the 
PaLoc is replaced by a 115 bp fragment in non-toxigenic strains which supports this 
argument. The flanking regions of PAIs are characterised by direct repeats which are 
involved in recombination events. This can lead to deletion of the PAI (Alouf & Popoff, 
2006). Characteristics representative of a PAI include presence in pathogenic strains and 
absence in less pathogenic strains of the same species, encoding of toxins, mobility 
between genomes (in some cases mediated by bacteriophage) and genetic instability 
(prone to deletions) (Woodford & Johnson, 2004).  
 
Sebaihia et al. (2006) reported that C. difficile strain CD630 possesses a highly plastic 
genome consisting of 11% mobile genetic elements (transposons, prophages, insertion 
sequences, introns). It is understood that pathogens with high genetic flexibility, such as 
C. difficile, may be more competent in colonisation of new ecological niches and may 
have a selective advantage over other organisms with less plastic genomes (Hacker et al., 
2003). Thus this foreign DNA may have been originally integrated to give C. difficile an 
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advantage over other organisms due to selective pressure. We may already be seeing the 
evidence of this in the form of the hypervirulent ribotypes recently emerging to cause 
increased severity of disease.  
 
1.4.5.2. Evolutionary origins of the PaLoc and horizontal gene transfer  
Horizontal gene transfer (HGT) also occurs between microbes within the host 
environment. There are a number of studies demonstrating the transfer of antibiotic 
resistant determinants between Gram positive and Gram negative bacteria within the 
intestinal tracts of humans and animals (Shoemaker et al., 2001; Igimi et al., 2008). 
Indeed the human gut is an environment where HGT should occur frequently, as there is a 
constant supply of nutrients, numerous bacteria (10
12
/g) and surfaces for bacterial 
adherence (Shoemaker et al., 2001).  
 
Transfer of genes can occur in many ways. The first process is usually via transformation, 
involving the stable uptake of extracellular DNA, under natural bacterial growth 
conditions called natural transformation. The ability of DNA acquisition via 
transformation amongst a broad range of bacteria also indicates that this ability is 
conserved amongst many species and thus is important in evolution (Thomas & Nielson, 
2005). Conjugative transfer is a process by which bacteria acquire plasmids. Bacteria are 
known to form a pilus to allow the transfer of plasmid material to other cells, which results 
in a junction between the donor bacteria and a pore through which the plasmid DNA and 
genes can be transferred to the recipient cell. Plasmids are small genetic elements which 
can be transferred quickly, and are facilitated by transposons, insertion sequences and 
other mobile elements which allow integration of the DNA into the host genome (Madigan 
& Martinko, 2005). DNA can also be incorporated into a bacterium by bacteriophage, in a 
process known as transduction (Elliott et al., 2007). Lytic bacteriophage incorporate host 
DNA into their genome, and this gets transferred as the bacteriophage replicates, resulting 
in a transducing particle which is released along with normal phage.  
 
Bacterial genomes are highly plastic, and thus some genes have the ability to be 
horizontally transferred. For example, it has been hypothesised that species related to C. 
difficile may have evolved from a common ancestor as many genes shared by these 
species have high sequence identity (Von Eichel-Streiber et al., 1992; He et al., 2010). C. 
difficile’s close relatives include C. sordellii known to cause toxic shock, and C. novyi 
INTRODUCTION 
 
35 
 
which is present within soil, manure and also produces toxins. The toxin gene tcdB has 
85% homology and 74% identity with TcsL of C. sordellii and the G+C content of C. 
difficile toxin A and B encoding regions are ~28% G+C, which is similar to that of the 
entire C. difficile genome (G+C content of ~29%) (Voth & Ballard, 2005). A feature of a 
typical PAI is a different G+C content from the rest of the genome and the C. difficile 
PaLoc does not show this variation. Therefore it may be plausible that the acquisition of 
virulence genes by C. difficile was not a recent event, and that the toxins which are so 
prevalent within the clostridial family may have in the past been part of a plastic, mobile 
gene pool where HGT may have occurred frequently within ancestors of the organism, 
resulting in the spectra of toxin- possessing clostridia which we see today.  
 
 
1.4.5.3. Evolutionary origins of the PaLoc and codon usage 
Codon usage bias refers to the frequency at which synonymous codons occur within DNA, 
which is important when attempting to understand how an organism has evolved (Bulmer, 
1991). Codons are recognised by several tRNAs, and those recognised by the most 
abundant tRNA are used more often than those recognised by the rarer tRNAs. In E. coli 
the quantification of cytoplasmic tRNA revealed that the relative abundance values of 
varying tRNA molecules were different (Ikimura, 1981). This difference is thought to be 
associated with amino acid abundance in proteomes, where the tRNA abundance 
correlated with the abundance of codons in genes of unicellular organisms, such as E. coli 
and Saccharomyces cerevisiae. This lead to the theory that codon usage and tRNA genes 
co-evolved, allowing for optimal translation in organisms. Altered codon usage in 
organisms is often indicative of some sort of HGT having occurred.   
 
There currently is little literature regarding the codon usage within the C. difficile PaLoc 
and no evidence of tRNA sequences either within or outside of the PaLoc (Braun et al., 
1996).  Even so, some species of clostridia do show signs of HGT within their genomes, 
such as C. botulinum type A strain that possesses a chromosomally encoded BoNT locus, 
whose downstream boundary is flanked by two genes with high sequence similarity to IS 
element IS1069 of Lactococcus lactis (Bruggeman, 2005).  
 
A recent paper by He et al. (2010) examined the phylogeny, HGT, recombination and 
evolutionary history of C. difficile at the whole genome level. It has been found that 
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strains associated with disease evolved from multiple lineages, suggesting that C. difficile 
is more dynamic than previously thought. This has refuted the idea that these virulent 
isolates evolved from a single lineage. Indeed the paper suggests that the C. difficile and 
C. tetani lineages diverged around 2.34 billion years ago, and C. difficile itself 85 million 
years ago (He et al., 2010). Interestingly although this common ancestor of C. difficile is 
millions of years old, the lineages all contained isolates of 017, 078 and 027 ribotype, 
which implies that there may be genetic elements conferring virulence characteristics 
which are common to all strains. Indeed this poses questions about how host-pathogen 
interactions have changed in the past thirty years, as C. difficile was only implicated as a 
cause of CDAD since then. Have changes in human activity, such as antibiotic usage 
affected the recent evolution of C. difficile? 
 
1.4.6. Variant C. difficile toxins 
While the 19.6 kb PaLoc is present in all toxigenic isolates of C. difficile with a defective 
PaLoc, truncated tcdA genes are still capable of causing clinical disease (Stabler et al., 
2008). Indeed the DNA sequence of the PaLoc varies between C. difficile strains; a factor 
which has been exploited by Rupnik et al. (2001) in the construction of the toxinotyping 
classification system (as described in Section 1.5.2). Currently 31 toxinotypes have been 
identified (Rupnik et al., 2009).  
 
Within the PaLoc variations such as deletions are usually located in the repetitive regions 
of tcdA 3’ and 5’ ends (Bruggeman & Gottschalk, 2009). Interestingly in tcdB variations 
only occur at the nucleotide level, and no truncated forms of tcdB have been found yet. 
This suggests that tcdB is essential for disease manifestation when compared to tcdA 
where deletions can range from 100 bp to 5.9 kb in toxinotype X (Soehn et al., 1998). 
Toxinogenic C. difficile strains usually produce both toxins (A
+
B
+
); however some variant 
toxin strains have been reported. There are seven toxin production types of C. difficile 
identified to date as listed in Table 1.2.  
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Table 1.2: Seven types of toxin production in C. difficile 
The ability of strains to produce toxin A, toxin B and the binary toxin CDT are displayed. The 
corresponding toxinotype and molecular background of the strains is listed. Adapted from Rupnik et al. 
(2008). 
 
 
 
 
The best characterised strains are the atypical 8864 strain and serogroup F strain 1470, 
which both have truncated 3’ ends on their tcdA genes, resulting in a 6.0 kb deletion in 
8864 and a 1.7 kb deletion in the immunodominant repetitive ligand domain of 1470 
(Letournier et al., 2003). Other studies have indicated that some variant strains in 
serogroups F and X have a mutation in 5’ end of tcdA, which results in the untimely 
termination of tcdA translation. Although strain 1470 is not known to cause CDAD, other 
strains belonging to the serogroups X and F have been involved in CDAD (Letournier et 
 
Toxin 
Production 
Type 
Toxinotype Molecular background 
 
A+ B+ CDT- 
 
0 
Minor types: I, II, XII, XIII, XVIII, 
XIX, XX 
Major types: XXI 
 
 
CDT- : absence of entire/ large part of CDT locus 
   
A+ B+ CDT+ Minor types: XXIV 
Major types: III, IV, V, VI, VII, 
IX, XIV, XV, XXII, XXIII 
CDT+ : presence of full length CDT locus 
   
 
A- B+ CDT- 
 
VIII, some 0 strains 
 
A-: nonsense mutation at aa position 47 in tcdA gene 
A-: mechanism unknown 
   
 
A- B+ CDT+ 
 
X 
XVI, XVII, some V-like strains 
 
A-: rearrangement in PaLoc and large deletion 
causing probably 
changes in regulation and low or no transcription of 
truncated tcdA 
A-: mechanism unknown 
 
   
A+ B- CDT+ IX-like B-: mechanism unknown 
 
 
A- B- CDT+ 
 
XIa, XIb 
some strains without PaLoc 
 
A-, B-: only small non-functional part of PaLoc 
present 
A-, B-: no PaLoc 
 
   
A- B- CDT- PaLoc and CDT locus negative 
strains 
Complete absence of tcd and cdt genes 
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al., 2003). The cytotoxins produced by these strains display unusual cytopathic effects in 
cell culture reminiscent of that exhibited by the lethal toxin of C. sordellii (Sambol et al., 
2000). 
 
Deletions in the tcdC gene have recently become important as this gene encodes the 
negative regulator of the toxin (Dupuy, 2008). These types of deletion can be 
differentiated into four groups from 18 bp to 56 bp (Curry et al., 2007). The BA/NAP1 
027 ribotype strain which demonstrates high toxin A and B production and binary toxin 
production is characterised by a deletion in the tcdC locus (Jank et al., 2007). These 
hyper-virulent toxin variant strains demonstrate increased morbidity and mortality 
compared to other isolates (Drudy et al., 2007). Only in two toxinotypes is the 
conformation of the PaLoc totally changed- in toxinotypes X and XI, the latter of which 
only has tcdC and two thirds of tcdA left.  
 
Insertions within the PaLoc, although rare, do occur in several toxinotypes (Bruggeman & 
Gottschalk, 2009). Toxinotype X has an insertion of 1.1 kb between tcdE and tcdA in 
strain 8864, and a 2 kb insertion in tcdA in strains of toxinotype XIV (Alouf & Popoff, 
2004). This 2 kb insertion at the 5’ end of tcdA was found to be an IStron: CdISt1, excised 
from mRNA and specific only to C. difficile, and has now been found in other toxinotypes 
(XVII, XXII, and XXIII) (Mehlig et al., 2001; Bruggeman & Gottschalk, 2005). It has 
been suggested that truncations and deletions within a genome, as in the C. difficile tcdA 
and tcdC genes, may represent a specific form of adaptation for the pathogen to certain 
niches, hosts, tissues or during transition of the pathogen from a chronic state of infection 
to an acute state or vice versa (Alouf & Popoff, 2004).  
 
1.4.7. Binary toxin genes 
Several C. difficile strains express a binary toxin (CDT) in addition to toxins A and B 
which is part of a family of adenosine diphosphate (ADP) ribosylating toxins. The CDT is 
unrelated to tcdA and tcdB, but is homologous to the toxins expressed by the VIP1 genes 
in Bacillus cereus, CST of C. spiroforme and the C2 toxin in C. botulinum (Table 1.3; 
Durre, 2005). It is also closely related to the C. perfringens Iota Ia and Ib toxins, sharing 
approximately 80% and 82% amino acid sequence identity respectively. Differences 
within the ADP ribosylating toxins family include varying substrate specificity for actin 
isoforms and in the steps of cellular uptake (Barth et al., 2008). The protein components 
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of CDT and toxins from other clostridial species, such as C. sporogenes and C. 
perfringens, are interchangeable, generating biologically active chimeras. As these toxins 
commonly cause gastrointestinal infections in animals and humans this indicates potential 
evolutionary links between these pathogens (Barth et al., 2004; Geric et al., 2006). This 
relatedness demonstrates that binary toxin synthesis in these species may have resulted 
from a shared evolutionary past, supporting the hypothesis that there may have been a 
common ancestor from which C. difficile evolved. 
 
Table 1.3: Binary Toxins that modulate the actin cytoskeleton 
The binary toxins depolymerise actin filaments and alter cell barriers using ADP- ribosylation. 
 
 
 
CDT is located on a 4.3 kb chromosomal locus, and is composed of two unlinked 
molecules needed for toxin activity; CDTa and CDTb, of which CDTa is the enzymatic 
component and CDTb is the binding component (Perelle et al., 1996; Geric et al., 2006). 
The binary toxin is an ADP (adenosine diphosphate) ribotransferase which affects the 
actin cytoskeleton of cells and is known to cause fluid accumulation in rabbit ileal loops 
(Geric et al., 2006). In C. difficile, binary toxins are usually produced by variant strains 
(Table 1.3), and it has been suggested that binary toxin production contributing to the 
virulence of emerging epidemic strains although the significance of this contribution is 
widely debated (Barth et al., 2004).  
 
 
Pathogenic  
Species 
Toxin Components  Cellular 
Targets 
Substrate 
 
C. difficile 
 
CDT 
 
 
CDTa (Enzyme, 48 kDA) 
CDTb (Binding, 94 kDa) 
 
Cellular & 
Muscular G-
actin 
 
[Modification  
sites all at 
Arg 177] 
 
α- and β/γ Actin 
    
C. perfringens E Iota 
 
Ia (Enzyme, 48 kDa) 
Ib (Binding, 98 kDa) 
α- and β/γ Actin 
    
C. spiroforme CST Sa (Enzyme, 44 kDa) 
Sb (Binding, 92 kDa) 
α- and β/γ Actin 
     
C. botulinum C, 
D 
C2 
Toxin 
C2I (Enzyme, 49 kDa) 
C2II (Binding, 81 kDa) 
Cellular G-
actin 
β/γ Actin 
   -  
B. cereus VIP VIP1 (Enzyme, 52 kDa) 
VIP2 (Binding, 80 kDa) 
- α- (?) and β/γ 
Actin 
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The contribution of CDT to strain virulence is widely debated. Recently CDT has been 
shown to cause rearrangements in human colonic carcinoma cells, forming long (150 mm) 
microtubules that wrap and embed clostridia in the gut, thus leading to the theory that 
CDT assists colonisation by increasing adherence of the pathogen (Schwan et al., 2009). 
Indeed this phenomenon is not confined to CDT and is shared with the C2 toxin of C. 
botulinum and the Ia toxin of C. perfringens suggesting that binary ADP- ribosylating 
toxins play an important role in pathogenesis (Schwan et al., 2009). 
 
CdtB binds to host cells via specific receptors as “B” monomers which are generated post 
proteolysis of the “B” precursor molecule, which then form heptamers as the toxin binds 
to the cell surface/ solution. The heptamer complex then acts as a docking platform that 
translocates CdtA into the cytosol by acidified endosomes, where it ADP-ribosylates G 
actin molecules (Barth et al., 2004; Rupnik et al., 2009). ADP ribosylation of G actin 
occurs at Arginine 177, thus blocking actin polymerisation (Schwan et al., 2009). This 
results in cytoskeletal disarray, cell death, proteolysis of mitogen activated protein kinases 
(MAPK) which subsequently inhibit cell signalling; or result in an increase of intracellular 
levels of cyclic AMP (adenosine monophosphate) leading to oedema and 
immunosuppression (Barth et al., 2004).  The prevalence of binary toxin producing strains 
of C. difficile is 1-6% (Stare et al., 2007). C. difficile strain CD630 is CDT negative, but 
has regions which possess similarity to the binary toxin regions, thus representing a 
truncated CDT locus.  
 
1.4.8. Genetic plasticity of the C. difficile 630 genome  
The sequencing of the C. difficile 630 chromosome has revealed a highly plastic and 
mobile genome with relatively high number of genetic elements such as introns, 
transposons, prophage and insertion sequence (IS) elements (Bruggeman & Gerhard, 
2009). Lateral gene transfer of mobile elements such as these brings about sequence 
reassortments in bacterial genomes. In human bacterial pathogens the majority of genes 
acquired in this way confer pathogenicity and resistance to antibacterial agents (Woodford 
& Johnson, 2004).  
 
The existence of ten CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) 
elements within the genome supports the idea that C. difficile has an acquired immunity 
(Sebaihia et al., 2006; Karginov & Hannon, 2010). The spacer regions in the CRISPR 
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elements are homologous to bacteriophage and plasmid sequences and are thought to 
confer resistance to prophage infection (Sorek et al., 2008). Sebaihia and colleagues have 
described CRISPR sequences as sampling agents, preserving a record of all foreign DNA 
encountered by the cell. The CRISPR element in C. difficile is encoded on mobile 
elements: two prophage (CD0904-979 and CD2889-2952), and a skin element discussed 
in Section 1.3.4.2. The genes located near the CRISPR regions are known as cas genes. 
These genes are thought to be linked to the CRISPR–mediated acquired immunity through 
RNA interference systems, recognised as the CRISPR-cas system (CASS) (Bruggeman & 
Gottschalk, 2009). The overall function of CRISPRs is yet to be elucidated. Interestingly, 
their frequency in the 630 genome is the highest identified in any bacterium to date 
(Bruggeman & Gottschalk, 2009). 
 
Seven conjugative transposons have been also been identified in strain 630 which carry 
the majority of antibiotic resistance genes in the genome and exhibit 58-77% similarity to 
the vancomycin resistance locus in Enterococcus faecalis (Sebaihia et al., 2006). One 
particular transposon Tn5397 harbours a group II intron capable of entering into the 
genome at specific sites via self splicing from mRNA (Mullany et al., 1996; Bruggeman 
& Gerhard, 2009). Sebaihia et al. (2006) have also identified several copies of chimeric 
genetic elements within the C. difficile 630 genome called IStrons which comprise of an 
insertion sequence and a group 1 intron. IStrons merge the high mobility of insertion 
sequences with the exact splicing of introns for excision by mRNA and are not usually 
found in bacterial genomes (Bruggeman & Gerhard, 2009). These were first identified in 
strain C34 by Braun et al. (2000) where a copy inserted itself into gene tcdA. The IStron, 
however, did not affect toxin A production as it was excised accurately from the primary 
transcript, thus allowing toxin expression. This demonstrates the high genomic plasticity 
within the 630 genome and as further sequencing projects are completed (R20291 and 
several other strains - http://www.sanger.ac.uk/Projects/C_difficile/) more light will be 
shed about the C. difficile genome. 
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1.5. MOLECULAR GENOTYPING OF C. DIFFICILE 
1.5.1. General typing methods  
Genotyping of pathogenic bacteria, such as C. difficile, enables the source of outbreaks to 
be identified and aids in understanding the epidemiology of disease. Currently there are a 
range of techniques used to type C. difficile. These include toxinotyping, pulsed field gel 
electrophoresis (PFGE), PCR ribotyping, multilocus sequence typing (MLST), multilocus 
variable-number tandem-repeat analysis (MVLA) and restriction endonuclease analysis 
(REA). Each is described in this section in detail (Table 1.4; Rupnik et al., 1998; Marsh et 
al., 2010). 
 
Pulsed field gel electrophoresis (PFGE) is based on the digestion of chromosomal DNA 
by restriction enzymes that cleave and produce HMW fragments (~10Mb) that are 
separated in agarose gels by a complex form of electrophoresis. The electrical field 
regularly changes orientation causing the DNA to also alter its direction (Primrose & 
Twyman, 2007). PFGE has been widely used to type outbreaks of C. difficile; however 
many strains (Serogroup G) are not typable by PFGE due to rapid degradation of DNA 
during the procedure resulting in undistinguishable smears (Bidet et al., 2000; Alonso et 
al., 2005).  
 
PCR ribotyping is the most common method for typing of C. difficile, and is based on 
identification of mutations within the 16S-23S rRNA intergenic spacer region (Stubbs et 
al., 1999). Primers complementary to the 3’ end of the 16S rRNA gene and to the 5’ end 
of the 23S rRNA gene are used to amplify the variable length intergenic spacer region 
(Bidet et al., 2000). PCR ribotyping is faster than PFGE and is able to type strains from a 
range of serogroups. Indeed, Stubbs et al. (1999) have created a library of 116 distinct 
types of C. difficile based on PCR ribotyping. 
 
Multi locus sequence typing (MLST) has been used to type C. difficile, but its 
discriminatory power is the subject of debate. Indeed Killgore et al. (2008) completed a 
review of seven typing methods for C. difficile and concluded that MLST was better suited 
to investigations of population structure (Marsh et al., 2010). MLST genotyping has been 
developed for investigation of clonal relationships between bacterial populations and for 
global epidemiological analyses using nucleotide sequences of housekeeping genes 
(Woodford & Johnson, 2004; Griffiths et al., 2010). Each allele is assigned a unique 
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sequence type number and laboratories can perform their own MLST analyses and keep 
control of their data using MLST databases (http://pubmlst.org/). Surprisingly there is only 
a single report of C. difficile MLST which was conducted by Lemee et al. (2004), despite 
its high throughput and portability between research laboratories (Dawson et al., 2009).  
 
Multilocus variable-number tandem repeat analysis (MVLA) is based on PCR 
amplification and fragment analysis of repeat loci. Amplification is cheap and yields 
results quickly (Marsh et al., 2006). Indeed MVLA is a highly discriminatory method for 
C. difficile genotyping and useful to distinguish between strains from different outbreaks 
(Marsh et al., 2010). Restriction endonuclease analysis (REA) is able to distinguish sub-
types of C. difficile (Dawson et al., 2009). REA is a standard in C. difficile genotyping and 
has been instrumental in the typing of the current B1/NAP1 clone strains (Marsh et al., 
2006). The technique however is not readily transportable between laboratories as 
interpretation of REA banding patterns is subjective. For accurate comparison bacterial 
strains must be run on the same gel which requires exchange of reference strains between 
research groups (Zaisz et al., 2009). 
 
Amplified fragment length polymorphism (AFLP) analysis has also been used for typing 
of C. difficile. AFLP involves amplification of multiple genomic restriction fragments by 
PCR, resulting in high-resolution sub-genomic fingerprints (Klaassen et al., 2002). It has 
been found that AFLP is more reliable at genotyping C. difficile than PFGE (Klaassen et 
al., 2002). Arbitrarily primed PCR has also been used as a genotyping technique; however 
the technique does not provide adequate discriminatory power to distinguish genotypes 
and suffers from lack of reproducibility (Marsh et al., 2006). Surface layer protein (Slp) 
gene A sequence typing has been used as a reproducible method for genotyping (Kato et 
al., 2005). 
 
An analysis carried out by Killgore and colleagues (2008) compared seven genotyping 
techniques; REA, PFGE, PCR-ribotyping, MLST, MVLA and SlpA sequence typing, and 
found there is no single method that is easily transportable between research laboratories 
which has a high level of discrimination (Killgore et al., 2008).  
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Table 1.4: Comparison of Molecular Genotyping Techniques 
A general comparison of molecular genotyping techniques used for C. difficile is shown. The most widely 
used method of genotyping is PCR ribotyping which is able to recognise strains. 
 
 
1.5.2. Toxinotyping of C. difficile 
The toxinotyping methodology was established after 1980 when variant strains of C. 
difficile emerged (Figure 1.16). Subsequent restriction fragment length polymorphism 
analysis of the toxin A and B genes in the PaLoc showed variations in the regions 
encoding toxin A (Bruggeman & Gottschalk, 2009). These variations are the basis for 
distinguishing strains into toxinotype. Toxinotyping is now considered a highly important 
method for understanding the toxin production in C. difficile isolates, and as such has 
changed laboratory diagnosis of disease and scientific understanding of the role of toxins 
in pathogenesis and evolution (Rupnik, 2001; 2008).  
 
In 1985 Delmee et al grouped C. difficile strains into 30 serotypes, of which 9 were of 
variant toxinotype. Currently 15 serogroups are known to be variant (Rupnik, 2008). 
Typing 
Technique 
DNA Target Advantage of Typing Method Disadvantage of Typing Method 
 
PFGE 
 
smaI Restriction 
sites 
 
Molecular fingerprinting technique for 
typing clinical isolates and distinguishes 
between subtypes 
 
Laborious and time consuming. Inter-
laboratory comparisons difficult. DNA 
degradation results in untypeable results 
 
PCR 
Ribotyping 
 
16S-23S rRNA 
Interspacer 
Region 
 
Gold-Standard, recognises many 
strains, easily reproducible and 
portable between laboratories 
 
Limited discriminatory power, doesn’t 
distinguish between sub-types 
 
MLST 
 
 
 
 
MVLA 
 
 
REA 
 
 
 
AFLP 
 
 
 
SlpA 
sequence 
type 
 
Housekeeping 
genes (7 Loci) 
 
 
 
DNA Repeat 
Units 
 
HindIII 
Restriction sites 
 
PstI and MseI 
Restriction sites 
 
 
 
Surface layer 
protein A gene 
 
Easily Reproducible 
 
 
 
 
Can sub-type strains 
 
 
Distinguishes sub-types 
 
 
 
Based on PCR so DNA degradation is 
not an issue 
 
 
PCR amplification is transferable 
between laboratories. Distinguishes 
between sub-types 
 
 
Limited discriminatory power, time 
consuming, doesn’t  distinguish between 
sub-types, limited research conducted in 
C. difficile typing 
 
Can be too discriminatory 
 
 
Laborious and time consuming. Inter-
laboratory comparisons difficult. 
 
 
Uses Fluorescent labels, requires 
appropriate analysis equipment 
 
 
Only uses the sequence of one locus 
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Further studies conducted using PCR ribotyping methods and REA typing show high 
correlation to toxinotyping. Strains of a given ribotype tend to belong to a certain 
toxinotype, however ribotyping remains the more discriminative method as a single 
toxinotype can often include several ribotypes (Stubbs et al., 1999). There are now 31 
known toxinotypes of C. difficile, grouped from toxinotype 0 which is the reference strain 
VPI10463, to XXXI (http://www.mf.uni-mb.si/mikro/tox/) [accessed on 12/2011]. 
 
Toxinotyping is conducted via a restriction fragment length polymorphism- polymerase 
chain reaction – RFLP PCR- method. The 19.6 kb PaLoc region is amplified in order to 
produce ten PCR fragments that are then compared to reference strain VPI 10463 for 
length and restriction site polymorphisms (Rupnik et al., 2008). All toxin genes are 
individually amplified in three fragments (defined by Rupnik et al., 1999) corresponding 
to the catalytic domain (A1 & B1), putative translocation domain (A2 & B2) and the 
repetitive domain of each protein (A3 & B3) (Rupnik et al., 1997). However this method 
has been modified to only amplify the two most variable regions of the PaLoc- regions B1 
and A3 with the restriction enzymes HincII/AccI and EcoRI, and the restriction patterns 
determined. The strains with toxin genes similar to the reference strain VPI 10463 belong 
to toxinotype 0. Strains with similar toxin changes were classified in to variant 
toxinotypes from I - XXVII (Rupnik et al., 2008; Rupnik et al., 2009).  
 
Deletions in the PaLoc are usually found in tcdA and to date no form of significant 
deletion in tcdB is known (Figure 1.17). This may be due to the larger region of repeat 
regions within tcdA compared to tcdB. The presence of such short homologous regions of 
DNA in tcdA may assist in insertion and deletion events in these repeat regions (Rupnik, 
2008). Minor toxinotypes are defined as having variations in only one part of the toxin 
genes, with the sole difference usually being an insertion or deletion in the A3 fragment of 
C. difficile. Major toxinotypes show changes in all three fragments or at least in two 
fragments of both toxin genes (Rupnik, 2008). 
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Figure 1.16: Toxinotyping ORFs of C. difficile 
The restriction fragment areas are shown here in the schematic representation of the 5 open reading frames 
of C. difficile. The toxin A and B genes and accessory genes tcdR, tcdC and tcdE and varying areas where 
restriction enzymes act upon these genes are depicted. Restriction enzymes used: A – AccI, E – EcoRI, Ec – 
EcoRV, H –HindIII, Hc – HincII, N – NsiI, Nc – NcoI, P – PstI, R –RsaI, S – SpeI, X – XbaI 
Taken from http://www.mf.unimb.si/mikro/tox/images/PaLoc%20PCR%20in%20nontox.pdf 
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Figure 1.17: Detailed schematic representation of the PaLoc region  
In toxinotype 0 and representative variant toxinotypes the presence or the absence and the exact positions of 
restriction site are shown: A – AccI, E – EcoRI, Ec – EcoRV, H –HindIII, Hc – HincII, N – NsiI, Nc – NcoI, 
P – PstI, R –RsaI, S – SpeI, X – XbaI. Taken from Rupnik, (2008). 
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1.6. CLINICAL DIAGNOSIS OF C. DIFFICILE 
1.6.1. Diagnostic sensitivity 
Current detection of C. difficile is conducted either invasively in the patient or non-
invasively in the laboratory. Usually the effectiveness of such tests is defined by their 
sensitivity, specificity, and predictive values. The sensitivity in terms of a diagnostic test 
is the proportion of persons with a disease identified as positive for a disease by the assay 
(Altman & Bland, 1994). The specificity in terms of a diagnostic test is the proportion of 
persons without a given condition/disease who are identified by the assay to be negative 
for the condition; thus the assay is specific (Saah & Hoover, 2007).  
 
The diagnostic specificity of an assay is usually lessened by sample contamination; 
however the diagnostic sensitivity and specificity of an assay is very different to the 
analytical sensitivity and specificity. To explain, the analytical sensitivity of an assay 
represents the smallest amount of a substance (bacteria in this case) that can be accurately 
measured by an assay. Thus the analytical specificity of an assay is the ability of an assay 
to measure one particular organism in a sample rather than others (Saah & Hoover, 2007). 
Thus the diagnostic sensitivity and specificity of an assay defines its operational ability- 
but cannot be extrapolated to a clinical setting. 
 
Predictive values are used to measure if an assay will give the correct clinical diagnosis 
(Altman & Bland, 1994). The positive predictive value (PPV) of a test is the probability 
that a person who has a positive test result truly has the disease. To be precise, this means 
the PPV is the number of patients with the disease out of every 100 patients with a 
positive test result who are correctly diagnosed (Altman & Bland, 1994; Saah & Hoover, 
2007). The negative predictive value (NPV) is the probability that a person with a negative 
test result truly does not have the disease; i.e. the NPV is the number of patients without 
the disease out of every 100 patients with a negative test result who are correctly 
diagnosed (Altman & Bland, 1994; Saah & Hoover, 2007). 
 
All these statistical definitions are linked: the higher the diagnostic sensitivity of an assay, 
the better the NPV, and the higher the specificity, the better the PPV (Saah & Hoover, 
2007). Accordingly, if a diagnostic assay has perfect sensitivity and specificity (100%) 
then all persons with positive test results would have the disease, and all persons with 
negative test results would not have the disease. 
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1.6.2. False positives and false negatives 
When performing diagnostic tests it is possible that false positive and false negative 
results can be obtained (Table 1.5). False negative results, where the disease has not been 
detected by the assay can lead to infected patients not being treated for potential CDI and 
increased transmission risk (Planche & Wilcox, 2010). False positive results can also have 
consequences. Importantly they can diminish the diagnostic sensitivity of an assay, cause 
unnecessary introduction of CDAD antibiotic treatment to patients, and in certain cases 
false positive patients may be cohorted with patients who truly have CDI which in turn 
can lead to acquisition of genuine infection (Planche & Wilcox, 2010). Thus an effective 
C. difficile diagnostic assay must be able to define true positives and true negatives. This 
would require a standard reference assay to be developed in CDI diagnosis. 
 
Table 1.5: False Positive and False Negative results   
This table lists the possible explanations of false positives and false negative results. It is important to have a 
diagnostic assay capable of distinguishing true positives and negative cases of CDI (Adapted from 
Woodford & Johnson, 2004). 
 
 
 
 
1.6.3. Diagnostic methods for C. difficile detection 
The sensitivities and specificities for the tests described below are detailed in Table 1.6. 
 
1.6.3.1. Culture 
C. difficile can be detected via its colony morphology and its definitive odour- which has 
previously been likened to horse manure (Aktories et al., 2000). There is a high NPV of 
 
Reasons for False – positive results  Reasons for False - negative results 
In PCR- carry over contamination from previous 
amplified products 
 
 
Inhibition of PCR 
Presence of exogenous target DNA in kits  Inadvertent loss of template nucleic acid targets 
due to poor extraction methods 
Poor primer design (Non specificity of primers)  
 
Poor primer design- (non conserved regions at 
primer sites in variant strains) 
Unfavourable amplication conditions  Poor sensitivity of nucleic acid amplification/ 
detection  in assay 
Contamination through laboratory staff  Digestion of nucleic acid template with DNAses and 
RNAses from exogenous sources 
  Poor specificity/ sensitivity 
  Unfavourable amplification conditions 
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82-92% of odour assessment for the presence of C. difficile infection (Rupnik et al., 
2009). On media colonies are typically cream in colour, and as they age they can fade to 
white and display a fried- egg appearance on agar due to spore formation. Also, when put 
under ultraviolet light, at ~365 nm in wavelength, the colonies can fluoresce chartreuse in 
colour, however this is not universal across strains. It must be noted that colonies grown 
on selective agar called cycloserine-cefoxitin fructose agar (CCFA) first described in 
1979, will auto-fluoresce due to the presence of a neutral red pH indicator (Aktories et al., 
2000).  
 
Culture on CCFA is not very specific as non-toxinogenic isolates can grow, but is very 
sensitive for C. difficile growth, and requires between 40-48 hours incubation (Delmee et 
al., 2005). Culture then requires additional testing to determine if the strain is toxigenic. 
Also ethanol shock has been shown to enhance the isolation of C. difficile pre-inoculation. 
Another alternative of CCFA is CDMN agar: Clostridium difficile moxalactam 
norfloxacin agar, found to be 20% more effective at isolating C. difficile (Oxoid) than 
CCFA (Aspinall et al., 2002). CDMN contains 32mg/l moxalactam, 16 mg/l norfloxacin 
and 0.5 g/l cysteine hydrochloride and has been found to inhibit growth of faecal 
streptococci, other Clostridium species and Bacteroides, unlike CCFA (Aspinall et al., 
2002; Jobstl et al., 2009).   
 
Stool culture, however, is labour intensive with results not available until 76-92 hours, 
thus few laboratories routinely perform stool cultures. Also stool culture does not 
differentiate between toxigenic and non-toxigenic strains; therefore stool culture 
diagnostic tests are usually conducted in conjunction with toxigenic tests in a two step 
algorithm (Goldenberg et al., 2009). This improves sensitivity to 90% and specificity to 
98% (Poutanen & Simor, 2004). Stool culture does however provide an advantage when 
strain typing during an outbreak (Poutanen & Simor, 2004). Toxigenic culture is the 
selective culture of C. difficile followed by confirmation of toxin production (Goldenberg 
& French, 2011). This assay measures toxin production in vitro, which is non-comparable 
to in vivo toxin production, leading to lower specificity. This assay takes 4-5 days to 
confirm the presence of C. difficile (Planche & Wilcox, 2011). 
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1.6.3.2. Cytotoxicity assay 
There is currently no universal standard test for C. difficile, but the cell cytotoxicity assay 
(CCTA) is considered to be the reference “gold standard” (Rupnik et al., 2009). A 
cytotoxic assay is conducted by inoculating a faecal filtrate sample onto cultured cell 
monolayers, which should display a cytopathic effect that is neutralised by a specific cross 
reacting C. sordellii antitoxin if toxin B is present (Delmee et al., 2005). Cultures are 
examined microscopically at between 24-48 hours and either Vero or Hep2 cell lines are 
used (Planche & Wilcox, 2011). CCTA is specific and sensitive, taking between 48-72 
hours for results to be obtained, specifically 24 hours first for cytotoxicity demonstration, 
and 24 hours secondly for neutralisation of toxicity (Poutanen et al., 2004; Goldenberg et 
al., 2009). The diagnostic sensitivity is relatively high; 94- 100% and specificity is 99% 
(Snell et al., 2004). The CCTA however is labour- intensive and expensive as tissue 
culture facilities are required and results are known to vary according to the type of cell 
line supplied and reagents used and only detects toxin B (Poutanen et al., 2004). Thus it 
has been suggested that a two step algorithm of stool culture with CCTA can increase 
sensitivity of CDI detection (Arnold et al., 2011). 
 
1.6.3.3. Enzyme Immuno-Assays 
Enzyme immunoassay (EIA) kits detect either toxins A and B, or only toxin A. EIAs are 
widely available from companies, are easy to perform and are rapid, yielding results 
within 20 minutes to an hour (Tenover et al., 2011). This method is less sensitive than the 
CCTA; even so studies evaluating commercial kits have found most tests to be reliable 
when compared with CCTA (Belanger et al., 2003; Planche et al., 2008; Tenover et al., 
2010). Previous studies have found combined use of EIA and CCTA gives a PPV of 99.5 
% leading to the proposal of a two-step algorithm (She et al., (2009). More recent studies 
have found that EIA kits can deliver false positive results and have sensitivities of 
approximately 60% (Tenover et al., 2010). Indeed some EIAs tested by Planche (2008) 
were found to have overestimated cases of C. difficile by 20%. The findings and concerns 
from Planche et al (2008) were echoed by Eltringham (2009) finding only a 10% PPV. 
Thus EIAs should not be used as standalone tests for CDI. 
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1.6.3.4. Antigen Enzyme Immunoassays: Glutamate dehydrogenase 
Glutamate dehydrogenase (GDH) is a common antigen produced by all C. difficile isolates 
(Lyerly et al., 1991; Carmen et al., 2012). Early commercial GDH tests cross reacted with 
other species, especially C. botulinum, C. sporogenes, and Peptostreptococcus anaerobius 
(Williams & Spencer, 2009). Current commercial tests detect GDH within 15 minutes, and 
cost approximately £6 per test (Inverness Medical, 2009). Although the tests are rapid, 
easy to perform and sensitive, they are not specific for diagnosis of toxinogenic strains, 
thus detection algorithms are still used (Snell et al., 2004; Gilligan, 2008; Eastwood et al., 
2009).  
 
It has been widely suggested that GDH assays should be used in conjunction with CCTAs 
which yields better PPV and NPV (Ticehurst et al., 2006; Fenner et al., 2008). 
Commercial assays, such as the CDIFF Quik Chek Complete (TechLab) have GDH 
detection alongside toxin detection in a lateral flow type of assay (Quinn et al., 2010). 
Swindells et al. (2010) found that this particular commercial assay was highly sensitive 
(100%) and could be relied upon for exclusion of patient carriage of C. difficile as the 
NPV was 100% when compared to both CCTA and stool culture.  
 
Conversely, more recent studies which tested the GDH, EIAs and/ or CCTA combinations 
and/or CCTA, found they missed 23-24% of positive specimens, and some even had 
reduced sensitivity (83.1%) (Sloan et al., 2008; Novak-Weekley et al., 2010). Real time 
PCR and PCR have also been used in these algorithms, invariably having high sensitivity 
and high specificity compared to all other diagnostic methods (Doing et al., 2010). An 
issue with these two/three step algorithms is the turnaround time and cost as the combined 
use of CCTA and GDH assays, or RT-PCR and GDH assays could be costly in terms of 
diagnosis. An ideal assay would also have a rapid turnaround time. Even so, these 
disadvantages can be offset by reducing unnecessary antibiotic usage and infection control 
measures in the hospital and streamlining of isolation facilities within a hospital (Williams 
& Spencer, 2009). Interestingly it has recently been observed that the sensitivity of the 
GDH assays may vary according to PCR ribotype, and that GDH is less sensitive than 
PCR in detection of ribotypes 002, 007 and 106 (Tenover et al., 2010). Hence there is 
some debate regarding the effectiveness of GDH assays; however despite these concerns 
GDH detection does offer a high NPV and may in future partly replace culture methods if 
used in effective algorithms (Fenner et al., 2008). 
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1.6.3.5. Faecal Lactoferrin 
Lactoferrin is a glycoprotein secreted by mucosal membranes and is a component of 
polymorphonuclear leucocytes (Kane et al., 2003). Lactoferrin is highly expressed in 
patients with severe bowel inflammation and also those with C. difficile infection (Wren et 
al., 2009). A test for lactoferrin could be used in conjunction with other tests as an 
algorithm, as with the GDH assays. Indeed Wren et al. (2009) examined the potential of 
faecal lactoferrin tests for use in C. difficile diagnosis, as the correlation between 
lactoferrin production and CDAD is highly significant (Williams & Spencer, 2009). It was 
established that faecal lactoferrin is a useful marker for indication of the presence of 
inflammatory diarrhoea (Wren et al., 2009).  
 
1.6.3.6. Polymerase Chain Reaction 
PCR methods for the detection of C. difficile toxin A or B or both have been developed 
with high specificity and sensitivity, but there is no standardisation of the PCR methods 
and no commercial assays are available (Poutanen et al., 2004). PCR for toxin B has a 
minimum detection limit of 1 x 10
5
 C. difficile per gram of stool, with a sensitivity of 95% 
when compared to CCTA (Goldenberg et al., 2009). The turnaround time though, is rapid 
within 4 hours, but when compared to stool culture sensitivity is reduced to 83.6% with a 
specificity of 98.2%. PCR methods offer greater specificity and sensitivity, although their 
cost is high, but in the future it is possible that detection of toxin B may be reduced due to 
mutations within the PaLoc (Rupnik et al., 2009).  
 
1.6.3.7. Real Time Polymerase Chain Reaction  
Real Time PCR is a very sensitive and specific, targeting specific genes that are associated 
with toxin production (Knetsch et al., 2011). RT PCR requires labour intensive 
purification of the sample before PCR can be conducted resulting in the total time for 
sample preparation and detection to be in excess of 8 hours (Rinttila et al., 2004). The 
method itself is more powerful than conventional PCR and the C. difficile genes detected 
include tcdA, tcdB, tcdC regulator and gluD and 16S genes (Rinttila et al., 2004; Van den 
Berg et al., 2005). RT PCR has high concordance with toxin culture, and thus is widely 
used to detect toxigenic C. difficile strains directly from faeces (Belanger et al., 2003; Van 
den Berg et al., 2007).   
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The commercial assays all target tcdB and include the ProGastro assays for use with the 
Cepheid Smart Cycler, the similar GeneXpert 
TM
 (Cepheid), and the BD Gene Ohm assay 
(Doing et al., 2010). The Xpert and BD Gene Ohm assays have been directly compared to 
stool culture and CCTA, both giving 100% sensitivity but individually for stool culture the 
Xpert and BD Gene Ohm is 97% specific (Table 1.7; Swindells et al., 2010). These new 
RT PCR assays have a relatively rapid turnaround time and when used in conjunction with 
other assays, such as GDH, have high sensitivity (Larson et al., 2004). The commercial 
assays developed to address the issue of turnaround time have led to improved, faster and 
more sensitive assays despite the cost. Even so, a 2 hour assay turnaround is still relatively 
long for a diagnosis to be made.  
 
1.6.3.8. Diagnostic Imaging Methods 
Flexible sigmoidoscopy is used to detect PMC in patients, and is superior to the cytotoxin 
tests (Johal et al., 2004). In rare cases where stool cytotoxin tests may have produced false 
negative results, invasive flexible sigmoidoscopies are used to examine the sigmoid region 
of the colon (Johal et al., 2004). The process takes between 20-30 minutes and causes the 
patient slight pain in the bowel due to the presence of air. 
 
Areas which escape detection via sigmoidoscopies are detected via colonoscopies (Bartlett 
& Gerding, 2008). PMC is often not present using this visualisation technique and as such 
colonoscopies are deemed insensitive. There are also risks of perforation occurring in 
severe cases of colitis. Computed tomography scans are also used for severe cases of 
CDAD, and characteristic features which can be seen in the scans include inflammation of 
the mucosa which can be easily identified by clinicians (Bartlett & Gerding, 2008). 
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Table 1.6: Comparison of current C. difficile detection methods 
The sensitivities and specificities (as described in Section 1.6.1) for each detection method are compared. 
The times to perform the assay and the advantages of each assay are listed.  
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1.6.3.9. Summary of C. difficile diagnostics 
The gold standard for C. difficile diagnosis is the cell cytotoxin neutralisation assay 
against which all other C. difficile diagnostics are measured. There is considerable debate 
as to the effectiveness of the various methods currently used for C. difficile diagnosis, and 
although varying algorithms have been implemented across some laboratories, there is a 
pressing need for the diagnostic methodology to be standardised to enable accurate 
diagnosis and to enable comparisons between laboratories. The widely differing 
sensitivities and specificities of the various assays is a cause for concern as the literature 
and relevant statistics regarding the diagnostics is often confusing, conflicting and limited. 
This is not to say, however, that assays such as RT PCR are not effective- the problem is 
their long turnaround time. Current assays target toxin B of C. difficile (RT PCR and 
CCTA), and EIAs can target toxin B or both toxins A and B; however these tests have 
been suggested to be used in two/three step algorithms to enable accurate diagnosis to be 
made and avoid false negative or positive results. Indeed the limitations of current 
diagnostic assays for C. difficile detection have a considerable impact upon treatment, as 
early treatment of the disease may reduce the spread of the organism and reduce patient 
mortality. Thus there is a pressing need to develop an assay which rapidly detects 
toxigenic C. difficile with ease and has high specificity, sensitivity and predictive values. 
 
 
1.7. TECHNOLOGY FOR PATHOGEN DETECTION 
1.7.1. Microwave-accelerated metal - enhanced fluorescence 
Detection of human pathogens using DNA based assays is often labour intensive and 
costly due to the need for the inclusion of a purification step to remove inhibitory 
biological materials (Section 1.6) (Belanger et al., 2003; Rintilla et al., 2004; Eastwood et 
al., 2009; Knetsch et al., 2011). A new platform technology called microwave accelerated 
metal enhanced fluorescence (MAMEF) has recently been developed which eliminates the 
need for extensive sample purification and has been used successfully to detect pathogenic 
spore formers such as Bacillus anthracis ((Geddes & Lakowicz, 2002; Aslan et al., 2007; 
2008). The approach combines two technologies, metal enhanced fluorescence (MEF) and 
the low power microwave heating of metal, to yield a system with a level of sensitivity 
comparable to that of RT PCR, but with a much shorter turnaround time of 60 seconds. 
There are two key processes involved in MAMEF: firstly DNA extraction from the 
microorganism and secondly the MAMEF itself. To release DNA the microorganism is 
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lysed using low power microwaves in a cavity. The cavity itself comprises a glass slide 
with aluminium triangle structures adhered to the surface and silicone isolators use to hold 
the aqueous solution of microorganisms. The metal used in this activity can be changed 
and more recently a gold “bow tie” triangle has been used for microwave lysis as the 
power generated is higher than aluminium (Figure 1.18; Geddes & Lakowicz, 2002; 
Zhang et al., 2011). Indeed this method is capable of extracting DNA from whole spores 
of B. anthracis and vegetative cells of a range of pathogens (Aslan et al., 2007; 2008; 
Tennant et al., 2011; Zhang et al., 2011). 
 
 
 
 
Figure 1.18: Aluminium “Bow tie” Structure used in MAMEF 
The aluminium triangles are used to extract DNA from the target microorganism. To release DNA the 
microorganism is lysed using low power microwaves in a cavity. The cavity itself comprises a glass slide 
with aluminium triangle structures adhered to the surface and silicone isolators use to hold the aqueous 
solution of microorganisms. Image taken from Aslan et al. (2008). 
 
 
The MAMEF bioassay comprises a silvered glass slide (Silver island film- SiF) which 
contains silver nanoparticles, biomolecules and aqueous media. The silver nanoparticles 
act as a platform for the anchorage of biomolecules, such as DNA probes (specific to the 
microorganism), which is facilitated through the addition of stable thiol groups to the 
DNA (Aslan et al., 2008). Once target DNA from the microorganism adheres to the 
anchored DNA a further reporter biomolecule fluoresces and this fluorescence is enhanced 
by the silver nanoparticles (Geddes & Lakowicz, 2002; Geddes et al., 2003; Aslan et al., 
2007; 2008; 2010; Tennant et al., 2011; Zhang et al., 2011). 
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Microwave power is used to increase fluorescence (hence metal enhanced fluorescence) as 
the excited fluorophores transfer their energy to the silver nanoparticles and are 
subsequently thought to become more photostable. The energy is transferred via surface 
plasmons which are fluctuations in electron density at the surfaces of metal, which 
become excited when they react with a photon (Aslan & Geddes, 2008). For MEF silver is 
currently used as the metal, but in the rationale for MEF can apply to any metal that 
supports plasmon resonance (Aslan & Geddes, 2008). Silver is employed firstly as 
platform for bimolecular recognition events to occur, secondly as an amplifier of 
fluorescent signatures, and thirdly a low temperature surface (during microwave heating) 
to create a temperature gradient. As the metals are not heated by the microwaves, they 
remain at a lower temperature than the water, thus causing mass transport of warmer 
biomolecules to the colder silver nanoparticles on the surface (Aslan et al., 2005). 
 
In the case of the B. anthracis DNA assay focussed microwave heating with pulses of 20 
seconds was found to be sufficient to extract DNA from vegetative organisms and whole 
spores (Aslan et al., 2008). Indeed the focussed microwaves were capable of inducing 
structural changes in the spores which was visualised via transmission electron 
microscopy (TEM) (Figure 1.19; Aslan et al., 2010). Specifically for the MAMEF 
component of the assay a single stranded nucleotide anchor probe (Figure 1.20), with a 
nucleotide sequence specific to B. anthracis DNA, was attached to the silvered film and 
target B. anthracis oligonucleotide and a fluorophore labelled oligonucleotide were 
incubated alongside an anchor DNA probe and subsequently low power microwave 
heating for 30 seconds was employed for MEF (Aslan et al., 2010). Thus the total time for 
B. anthracis detection was < 60 seconds. 
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Figure 1.19: Extraction of B. anthracis DNA 
(a) Transmission electron microscopy (TEM) images of B. anthracis spores before and after low power 
microwave heating. (b) TEM images of vegetative organisms both before and after 20 low power microwave 
exposure between aluminium triangles. (c) Gel electrophoresis study of DNA extracted from vegetative 
cells. The markers are shown in lanes 1 and 2, and in lane 3 DNA can be seen from unmicrowaved 
vegetative cells, and in lane 4 DNA can be seen from microwaved spores. (Taken directly from Aslan et al., 
2010). 
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Figure 1.20: Probe design for B. anthracis assay 
This image shows the configuration for the DNA based hybridisation MAMEF assay designed specifically 
for B. anthracis. The anchor probe is adhered to silvered glass, and when hybridisation occurs the 
fluorescent probes fluoresces. Image taken directly from Aslan et al., (2007). 
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1.8. AIMS AND OBJECTIVES OF STUDY 
1.8.1. Hypothesis 
 
 We hypothesise that the structure and physical properties of the spore form of C. difficile 
contributes to the virulence of the organism and to the ability to release DNA following 
microwave treatment. 
 
 Based on bioinformatic analysis of the whole genome of C. difficile we hypothesise that 
the pathogen may have evolved from an ancestor which was an insect pathogen. 
 
 We hypothesise that the toxin genes within C. difficile may have been acquired through 
horizontal gene transfer over its evolution from other bacteria. 
 
 We hypothesise that the toxin genes may also have been a relic of an insect associated 
toxin ancestor gene, and indeed genes within the whole genome may also have some 
insect associations. 
 
 Our final hypothesis is that the nucleotide sequences of toxin A and toxin B genes contain 
conserved regions encoding structures essential to the biological function of each toxin. 
The conserved nature of these sequences make them ideal target for detection probes. 
 
 
1.8.2. Aims  
The main aim of this thesis was to design an assay based on conserved highly specific 
regions of toxin A and B capable of detecting the presence of toxigenic C. difficile in a 
faecal samples within 60 seconds. The clinical application of such a detector would be to 
rapidly diagnose potential C. difficile infection within patients, thus allowing clinicians to 
determine the best course of treatment for the patient, preventing cross infection and 
further development of PMC.  
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The specific aims of this PhD are: 
 
1. To characteristic the structure of C. difficile spores with a view to understanding its 
contribution to adherence and pathogenicity 
 
2. To employ a bioinformatic based approach to investigate the evolutionary origins.  
 
3. Determine the ability of C. difficile to infect and colonise invertebrates with a view to: 
i) Understanding the biological history of the pathogen. Did it originally evolve as 
an insect pathogen? 
ii) Determine the feasibility of establishing a non-mammalian infection and 
colonisation model. 
iii) To provide a model system with which to assess the efficacy of a C. difficile 
detection assay.  
 
4. To identify conserved genetic signatures within toxins A and B of C. difficile using a 
bioinformatics based approach which could form the basis of a specific diagnostic assay. 
 
5. To determine the specificity of conserved genetic signatures against a range of C. 
difficile isolates, related species and unrelated species for specificity. 
 
6.  Incorporate specific toxin A and B probes within the MAMEF technological platform 
and determine its ability to detect the presence of bacterium in a range of organic matrices 
including faeces. The sensitivity of the assay will also be determined.
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2.1. ABSTRACT 
C. difficile, a Gram positive spore-forming bacterium, is the commonest cause of hospital 
acquired infection in the United Kingdom. Its prevalence is partly due to its ability to 
produce resistant spores, enabling the organism to colonise healthcare environments and 
infect susceptible individuals. In preliminary studies the composition of culture media had 
a marked effect on the ability of individual clinical C. difficile isolates to form spores and 
germinate.  
 
To determine if spore structure contributed to surface binding we characterised the surface 
properties of spores produced by 21 clinically relevant isolates with regards to their 
hydrophobicity and ability to adhere to hospital grade stainless steel. Overall, isolates of 
hypervirulent ribotype 027 and UK epidemic ribotypes 001, 078 and 106 appeared to be 
more hydrophobic than isolates occurring less frequently in the UK. We also found that 
spores of highly hydrophobic isolate DS1813 (ribotype 027) adhered more strongly to 
human gut epithelial cell lines Caco-2 and HT-29 than spores of lowest hydrophobic 
isolate DS1748 (ribotype 002).  
 
Examination of the structure of spores from a range of clinical isolates by electron 
microscopy revealed differences: most notably the presence of a pronounced exosporium 
layer surrounding hydrophobic DS1813 spores. This outer layer is thought to contribute to 
hydrophobicity and spore attachment, and appeared to be absent from spores of other 
strains examined. Based on these results we hypothesise that differences in spore surface 
properties could contribute to the spread and prevalence of virulent strains of C. difficile.  
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2.2. INTRODUCTION 
C. difficile is an anaerobic, spore-forming Gram positive bacterium implicated as the 
primary cause of antibiotic associated diarrhoea in the UK. Between 2004 - 2008 C. 
difficile was involved in 10.5 per 1000 deaths in England and Wales, compared to 3 per 
1000 deaths for Methicillin Resistant Staphylococcus aureus (Office of National Statistics, 
2010). Alterations in colonic microbiota, usually due to broad spectrum antibiotic 
treatment, is thought to increase sensitivity to C. difficile infection enabling the vegetative 
organism to produce potent cytotoxins which destroy intestinal epithelial cells, increase 
vascular permeability and ultimately leads to the formation of pseudomembranes 
composed of neutrophils, fibrin, mucosa and cellular debris as described in Section 1.2 
(Poutanen & Simor, 2004; Rupnik et al., 2009). The subsequent bloody diarrhoea results 
in the release of large numbers of spores into the environment.  
 
The formation of spores occurs when the vegetative organism is subjected to some type of 
stress, usually nutritional limitation, and allows the organism to survive in a dormant state 
until conditions improve- a situation that can be anything from a couple of months to  
several years
 
(Setlow, 2003). Indeed it is this ability to form spores which enables the 
bacterium to survive outside of the anaerobic environment of the gut and spread from 
person to person within healthcare facilities. In addition to protecting the organism from 
the toxicity of oxygen and a shortage of nutrients the spore also confers increased 
resistance to general-purpose disinfectants; a property which is thought to contribute to the 
transmission of the organism as a consequence of ineffectual disinfection (Cardiff & Vale 
NHS, 2007; Rupnik et al., 2009).  
 
It has been suggested that sub-inhibitory levels of non-chlorine based hospital cleaning 
agents may exacerbate the problem of transmission by stimulating epidemic strains of C. 
difficile to convert to chemically resistant spores and thereby avoid the attentions of the 
biocide (Ronner et al., 1990; Fawley et al., 2007). As well as conferring resistance to 
chemical insult, the spore also contributes to transmission by mediating attachment to 
surfaces commonly found in the healthcare environment, such as bed linen and stainless 
steel (Hellickson & Owens, 2007). This ability to attach to surfaces further increases 
biocide resistance, particularly in the presence of organic matter such as faeces, and as 
such presents a considerable challenge for those seeking to break the infection cycle. 
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The attachment of a spore to a specific surface is primarily influenced by the hydrophobic 
properties of the surface, the spore, and to a lesser degree by spore surface structures such 
as appendages and an exosporium (Doyle & Rosenburg, 1990; Husmark & Ronner, 1992; 
Klavenes et al., 2002; Setlow, 2003). The exosporium is a loose outer layer which 
surrounds spores produced by some, but not all, members of the Bacillus and Clostridium 
spp. including C. difficile (Henriques & Moran, 2007). The spore architecture of Bacillus 
and Clostridium spp. is highly similar as shown in Figure 2.1 and Section 1.3.4. Whilst the 
morphology of spores has been well understood, its protein composition and structures 
have yet to be fully elucidated (Husmark & Ronner, 2002). 
 
 
 
Figure 2.1: Clostridium difficile spore of strain 630 
This transmission electron microscopy images clearly shows the layers of the spore in detail. The spore 
comprises of a core which contains ribosomes. Surrounding the electron dense core is a membrane further 
enveloped by a cortex layer which in itself is formed of concentric layers (Driks, 2004). These areas function 
to protect the spore and keep it dry (Driks, 2009). The spore is also surrounded by an exosporium layer. This 
image was taken from Lawley et al. (2009). 
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It has been suggested that the hydrophobicity of the exosporium plays a key role in 
attachment to environmental and cellular surfaces (Koshikawa et al., 1989). The 
hydrophobicity of the exosporium of enterotoxigenic isolates of Bacillus cereus enables 
the spore form of this organism to adhere to environmental surfaces and resist cleaning 
and rinsing procedures (Faille et al., 2002). In addition a correlation has been 
demonstrated between spore hydrophobicity and the ability of pathogenic isolates of B. 
cereus to adhere to human colon carcinoma cells, germinate and express their exotoxins 
(Andersson et al., 1998). 
 
Following attachment to the intestine the spores of C. difficile must also germinate and 
express toxins if they are to initiate an infection. The mechanisms by which spores of C. 
difficile determine that conditions have improved sufficiently to support growth have yet 
to be fully elucidated. In the case of other spore forming organisms such as Bacillus spp, 
specific receptors within the spore have been identified which respond to LMW 
germinants such as amino acids, nucleosides, sugars, or salts and initiate germination 
(Moir, 2006). Somewhat surprisingly, given that the proteins involved in germination are 
remarkably conserved across the Bacilli and Clostridia, bioinformatic analysis of the 
genome sequence of C. difficile strain 630 has failed to reveal the presence of homologs to 
known germinant receptor genes (Sebaihia et al., 2006; Lawley et al., 2009). While 
specific receptors have not been identified studies have shown that in vitro C. difficile 
spore germination is triggered by the amino acids glycine, alanine, cysteine and 
phenylalanine as well as the bile salt taurocholate. The bile salt chenodeoxycholate 
inhibits taurocholate-induced C. difficile spore germination (Giel et al., 2010).  
 
It has recently been hypothesized that C. difficile spores require the presence of 
taurocholate and glycine to trigger germination in the gut. Thus spores remain dormant in 
the lower intestine while the available taurocholate is deconjugated to cholate and taurine 
by members of the commensal microbiota. Treatment with broad spectrum antibiotics 
subsequently alters the composition of the gut microbiota such that organisms which 
deconjugate taurocholate are inhibited allowing the local concentration of taurocholate to 
increase and the concentration of inhibitory chenodeoxycholate to decrease. As a 
consequence C. difficile spores bind both taurocholate and glycine and thus trigger 
germination (Rameirez et al., 2010). 
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2.3. RESEARCH AIMS 
The aims of this chapter are to: 
 
 Determine if media composition affects the ability of C. difficile to form spores and 
germinate 
 Understand if spore surface structure plays a role in virulence 
 Establish if spores are able to adhere to a range of surfaces, including hospital grade 
stainless steel and human adenocarcinoma colonic cell lines 
 Examine any potential differences in the surface structure of spores of varying strains 
using electron microscopy 
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2.4. MATERIALS & METHODS 
2.4.1. Strains, growth conditions and media composition 
The clinical isolates of C. difficile used in this study are shown in Table 2.1 and were 
obtained from the National Anaerobic Reference Unit, Cardiff Wales, except strain 
CD630 which was obtained from the National Collection of Type Cultures (NCTC), 
Health Protection Agency, UK. Bacillus atrophaeus ATCC 9372 was purchased from 
American Type Culture Collection, (ATCC, Rockville, MD, USA).  
 
Table 2.1: Strains of Clostridium difficile used in this study 
The bacterial species and strains listed above were used in this study. These strains are clinically relevant 
isolates obtained from the National Anaerobic Reference Unit, University Hospital Wales, Cardiff, courtesy 
of Dr. J. S. Brazier and Dr. Val Hall. The strain designation, isolate source and the PCR ribotype are listed.  
 
Clostridium difficile Strains PCR Ribotype Source Toxin Production 
DS1759 001 Maidstone tcdA
+ 
tcdB
+
 
DS1747 001 St. James, Leeds tcdA
+ 
tcdB
+
 
R8652 001 NCTC tcdA
+ 
tcdB
+
 
DS1750 001 St. James, Leeds tcdA
+ 
tcdB
+
 
DS1813 027 Hinchingbrooke tcdA
+ 
tcdB
+
 
DS1801 027 Leicester tcdA
+ 
tcdB
+
 
R20291 027 Stoke-Mandeville tcdA
+ 
tcdB
+
 
DS1807 027 Salford tcdA
+ 
tcdB
+
 
R10459 106 Dudley tcdA
+ 
tcdB
+
 
DS1798 106 Poole tcdA
+ 
tcdB
+
 
DS1787 106 Leicester tcdA
+ 
tcdB
+
 
DS1771 106 Bristol Southmead tcdA
+ 
tcdB
+
 
DS1742 014 Bristol Frenchay tcdA
+ 
tcdB
+
 
DS1748 002 Leeds tcdA
+ 
tcdB
+
 
DS1721 005 Leicester tcdA
+ 
tcdB
+
 
DS1752 012 Bradford tcdA
+ 
tcdB
+
 
CD630 012 NCTC tcdA
+ 
tcdB
+
 
DS1723 078 Leicester tcdA
+ 
tcdB
+
 
DS1724 020 Leicester tcdA
+ 
tcdB
+
 
DS1684 010 Brighton tcdA
- 
tcdB
-
 
DS1665 023 Bath tcdA
+ 
tcdB
+
 
Other Species    
Bacillus atrophaeus ATCC 
9372 
 ATCC  
 
Cultures of C. difficile were grown in brain–heart infusion (BHI) broth and agar (Oxoid, 
Basingstoke, Hampshire, UK) unless otherwise indicated. Others were grown on 
Columbia agar media. Media was degassed in anaerobic conditions (a mixture of 80% N2, 
10% CO2 and 10% H2) for 24 h prior to use. Cultures were incubated anaerobically at 
37
o
C for 48 h in a Bug Box Plus anaerobic cabinet (Ruskinn Technology Ltd, Bridgend, 
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Wales). Cultures were tested for purity by streaking pure colonies onto BHI agar and re-
incubating. To enable germination of C. difficile spores, 1% (w/v) of the bile salt sodium 
taurocholate (ST) (Sigma Aldrich, Dorset, UK) was added to specified media before 
autoclaving. Colonies were streaked to purity. Columbia agar and broth (Difco, Franklin 
Lakes, NJ, USA) was also used in experiments in this Chapter.  
 
Media composition: Columbia agar media (Difco, USA) contained approximately per 
litre: Pancreatic Digest of Casein (12.0 g) , Peptic Digest of Animal Tissue ( 5.0 g), Yeast 
Extract  (3.0 g), Beef Extract  (3.0 g), Corn Starch (1.0 g), Sodium Chloride  (5.0 g), Agar 
(13.5 g), Colistin (10.0 mg), Nalidixic Acid (10.0 mg). Brain Heart Infusion agar (Oxoid 
Ltd, Basingstoke, UK) contained approximately per litre: Calf brain infusion solids (12.5 
mg), Beef heart infusion solids (5.0mg), Protease peptone (10.0mg), Sodium chloride 
(5.0mg), Glucose (2.0 mg), Disodium phosphate (2.5 mg), Agar (10.0 mg). 
 
2.4.2. Spore production and enumeration  
To produce spores, a single colony harvested from the appropriate agar plate was used to 
inoculate 10 ml of the corresponding degassed broth which was incubated for 10 d at 37
ο
C 
in the anaerobic workstation. At the end of this period the cultures were centrifuged 
(Heraeus Biofuge primo R, Fisher, UK) at 5 000 x g for 15 min at room temperature and 
the supernatant discarded. The retained pellet was resuspended in 10 ml sterile deionised 
water (sdw) and centrifuged at 5 000 x g again. This washing cycle was repeated a further 
two times at the end of which the spore pellet was resuspended in 1 ml of sdw and heated 
in a heating block (Techne, driblock, UK) to 80
o
C for 10 min to inactivate any remaining 
vegetative cells and stored at 4
o
C. 
 
The number of spores produced following broth culture was determined using a method 
based on that of Miles & Misra (1938). An aliquot of 20 µl of extracted spores was 
serially diluted in degassed sterile broth media (180 μl) using a microtitre plate (Sterilin 
Ltd., Teddington, Middlesex, England) until a dilution down to 10
-10
 was achieved. A total 
of three 10 µl aliquots from each dilution were spotted onto the surface of the appropriate 
degassed agar plates (neat to 10
-10
). Once inoculated, spots were allowed to dry at 25
o
C 
and the plates were incubated anaerobically for 48 h at 37
o
C. Colony forming units (cfu) 
were counted from each spot on the microtitre plate and the mean number of colony 
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forming units per millilitre (cfu/ml) determined by multiplying the mean cfu by the 
dilution factor. Unless otherwise stated all organisms were stored as spores at 4
o
C.  
 
2.4.3. Transmission Electron Microscopy studies 
Spore samples produced as described in Section 2.4.2 (1 ml) were centrifuged at 2 000 x g 
for 4 min. The supernatant was removed and pelleted spores were fixed with 1 ml of a 2% 
(v/v) glutaraldehyde and 2% (v/v) Osmium tetroxide mix. This was left for 1 h at 22
o
C, 
after which the Osmium tetroxide- spore mix was centrifuged (Heraeus Biofuge primo R, 
Fisher, UK) at 2 000 x g for 2 min. BHI agar was prepared (3 g to 50 ml water) and 
molten agar (50
o
C) added to the stained spore pellet and left to set. The extra agar around 
the spores was removed and the agar-embedded spore pellets were dehydrated through an 
ethanol series from 50% ethanol to 100% alcohol for 10 min each. The 100% dehydration 
was repeated three times, and the ethanol was replaced with propylene oxide (PO) for 15 
minutes. 
 
Epoxy resin was composed of a mixture of araldite CY212, dodecyl succinic anhydride 
(DDSA) and benzyldimethylamine (BDMA) (Sigma-Aldrich, Dorset, UK). An equal 
quantity of PO was added to the resin and used to cover each spore pellet. The pellet was 
left for 36 h to allow resin infiltration. PO mixture was subsequently removed and pure 
Epoxy resin (Sigma-Aldrich, Dorset, England) was added to the samples which were 
embedded into a flat moulded tray and left in an oven at 60
o
C to harden for 48 h. 
Transverse sections were cut on a Microtome (Reichert-Jung, Depew, NY, USA) and 
stained on nickel grids with uranyl acetate and lead citrate. Images were taken on the 
Transmission Electron Microscope (Philips EM 208). Of each strain sample examined 
under TEM, 10 spores were viewed. 
 
2.4.4. Negative-stain electron microscopy of whole spore  
Spore samples were diluted in sdw, placed on Formvar-coated grids and examined after 
negative staining in 2% (w/v) methylamine tungstate. After 15–30 s the excess stain was 
withdrawn using filter paper. The grids were washed twice with water and dried by filter 
paper. Samples were examined immediately using a Phillips EM 208 transmission 
electron microscope with an accelerating voltage of 80 kilovolts (kV), and magnifications 
between 20,000 x and 55,000 x were used. 
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2.4.5. Microbial adhesion to hydrocarbon test 
To determine the hydrophobic characteristics of individual C. difficile spores from a range 
of isolates we used a hexadecane hydrocarbon based microbial adhesion to hydrocarbon 
test (MATH). The MATH assay has been commonly used to ascertain hydrophobic 
characteristics of bacteria and it is hypothesized that hydrophobic bacteria are more likely 
to adhere to the hydrocarbon and the hydrophilic bacteria tend to remain in water 
(Rosenberg et al., 1980). Thus the C. difficile spores of each isolate were suspended in 9 
ml of sdw to achieve an optical density of between 0.500-0.600 at OD600 (Ultrospec 1100 
pro UV/Visible spectrophotometer, Biochrom, Cambridgeshire, UK). A 4 ml aliquot of 
spore suspension in a Universal container was vortex mixed (VortexGenie, Fisher 
Scientific, UK) with 0.4 ml of the hydrocarbon n-hexadecane (Sigma-Aldrich, Dorset, 
England) at full speed for 1 min. The mixture was incubated at room temperature (22
o
C) 
for 15 min to allow the different phases to partition settle. Subsequently the optical density 
of the lower aqueous phase was determined. Each assay was repeated twice. Changes in 
hydrophobicity were calculated as a percentage from original OD600 to the final OD600 
post hexadecane exposure. 
 
2.4.6. Contact angle measurements 
To ascertain the hydrophobic characteristics of the surfaces tested in this study we 
employed a contact angle test upon the hospital grade stainless steel discs and the agar. 
The contact angle between the test surface and a droplet of water was measured using a 
horizontal projection technique. Briefly, a droplet of water was put onto the stainless steel 
disc and the agar and a light was used to project the image. The projection allows a crude 
measurement of the contact angle between the droplet and the surface using a protractor, 
the hypothesis being that the contact angle between the water and a hydrophobic surface 
(steel) would be less than the contact angle between the water and a hydrophilic surface 
(agar). 
 
2.4.7. Stainless steel plate transfer assay 
In order to assess adherence of spores to a hospital grade stainless steel surface and an 
agar surface considered to be representative of a hydrophilic surface, we employed a spore 
transfer assay. A stainless steel disc 2 cm in diameter with a Grade 2B finish 
(Goodfellows Cambridge Ltd, Huntingdon, UK) was inoculated with 10 μl of spore 
suspension (500 spores per 10 μl in units of cfu/μl) and left to dry at 25oC for 20 min. The 
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inoculated steel discs were aseptically attached to a steel rod plunger and securely fastened 
into the supporting metal frame as seen in Figure 2.2 (IKA, Labortechnik, Staufen, 
Germany). An electronic weighing balance was secured to a raising platform and 
positioned beneath the metal plunger. Either side of the platform, two Bunsen burners 
created a sterile vortex of air encompassing the platform area. A degassed BHI agar plate 
was placed directly under the metal plunger, on the tared electronic balance. The platform 
and balance were raised until the steel disc compressed the agar surface with a force of 
100 g (+/-5g) and held for 10 s. The balance was lowered; the agar plate replaced with 
another and the compressing process repeated a total of sixteen times for each inoculated 
disc. The compressed agar plates were anaerobically incubated at 37°C for 48 hours and 
the number of cfu on each plate counted. Sixteen strains of C. difficile were tested (Figure 
2.8). 
 
 
 
Figure 2.2: Plate transfer assay for spore transfer 
This image shows the transfer apparatus used to assess spore transfer from stainless steel. A: Apparatus set 
up for spore transfer. The plunger is attached to a supporting metal frame. To maintain a sterile environment 
a Bunsen burner is placed either side of an electronic balance with a BHI agar plate on it. The balance was 
tared with each agar plate and the spores plunged at a force of 100 g/ 10 s. B: An inoculated stainless steel 
disc fastened to metal plunger. C: BHI agar plate compressed aseptically with inoculated steel disc. As per 
Williams et al. (2009).   
 
 
 
 
 
 
 
 
 
 
Figure 1 A: Apparatus used for spore transfer.  B: Inoculated stainless steel disc fastened to 
the metal plunger.  C:  BHI agar plate compressed with an inoculated steel disc. 
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2.4.8. Preparation of mammalian cell culture lines  
Two human epithelial colorectal adenocarcinoma cell lines, Caco 2 (ATCC HTB-37) and 
HT 29 (ATCC HTB-38) were grown as monolayers in continuous culture as subsequently 
described. The two intestinal cell lines were passaged in minimum essential medium with 
Earle’s balanced salt solution (MEM/EBSS, Invitrogen, Paisley, UK) supplemented with 
10% foetal bovine serum, 1% non-essential amino acids, 1 mM sodium pyruvate, 2 mM 
L-glutamine and 50 µg/ml penicillin: streptomycin solution (Invitrogen, Paisley, UK) and 
incubated at 37°C in a 5% CO2 atmosphere in 25 cm
2
 vented flasks. Flasks were sub-
cultured after cells reached full confluence (analysed via phase-contrast microscopy 
according to cell density) every 6-7 days, at which point cells were washed 2 times in PBS 
(pH 7.2), detached from the plastic flask using a trypsin: EDTA (Ethylene-diamine-
tetraacetic acid) solution (Invitrogen) and seeded into new flasks to a cell density of 1-5 
for Caco 2 cells and 1-10 for HT 29 cells.  
 
2.4.9. Adherence ability of C. difficile spores to Human gut epithelial cell lines 
Spores of strain DS1813 at 1.40 x 10
8
 cfu/ml and DS1748 at 1.30 x 10
8
 cfu/ml were tested 
for adherence to Caco 2 and HT 29 cells. Caco 2 cells and HT 29 cells were prepared as 
detailed above. The initial cell density was at 1-2 x 10
5
 for each cell line. The cell density 
can be thus related to the ratio of bacteria per cell line. One hundred μl of 1.30 x 108 
cfu/ml spores were added to 1 ml 7 day old confluent Caco 2 gut epithelial cells in 
antibiotic-free Eagles minimum essential medium (EMEM) and left to incubate for 100 
min in a Bug Box Plus anaerobic cabinet (Ruskinn Technology Ltd, Bridgend, UK). Post 
incubation, the cell- spore mixture was washed in phosphate buffered saline (PBS; Sigma-
Aldrich, Dorset, UK) following centrifugation at 800 x g to remove any unattached spores. 
This washing step was performed three times in total and the supernatant from each wash 
step collected for enumeration of any spores not adhering to the cells. The supernatant was 
enumerated as per Miles & Misra (1938) on degassed BHI + 0.1% ST. Controls included 
PBS incubated with spores and EMEM incubated with the spores.  
 
This method was repeated for 15 day old confluent Caco 2 cells, which had spontaneously 
become differentiated and polarized, showing morphological changes, including tight 
junctions, cell polarity and formation of a microvilli brush boarder (Pinto et al., 1983). 
The experiment was also repeated using confluent 7 d and 15 d old HT 29 cell 
monolayers, these cells however remained in an undifferentiated state, but are documented 
      CHAPTER 2 
 
75 
 
to contain a small proportion (≤0.2%) of mucin-secreting goblet cells post-confluency 
(Pinto et al,. 1982; Lesuffleur et al., 1990). The human gut epithelial cell lines 
differentiated into a microvilli brush border at 15 d for Caco 2 and HT 29 cells. All tests 
were performed in duplicate. 
 
2.4.10. Statistical analysis 
Statistical analysis was performed using GraphPad Prism version 5.04 for Windows, 
(GraphPad Software, La Jolla California USA, www.graphpad.com). Statistical significant 
differences were tested for using one way analysis of variance (ANOVA) at the 95% 
confidence interval in conjunction with Dunnett’s post test. A P value of <0.05 was 
considered significant (Bowker & Randerson, 2006). 
 
2.5. RESULTS 
2.5.1. Spore germination 
We compared the ability of a representative collection of twenty one clinically relevant 
isolates of C. difficile to form spores when cultured in BHI media in the absence of the co- 
germinant sodium taurocholate. The average spore yield for each isolate following culture 
and enumeration on BHI based media are shown in Figure 2.3. Each result represents the 
mean of four individual assays. In the absence of sodium taurocholate, viable counts on 
BHI agar varied from 10
4
 - 10
7 
cfu/ml across the range of strains tested. While strain 
DS1759 (PCR ribotype 001) produced the highest yield of spores, this trait was not shared 
by other ribotype 001 strains (n=4). Indeed there was variation (Figure 2.3) in spore 
germination ability between strains of the same PCR ribotype. There is a significant 
difference in germination ability between each strain as determined via one way ANOVA 
(P=0.02). Further statistical analysis using Tukeys multiple comparison test confirms 
DS1759 is better able to germinate than other strains (P<0.05). 
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Figure 2.3: Spore formation and germination on BHI media 
A range of 21 clinically relevant C. difficile isolates were grown in BHI media and cultured without the 
germinant sodium taurocholate. There were variations in the ability of isolates to germinate on BHI media, 
and thus the number of viable spores (cfu/ml). Spores were produced in quadruplet and these values 
represent an average spore yield across strains and the difference is significant between strains as P = 0.02.  
(n = 4).  
 
2.5.2. The effect of media composition on spore formation 
To determine if the ability of C. difficile isolates to form spores was influenced by the 
composition of the media, and the ability of eight clinical isolates of C. difficile to form 
spores in BHI and Columbia broth was determined. Following incubation for 10 d, heat 
shocked cultures were diluted and plated onto either BHI or Columbia agar containing 1% 
sodium taurocholate to trigger germination. The ability of certain strains to form spores 
appears to be affected by the composition of the media. This was most evident for strains 
R20291 (ribotype 027, Stoke Mandeville isolate) (difference of approximately 3 log as 
shown in Figure 2.4) and DS1801 (ribotype 027) (difference of approximately 2 log as in 
Figure 2.4) which show the greatest difference in spore counts. There was no significant 
difference (one way ANOVA; P = 0.2519) in spore germination ability between BHI and 
Columbia media when the co-germinant sodium taurocholate. 
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Figure 2.4: Comparison of spore formation and germination of clinical isolates of C. difficile 
A further 8 clinical isolates were compared for spore germination ability. Spores generated in either 
Columbia or BHI broth were cultured on the corresponding agar media in the presence of 1% sodium 
taurocholate. Significant variations in spore germination ability in Columbia media can be seen for two 
isolates- DS1801 and R20191 in particular (P = 0.2519) (n = 4). 
 
Furthermore the percentage difference in the germination of spores between media with 
and without the supplement taurocholate was assessed (Figure 2.5). The percentage of 
spores that germinated in the absence of the co-germinant taurocholate differed markedly 
depending on the media and the isolate. Indeed the results suggest that Columbia media 
contains more essential co-germinants than BHI and that the isolates DS1801 and 
DS1813, both hypervirulent 027 ribotypes, differ in their germinant requirements from the 
other strains. 
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Figure 2.5: Percentage difference in germination of C. difficile spores between Columbia or BHI 
media. The percentage difference in spore germination between media with and without sodium 
taurocholate supplemented is shown together for clinically relevant C. difficile isolates. The isolates with the 
most marked difference (DS1813 and DS1801) grown in Columbia media germinate better with the 
germinant sodium taurocholate added.  
 
 
2.5.3. Hydrophobicity 
The ability of a spore to adhere to a surface is influenced by its hydrophobicity. To 
characterise the relative hydrophobicity (RH) of spores obtained from a range of clinical 
isolates, we employed the Microbial Adhesion to Hydrocarbon Test (Rosenberg et al., 
1990) with hexadecane as the organic solvent. Spores of B. atrophaeus ATCC 9372 
(Marker) were included as an internal control to enable a comparison to be made to the 
results from other studies. As expected the RH value for this strain was comparable to that 
reported by Wiencek et al. (1990). As can be seen from Figure 2.6 relative 
hydrophobicities ranged from 77% (DS1813 ribotype 027) to 14% (DS1748 ribotype 
002). Interestingly the most hydrophobic isolates appear to be those of hypervirulent or 
epidemic ribotypes (027, 001, 078, 106) suggesting a possible association with virulence. 
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There is a significant difference in the hydrophobicities within each PCR ribotype and 
between each strain (P < 0.0001).  
 
 
 
Figure 2.6: Relative hydrophobicity of the spore form of different ribotypes of Clostridium difficile  
A microbial adhesion to hydrocarbon test was used to determine the hydrophobic characteristics of the 
surface of C. difficile spores for a range of 21 clinical isolates. The highest percentage hydrophobicity 
demonstrates the most hydrophobic spores and the lowest percentage demonstrates the most hydrophilic 
spores. The percentage hydrophobicity is grouped according to PCR ribotype and there is significant 
difference between the strains according to hydrophobicity percentage (P<0.0001) (n = 2). 
 
 
2.5.4. Spore surface characterisation by electron microscopy 
To determine if variation in relative hydrophobicity could be related to spore surface 
architecture we employed transmission electron microscopy to characterise the spore 
forms of a range of C. difficile isolates. The most hydrophobic DS1813 (77% RH), 
DS1771 (72.2 % RH), DS1684 (45% RH) and hydrophilic DS1748 (14%) were examined 
under TEM. While the spores were structurally similar there were discernable differences 
between the strains. 
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Spores produced from strain DS1813 comprised an electron dense cortex surrounded by 
concentric rings of peptidoglycan, a second thinner outer coat layer and finally an 
exosporium which surrounded the majority (66%) of the spores observed (Figures 2.7 A, 
B, C). The exosporial layer is a bag–like structure surrounding the spore which can clearly 
be seen in Figure 2.7 B. The exosporial layer surrounds the spores of DS1813 (Figure 2.7 
A & C). It must be noted that this exosporial structure was not seen in some DS1813 
samples, which suggests that it is not strain specific. In contrast we were unable to detect 
the presence of an exosporial layer surrounding the spores of the other strains. Indeed the 
common concentric ring structure of the spore coat layers can be seen in each TEM image. 
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Figure 2.7: Transmission electron microscopy of C. difficile spores 
A: TEM image of a cross section of a hydrophobic spore produced by C. difficile DS1813. The exosporial 
layer can be seen. B: Negative stain electron microscopy of exosporium sac surrounding a spore of DS1813 
C: DS1813 with exosporium visible. Subsequent strains did not exhibit and exosporial layer D: Strain 
DS1771. E: Strain DS1684 F: Strain DS1748 (Images scale bar = 100 nm). 
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2.5.5. Ability of C. difficile spores to adhere to stainless steel 
Stainless steel is a material common in the hospital environment and thus we sought to 
determine if spores from a range of clinical isolates varied in their ability to adhere to this 
material. To achieve this, a plate transfer method was employed in which the percentage 
of spores which remained attached to the surface of a hydrophobic (>45 degree contact 
angle) steel disc was determined following consecutive impression on the surface of 16 
hydrophilic (0 degree contact angle) BHI agar plates. As can be seen in Figure 2.8, the 
adherence of spores from different clinical isolates varied from 18-100%.  
 
 
 
Figure 2.8: Percentage of C. difficile spores transferred from stainless steel to BHI plate 
The percentage of C. difficile spores was determined after transfer from a stainless steel disc onto the surface 
of BHI agar plates following 16 replica platings. The correlation between surface transfer and strains was 
not statistically significant (P>0.05). n=2. 
 
Differences in adherence to steel correlated with relative hydrophobicity as determined 
using the MATH assay, in that hydrophobic isolates adhered better than their hydrophilic 
counterparts. Thus spores of DS1813 adhered more strongly to steel than those of 
DS1748.  
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2.5.6. Adherence of C. difficile spores to human gut epithelial cell lines 
We employed a human gut epithelial cell model to determine the adhesive ability of 
spores derived from DS1813 and DS1748. We used two intestinal cell lines Caco 2 and 
HT 29.  Caco 2 cells originate from a colon carcinoma cell line which require 15 d culture 
to become fully differentiated, at which time they possess a microvilli brush border which 
is absent at day 7. HT 29 cells originate from an adenocarcinoma cell lines and do not 
spontaneously differentiate upon culture although some cells can develop goblet cells 
which produce mucus. 
 
Hence we sought to determine if spores of DS1813 and DS1748 differed in their ability to 
bind to these cells at different stages of development. There was a significant difference 
(one way ANOVA; P= 0.042) in the ability of spores of strain DS1813 to adhere to both 
cell lines in contrast to DS1748 (Figure 2.9). Interestingly there was no significant 
difference between DS1748 and DS1813 adherence to 7 d Caco-2 cells and 15 d HT 29 
cells; however there was a significant difference for both strains at 15 d old Caco 2 cells 
(P = 0.0393) and 7 d HT 29 cells (P = 0.0079). This difference in adherence ability may be 
attributed to the differences in surface properties between the spores of both strains. 
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Figure 2.9: Adherence of C. difficile spores to two separate human gut epithelial cell monolayers   
The spores of isolates DS1813 (hydrophobic) and DS1748 (hydrophilic) were assessed for adherence to 
monolayers of human colon adenocarcinoma grade II cell line (HT 29) and Caco 2 human colorectal cell 
lines. Spores were enumerated on 0.1% sodium taurocholate and BHI agar. These values represent an 
average spore adherence for strains DS1813 and DS1748 (n = 2). 
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2.6. DISCUSSION 
The spore form of C. difficile plays a key role in facilitating person to person spread of the 
pathogen. It allows the organism to survive in the hostile hospital environment protecting 
it from the toxic effects of oxygen and biocides. Currently there is considerable debate as 
to whether clinical isolates vary in their ability to form spores: it has been suggested that 
isolates of the hypervirulent type BI/NAP1/027 strains sporulate better than their non-
epidemic counterparts and that this difference results in increased disease occurrence and 
severity (Akerlund et al., 2008). However a recent conflicting study by Burns et al. (2010) 
demonstrated that sporulation rates of a number of strains of C. difficile, including those of 
non-clinical isolates, were broadly similar. Hence there was no preference of a particular 
strain/ribotype to possess increased sporulation ability. While we were unable to comment 
on the rate of spore formation we did observe that certain stains such as R20291 
(BI/NAP1/027) failed to achieve the same level of spores at 10 days as other isolates and 
that these differences were growth media dependent, raising the question as to their 
relevance in vivo.  
 
Once the spore has been released from an infected individual it must adopt strategies 
which enable it to survive and colonise the environment. The results of our study suggest 
that the emergence of epidemic and hypervirulent isolates may in part be due to their 
enhanced ability to adhere to organic (human adenocarcinoma cells) and inorganic 
(stainless steel) surfaces compared to non-epidemic strains. Using a simple MATH assay 
developed by Rosenberg et al. (1980) we observed what appears to be a relationship 
between PCR ribotype and spore hydrophobicity. The spores that demonstrated the 
highest levels of hydrophobicity were predominantly hypervirulent and epidemic 
ribotypes (027, 001, 106 and 078) while the hydrophilic spores were mainly non-epidemic 
clinical isolates. A similar association was seen when the binding of spores to stainless 
steel was examined. This material is widely used in the healthcare environment in the 
manufacture of surgical equipment and hand washing facilities, and as such represents a 
potential source of spore contamination. Thus spores from hypervirulent ribotypes may be 
better adapted to adhere to these surfaces and thus increase the potential for person to 
person spread. 
 
To determine if the observed differences in hydrophobicity and adherence were due to 
variations in spore structure we employed electron microscopy to characterise the 
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morphology of a range of spores with varying relative hydrophobicity as determined by 
MATH. Spores of hydrophobic DS1813, DS1771, DS1684 and hydrophilic DS1748 
strains were examined under TEM. While the spores of each isolate shared a number of 
common features- an internal core, cortex and outer coat layers- they differed with regards 
to the presence of an exosporium which was only present in strain DS1813.  
 
This bag like structure was recently described surrounding spores of another strain of C. 
difficile CD630
 
(Lawley et al., 2009) and is thought to contribute to spore hydrophobicity 
and play a direct role in adherence (Koshikawa et al., 1989; Charlton et al., 1999). Indeed 
it has been suggested that the degree to which a spore can adhere to a surface is directly 
influenced by the presence or absence of the exosporium in a range of Bacillus species, 
such as B. megatarium and B. cereus (Koshikawa et al., 1989). However this exosporial 
layer did not surround spores of every isolate examined, suggesting that there is no direct 
correlation between spore hydrophobicity and the presence of an exosporium. 
 
In addition to mediating binding to steel, the exosporium plays a central role in facilitating 
the attachment of spores to the cells lining the gut- an important first step in bacterial 
invasion. The human colonic cell lines Caco 2 and HT 29 are used as in vitro models due 
to their ability to retain key features of normal intestinal epithelial cells and thus were 
considered to be representative of cells potentially encountered by C. difficile during 
germination in vivo (Howell et al., 1992). Caco 2 cells become polarized and fully 
differentiate into mature cells having microvillus brush-boarder morphology by 15 d of 
culture, whereas 7 d old cells lack these features (Pinto et al., 1983).  
 
Parental HT 29 cells do not spontaneously differentiate in culture, and thus do not exhibit 
the same characteristics as Caco 2 cells after 15 d of prolonged cultivation (Pinto et al., 
1982; Roussett, 1986). However a small number of goblet cells are present post-
confluency capable of producing mucins (Pinto et al., 1982; Lesuffleur et al., 1990). Not 
surprisingly we found that the spores produced by the hypervirulent DS1813 (027) which 
possessed an exosporium were more efficient at attaching to both  HT 29 and Caco 2 gut 
monolayers than spores of DS1748. It has previously been observed that spores of C. 
difficile attach to the apical microvilli of human epithelial cells by means of their 
exosporium which, in addition to facilitating colonisation, acts as an anchor during 
germination (Panessa-Warren et al., 1997).  
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As C. difficile growth is restricted to oxygen limited environments, such as those 
encountered in the gut, there is considerable interest in the manner in which C. difficile 
spores regulate their germination. Bile salts such as taurocholate, which has a positive 
effect on germination, and chenodeoxycholate which has an inhibitory effect on 
germination, have been posited to have a central role in regulating germination and as 
such probably represent the means by which C. difficile spore “sense” their physical 
location. In addition to bile salts other amino acid based co-germinants have been 
identified in vitro such as glycine, alanine, cysteine and phenylalanine (Setlow, 2003; Sorg 
& Sonenshein, 2008; Giel et al., 2010). Indeed combinations of these amino acids are able 
to stimulate in vitro spore germination in the absence of taurocholate (Sorg & Sonenshein, 
2008).  
 
In the context of our study differences in the composition of BHI and Columbia media 
may account for the variation we observed in spore formation and germination. While 
there appears to be an association between the 027 ribotype and the ability to germinate in 
Columbia media in the absence of taurocholate, the limited number of isolates examined 
makes it impossible to draw any solid conclusions at this time. While commercial growth 
media in no way seeks to mimic the complex conditions encountered in the human gut, 
they do provide a system in which to compare the ability of different isolates to germinate. 
Indeed the results from this study suggest that further examination of strain DS1801 could 
aid our understanding of the factors that regulate germination. However the results 
obtained using these media must be treated with caution as they may simply represent 
media specific artefacts and bear no relationship to what actually happens in vivo. 
 
In conclusion we found that the surface properties of spores produced by hypervirulent 
and epidemic isolates of C. difficile made them better equipped than their non-epidemic 
counterparts to adhere to both gut cells and healthcare surfaces and as a consequence may 
enhance their opportunity to transfer to susceptible hosts and initiate new infections. By 
fully understanding this process by which spores attach to clinically relevant surfaces we 
hope to be able to develop strategies which could inhibit attachment of spores and thus 
block the infection cycle. We also conclude that that there is no direct correlation between 
spore hydrophobicity and the presence of an exosporium. Finally the study of the factors 
affecting germination and spore formation are extremely complex, particularly when 
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attempting to relate laboratory derived observations using a small number of isolates to 
events that are occurring in vivo. 
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3.1. ABSTRACT 
Conserved sequences within the gene encoding regions of C. difficile toxins A and B were 
identified using a restriction enzyme site based typing system developed by Rupnik et al 
(1998). These conserved sequences lacked the restriction sites targeted by the restriction 
enzymes used in Rupnik’s toxinotyping system. Bioinformatic analysis was employed to 
design probes specific to toxins A and B from these regions. From bioinformatic analysis 
we found that conserved regions within the toxin A and B gene sequences shared 
homology to virulence genes associated with insects.  
 
Candidate probes specific to toxins A and toxin B of C. difficile through bioinformatic 
analysis were synthesised and examined for specificity using a rigorous screening process  
against 58 clinical isolates of C. difficile, unrelated species, species from the LCT family 
and 10 human metagenomic gut DNA extracts. Probes which hit only with toxigenic C. 
difficile isolates were employed in the MAMEF based technological platform as described 
in Chapter 5. 
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3.2. INTRODUCTION 
As described in Section 1.4.5.1, the genes encoding toxin A and B are thought to have 
evolved as a result of horizontal gene transfer. Gene transfer events occur in organism 
evolution, conferring characteristics which enable an organism to survive. Indeed within 
C. difficile areas of sequence conservation have been identified. Thus, on the premise that 
structurally important regions of each toxin are likely to be highly conserved, the results of 
the restriction enzyme based toxinotyping method (previously described by Rupnik et al., 
1998; Section 1.5.2) were utilised to pinpoint potentially conserved nucleotide regions in 
C. difficile toxin A and toxin B, which were not restricted by the enzymes used by Rupnik. 
The regions A1, A2 and B3 lacked any of the restriction sites that the range of restriction 
enzymes Rupnik (1998) specifically used to digest the PaLoc of C. difficile VPI 10463. 
Thus these areas were considered suitable target for probe design (Figure 3.1). 
 
 
 
Figure 3.1: PCR amplification region of C. difficile  
The PCR amplification areas are shown here in a schematic representation. The variable regions include B1, 
B2 and A3. Thus the areas with highest sequence conservation were B3, A1 and A2. (Image taken from 
Rupnik et al., 1998). In toxinotype 0 and representative variant toxinotypes the presence or the absence and 
the exact positions of restriction site are shown: A – AccI, E – EcoRI, Ec – EcoRV, H –HindIII, Hc – 
HincII, N – NsiI, Nc – NcoI, P – PstI, R –RsaI, S – SpeI, X – XbaI.  
 
 
To confirm if the nucleotide regions defined above by Rupnik (1998) were indeed highly 
conserved, individual gene sequences from multiple isolates were directly compared using 
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a bioinformatics based approach. Bioinformatics is the application of information 
technology to the field of molecular biology and has enabled information regarding 
biological structures, such as DNA, proteins and RNA to be analysed (Zvelebil & Baum, 
2008). The genomic revolution was considered to have begun in the mid 1990s; however 
the roots of bioinformatics can be traced back to the 1950’s when bovine insulin was 
sequenced by Frederick Sanger and colleagues (Ryle et al., 1955). Indeed by the 1960’s 
the first database of protein sequences “Atlas of Protein Sequence and Structure” was 
published by Margaret Dayhoff with >100 protein sequences available (Primrose & 
Twyman, 2007). During the 1970s and 1980s DNA sequences became more accessible 
and predicted protein sequences from translation of sequenced genes were available. By 
1982 there were so many sequences available that they were collated into a database, 
known as GenBank, which today contains in excess of 30 million sequences (Benson et 
al., 1999). Thus as the amount of biological information has increased it has been 
necessary to employ computer based algorithms to analyse them (Primrose & Twyman, 
2007). 
 
The method used to compare the relationship of nucleotide sequences utilises alignment 
pairing comparisons: two sequences are analysed and the number of shared residues 
determined (pairwise alignments). This method deduces sequence similarity in DNA and 
protein sequences which are subject to evolutionary changes including mutations within 
their genome sequences. Specifically bases, and the amino acids they encode, can change 
over time as a result of point mutations within the genome. Synthesis of sequences from 
different organisms and gene duplications are quite common in organism evolution. As 
such, it is necessary to employ alignment comparisons to reveal any potential similarities, 
resulting in an alignment score, which represents the alignment quality and the 
evolutionary closeness of the sequences (Primrose & Twyman, 2007). Those sequences 
with a high alignment score are deemed as having homology, which suggests that the 
organism/gene may have evolved from a common ancestor/ ancestral gene. Thus an 
alignment of two sequences is essentially a hypothesis that the sequence residues of 
interest have evolved from the same ancestor.  
 
Multiple sequences can be aligned using online programmes such as ClustalW (EBI) 
(Larkin et al., 2007). ClustalW has a graphic interface which allows viewing of a set of 
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sequences easily; hence if the sequences show a similar alignment pattern they are likely 
to have derived from a common ancestral sequence (Woodford & Johnson, 2004). 
Multiple sequence alignments allow wider analyses of sequences to be made, such as 
relationships between families to be deduced, predicting sequences, and to construct 
phylogenetic trees (Zvelebil & Baum, 2008). In the case of this thesis, multiple sequence 
alignment (MSA) analyses were used to establish areas with conserved residues in the 
sequences of C. difficile toxin A and toxin B. 
 
To establish if a sequence has any homologs, various searching tools are available to 
detect homologs in databases. One such is BLAST (Basic Local Alignment Search Tool) 
[NCBI], which finds core similarities (defined by set parameters) between nucleotides 
and/or  proteins and can search for protein sequences using a nucleotide sequence and vice 
versa (Altschul et al., 1997). Firstly suitable matches are located within each database and 
are indexed according to rank by their similarities. The highest scoring sequences are 
deemed as having the most homology to the query sequence. These scores have an 
expectation value (E-value) which is the estimation of the probability of two random 
sequences aligning with a score higher than the defined parameter of S (Primrose & 
Twyman, 2007). E-values can vary from 0 to X, and those with an E-value closer to 0 are 
also deemed to have significant homology (Altschul et al., 1997). This approach was 
employed to deduce any probe similarities to database sequences. 
 
3.3. RESEARCH AIMS 
The aims of this chapter are to: 
 
 Analyse the toxin encoding genes tcdA and tcdB within the genome of C. difficile to 
identify conserved regions within each nucleotide sequence of each toxin 
 Determine the specificity of these conserved regions using bioinformatic analysis 
 Design candidate probes from regions specific to each toxin  
 Determine the ability of candidate probes to detect tcdA and tcdB targets 
 Determine the sensitivity of these candidate probes 
 Determine the specificity of the candidate probes against a range of C. difficile isolates, 
isolates from related Clostridium strains, other bacterial isolates and against human gut 
metagenomic DNA extracts 
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3.4. MATERIALS & METHODS 
3.4.1. Bioinformatic analysis of C. difficile sequences  
Submitted nucleotide sequences for the two C. difficile toxin genes tcdA and tcdB were 
collated from the National Centre for Biotechnology Information (NCBI) genomic 
database “GenBank” [http://www.ncbi.nlm.nih.gov/Genbank/] [Accessed 01/10/2008]. In 
total the nucleotide sequences from 20 toxin A entries and 18 toxin B entries, obtained 
from unrelated viable strains of C. difficile were accessed. One further toxin B sequence 
was obtained from Stabler et al. 2008.  
 
3.4.2. Conserved regions in C. difficile toxins A and B 
Conserved regions were pinpointed as described in Section 1.5.2 (Rupnik et al., 1999). 
 
3.4.3. Multiple Sequence Alignments of C. difficile sequences 
To confirm that the predicted conserved regions within toxins A and B contained regions 
of conserved nucleotide sequences, the multiple sequences deposited in the Genebank 
database were analysed using ClustalW Multiple Sequence Alignment (MSA) program 
provided by European Bioinformatics Institute (Larkin et al., 2007). The results of this 
analysis were displayed using Bioedit v7.1.3 (Hall, 2001) MSA viewer in which bases are 
colour coded to highlight conserved regions. 
 
3.4.4. C. difficile toxin A and B Probe Design 
Probes were designed to recognise nucleotide sequences within conserved regions of 
toxins A and B. As part of the design process we incorporated features which would 
enable us to utilise the probes in a future MAMEF assay (as described in Section 1.7). The 
anchor probe for the C. difficile assay was designed to be 17 nucleotides in length and to 
be separated from the 22 nucleotide fluorescent detector probe by a stretch of 5 
nucleotides. The anchor probe binds target DNA while the detector probe subsequently 
binds at a distance which positions the fluorophore optimally for biomolecular recognition 
to occur. The use of an anchor and detector probes also allows for two levels of sensitivity 
within the assay for each toxin. 
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3.4.5. In silico characterisation of probe properties 
3.4.5.1. Melting point and GC content analysis 
For PCR based annealing reactions to take place optimally, designed probes should ideally 
have a GC content of approximately 50% so the melting temperature can be adequate for 
PCR annealing (Primrose & Twyman, 2007). To achieve this aim we employed the 
following bioinformatic programs: 
i)  Oligoanalyser 3.1 program (Integrated DNA Technologies, 2009) 
[http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/Default.aspx] 
[Accessed 01/2009] 
ii) Primer 3 [http://frodo.wi.mit.edu/primer3/](Rozen & Skaletsky, 2000) 
[Accessed 01/2009]  
 
3.4.5.2. Probe secondary structure analysis 
Furthermore, the potential for secondary structures and primer dimers was assessed 
through manual analysis of the probe sequences. The formation of primer dimers and 
secondary structures within a PCR reaction are the result of non-specificity, where the 
probes can bind to themselves or each other, resulting in poor amplification and the 
generation of PCR products which are not the correct amplicon size. Sequences were also 
analysed for long repeats of nucleotides, as repeats of >3/4 nucleotides can lead to 
formations of secondary structures and non-specificity (Primrose & Twyman, 2007). 
Analysis was performed using the Oligoanalyser 3.1 program (Integrated DNA 
Technologies, 2009). 
 
3.4.5.3. Probe sequence homology search using BLAST 
We employed the Basic Local Alignment Search Tool nucleotide homology search 
facility: BLASTn: BLAST (NCBI) [http://blast.ncbi.nlm.nih.gov/Blast.cgi] to determine if 
probes had homology to sequences within the Genbank database. 
 
3.4.6. C. difficile toxin A and B- specific Probe Studies 
3.4.6.1. Bacterial species, growth conditions, and metagenomic DNA  
C. difficile isolates 
To enable the designed probes to be tested against a representative collection of C. difficile 
isolates, we supplemented the collection of isolates described in Chapter 2 with additional 
toxinotypes of C. difficile obtained from the National Anaerobic Reference Unit, Cardiff, 
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Wales, courtesy of Dr. Val Hall. These strains are shown in Table 3.1. These extra isolates 
also included clinical isolates from blood culture and variant isolates which only produced 
toxin B (Ribotypes 017, 047, 110). A further three toxinotypes were tested courtesy of Dr. 
Katie Solomon, University College Dublin, Ireland. Unless otherwise stated all organisms 
were stored as spores at 4
o
C as described in Chapter 2. In total 58 C. difficile isolates were 
tested.  
 
The purity of C. difficile strains was confirmed by using Clostridium difficile Moxalactam 
Norfloxacin (CDMN) antibiotic selective supplement (Oxoid, Basingstoke, Hampshire, 
UK). Contents of 1 vial of Oxoid CDMN supplement was reconstituted with 2 ml sdw and 
added to 500 ml molten (50
o
C) C. difficile agar base (Oxoid, Basingstoke, Hampshire, 
UK), together with 7% (v/v) defibrinated horse blood (SR0050) (Sigma Aldrich, Dorset, 
UK). This was mixed well and poured into sterile Petri dishes, left to dry and degassed. 
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Table 3.1: Table of isolates used in this study 
The additional isolates of C. difficile are listed. Isolates from blood culture are listed as (B/C). Toxin 
production for each strain and its PCR ribotype are shown, with additional information including the source. 
The isolates and information above was provided courtesy of Dr. Jon Brazier and Dr. Val Hall at the 
Anaerobic Reference Unit, University Hospital Wales, Cardiff, UK, 2008. 
 
C. difficile strain Year referred Source Ribotype Toxin Production 
Representatives of toxinotype VIII   
R9557 1996 Faeces 017 tcdA
- 
tcdB
+
 
R13695 2000 Faeces 017 tcdA
- 
tcdB
+
 
R18091 2003 Faeces 017 tcdA
- 
tcdB
+
 
R10542 1997 Faeces 047 tcdA
- 
tcdB
+
 
R18045 2003 Faeces 047 tcdA
- 
tcdB
+
 
R7771 1994 Faeces 110 tcdA
- 
tcdB
+
 
R17978 2003 Faeces 110 tcdA
- 
tcdB
+
 
Representatives of toxinotype XII   
R24498 2007 Faeces 056 tcdA
+ 
tcdB
+
 
DS2008/08 2008 Faeces 056 tcdA
+ 
tcdB
+
 
R26796 2008 Faeces 056 tcdA
+ 
tcdB
+
 
Blood culture isolates    
R2139 1985 B/C 017 tcdA
- 
tcdB
+
 
R9399 1996 B/C 001 tcdA
+ 
tcdB
+
 
R12824 1999 B/C 001 tcdA
+ 
tcdB
+
 
R13400 1999 B/C 014 tcdA
+ 
tcdB
+
 
R15552 2001 B/C 023 tcdA
+ 
tcdB
+
 
R17752 2002 B/C 001 tcdA
+ 
tcdB
+
 
R19058 2003 B/C 078 tcdA
+ 
tcdB
+
 
R19168 2004 B/C 046 tcdA
+ 
tcdB
+
 
R19222 2004 B/C 017 tcdA
- 
tcdB
+
 
R20408 2004 B/C 045 tcdA
+ 
tcdB
+
 
R22537 2006 B/C 014 tcdA
+ 
tcdB
+
 
R24626 2007 B/C 027 tcdA
+ 
tcdB
+
 
R25028 2007 B/C 005 tcdA
+ 
tcdB
+
 
R25577 2008 B/C 002 tcdA
+ 
tcdB
+
 
R26390 2008 B/C 027 tcdA
+ 
tcdB
+
 
R27038 2008 B/C 005 tcdA
+ 
tcdB
+
 
R27039 2008 B/C 002 tcdA
+ 
tcdB
+
 
R28614 2009 B/C 106 tcdA
+ 
tcdB
+
 
R30061 2010 B/C 014 tcdA
+ 
tcdB
+
 
R30359 2010 B/C 333 tcdA
+ 
tcdB
+
 
Other Strains     
R22680 - Faeces 017 tcdA
- 
tcdB
+
 
12727 - Faeces 001 tcdA
+ 
tcdB
+
 
11204 - Faeces 001 tcdA
+ 
tcdB
+
 
Isolates with designated toxinotype Toxinotype    
VPI 10463 0    
Toxinotype XIa XIa   tcdA
- 
tcdB
-
 
Toxinotype XIb XIb   tcdA
- 
tcdB
-
 
Toxinotype IX IX   tcdA
+ 
tcdB
+
 
  
 
 
 
     CHAPTER 3 
 
98 
 
3.4.6.2. Bacterial species unrelated to and related to C. difficile 
In addition to increasing the range of C. difficile isolates tested, the ability of the probes to 
react with other bacterial species was assessed. Thus to establish the specificity of the 
designed probes we tested them against a range of bacterial species from closely related 
Clostridium strains, to unrelated strains, as listed in Table 3.2. 
 
Table 3.2: Additional bacterial species used in this study 
The additional species and their strain designations used in this study are listed above. The species related to, 
and those not related to, C. difficile are shown. The species were obtained from the NCTC (National Culture 
Type Collection, HPA, London, UK), unless otherwise stated. Other isolates obtained from the anaerobic 
reference unit (ARU) at the University Hospital Wales (UHW) are listed as ARU, UHW. Those isolates and 
information was provided courtesy of Dr. Jon Brazier and Dr. Val Hall at the Anaerobic Reference Unit, 
University Hospital Wales, Cardiff, UK. 
 
Bacterial species Strain Source 
Unrelated Bacterial Species   
Methicillin-resistant Staphylococcus aureus NCIMB 9518 NCTC 
Staphylococcus aureus  NCTC 
Escherichia coli  K12 NCTC 
Bacillus subtilis 6051 NCTC 
Related Clostridium Species   
C. sordellii R20453 UHW 
C. sordellii 13356 UHW 
C. novyi R14479 UHW 
C. novyi 277 UHW 
C. septicum R22030 UHW 
C. perfringens 13170 NCTC 
C. perfringens type C 3180 NCTC 
C. coccoides 11035 NCTC 
C. leptum 753 DSM 
C. innocuum 1280 DSM 
  
 
 
3.4.6.3. Human Metagenomic gut DNA 
The human gut environment contains approximately 10
12
/g bacteria. Therefore the probes 
designed to detect C. difficile must be able to specifically detect the toxin genes amongst 
the numerous bacteria present (Shoemaker et al., 2001). Therefore to further confirm the 
specificity of the designed probes, metagenomic DNA samples from ten human volunteers 
were obtained from Cardiff School of Biosciences, Wales, Cardiff, UK, courtesy of Dr. 
Julian Marchesi. The metagenome was extracted from faecal matter (Dr. J. Marchesi-
personal communication) from humans in Zambia, France and the UK. 
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3.4.6.4. DNA Extraction from C. difficile using Chelex 100 Resin 
(Courtesy of Dr. J. Brazier; Personal communication) 
Chelex 100 Resin (BioRad Laboratories, UK) was dispensed into 2 ml sterile distilled 
water and vortex mixed well using a VortexGenie (Fisher Scientific, UK). Approximately 
100 μl Chelex 100 was added to an Eppendorf tube whilst gently agitated. A 10 μl loopful 
of C. difficile colonies from an overnight (24 h) agar plate culture on CDMN was taken 
and mixed into the Chelex 100. Subsequently the Eppendorfs were placed on a hot plate at 
100
o
C for 12 min, and then centrifuged for 10 min at 15,000 rpm. The supernatant was 
aliquoted out and stored as DNA extract at -20
o
C. Concentration of DNA measured using 
Biophotometer (Eppendorf, UK) DNA absorbance function calculating absorbance using 
the relationship that A260 of 1.00 = 50 µg/ml pure DNA. DNA purity was calculated at 260 
nm/280 nm. 
 
3.4.6.5. Probe Synthesis 
Probes were synthesised by Eurofins MWG Operon, Ebersberg, Germany, at HPSF 
purification, synthesis scale 0.05 μl. 
 
3.4.7. PCR for C. difficile 
3.4.7.1. Preparation of 1x Tris Boric EDTA Electrophoresis buffer 
A 10x TBE buffer stock containing 27.5 g boric acid (Sigma Aldrich, UK), 54 g Tris base 
and 20 ml 0.5M EDTA was prepared. To make a 1x solution of TBE, 100 ml 10x TBE 
buffer was added to 900 ml double diH2O water in a 1L Duran bottle. 
 
3.4.7.2. Preparation of 1% (w/v) Agarose 
In a 500 ml Duran bottle 200 ml 1x TBE buffer was added to 2 g molecular biology grade 
agarose (Sigma Aldrich, UK) and microwaved until all the powder dissolved. The agarose 
was left to cool and poured into a gel cast mould with comb (Biorad Laboratories, UK). 
 
3.4.7.3. PCR to detect Toxin B within C. difficile isolates 
As a control a primer known to detect toxin B within C. difficile isolates was employed 
(Wren et al., 1993). Only toxin B was detected via PCR as all C. difficile strains contain a 
stable toxin B gene.  
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3.4.7.4. PCR thermocycle optimisation conditions for designed probes 
To generate probes for use in a dot blot macroarray the hypothesised conserved regions of 
nucleotide sequences were amplified using PCR. The PCR thermocycle conditions for 
each of the probes were optimised to obtain definitive amplicons bands of the correct size. 
When optimising PCR conditions the annealing temperature was assessed by performing a 
temperature gradient (+/-10
o
C) thermocycle calculated by the thermocycler (Techne 
Touch gene gradient thermocycler). PCRs were performed using the Taq PCR core kit 
(Qiagen, Qiagen House, Crawley, West Sussex, UK). For the optimisation studies DNA 
extracted from C. difficile strain R20291 was used in each 20 μl reaction. Each 20 µl 
reaction contained: 9.9 µl sdw, 2.5µl PCR buffer, 5 µl Q solution, 0.4 µl of 25 mM MgCl2, 
2 µl of 10 mM deoxyribonucleotides (dNTPs), 1 µl primer mix, 1 µl template DNA and 
0.2 µl of 5 Units/ µl Taq polymerase. The PCR thermocycle programme employed was as 
follows: 94
o
C for 5 min and 30 cycles of 94
o
C (30 s), annealing gradients variable 
according to probe (Table 3.3) and 72
o
C (45 s). PCR products were gel electrophoresed in 
1% (w/v) agarose (Sigma Aldrich, UK) at 85 V, stained with SafeView
TM
 and 
photographed in a UV-transilluminator (ChemiDoc, BioRad laboratories, UK). 
 
Table 3.3: PCR Thermocycle annealing temperatures per probe 
The probes for each toxin were found to have the above optimal temperatures for PCR to occur. These are 
the temperature at which all further PCR reactions and dot blot reactions will be conducted. 
 
 
Clostridium 
difficile Toxin 
Anchor Probe F Primer 
5’              3’ 
(17 nt) 
Optimal 
Temperatures 
for PCR 
Detector Probe F Primer 
5’              3’ 
(22 nt) 
Optimal 
Temperatures 
for PCR 
Toxin A Probe 
from 
50 bp Region 
 
TTTGAATACTTTGCACC 
 
55.6 
 
TGCTAATACGGATGCTAACAAC 
 
66.9 
Toxin A Probe 2 
from 
76 bp 
 
TTTAATACTAACACTGC 
 
37.3 
 
TGTTGCAGTTACTGGATGGCAA 
 
66.9 
Toxin B Probe TCAAGACTCTATTATAG 48.4 TAAGTGCAAATCAATATGAAGT 60.1 
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3.4.7.5. Staining of PCR products in agarose gel using SafeView
TM
 
To visualise amplified DNA bands in a gel we used SafeView
TM
 (NBS Biologicals, 
Cambridgeshire, UK). SafeView
TM
 is as sensitive as ethidium bromide but does not suffer 
from concerns over its potential toxicity. Green fluorescence is emitted when it binds to 
ssDNA, dsDNA and RNA and has a fluorescence excitation maximum at approximately 
290-320 nm, emitting at 490 nm). The stain was added to molten agarose before setting, 
and to 1 x TBE buffer in a gel electrophoresis tank, at the specifications listed below: 
 
Table 3.4: Amount of Safeview
TM
 to use in an agarose gel 
The volume of Safeview
TM
 required for visualisation in an agarose gel is shown above. The volume of 
Safeview
TM
 required to be added to 1 x TBE buffer in a gel electrophoresis tank (Biorad laboratories, UK) is 
shown. Information is taken from NBS Biologicals, Cambridgeshire, UK). 
 
Size of Gel Cast  (cm) Agarose (ml) SafeView (µl) 
10 x 15 120 2.5 
10 x 6 50 1.75 
Tank Size TBE Buffer in tank  (ml) SafeView (μl) 
Small 250 10 
Medium 800 30 
  
 
3.4.8. Genomic DNA hybridisation dot blots 
3.4.8.1. Preparation of DIG-labelled Hybridisation Probes 
After PCR optimisation the product was labelled with digoxigenin (DIG) to enable 
detection in a larger macroarray via dot blot hybridisation (Figure 3.2). DIG is a non-
radioactive molecule with high immunogenicity which is a used as an alternative way of 
labelling oligonucleotides. The probes were prepared for dot blot hybridisation by 
performing a PCR reaction by replacing standard dNTPs with DIG-labelled dNTPs in a 
chemiluminescence-based method (Roche Diagnostics, Charles Avenue, West Sussex, 
UK). Further advantages of the DIG system is its high sensitivity, short exposure time, 
safety, and the probes are reusable (Roche Diagnostics:  
www.roche-applied-science.com/sis/lad/index.jsp?id=lad_040100). 
 
To label the probes a PCR labelling reaction was performed using the DIG-labelled 
dNTPs. Per 20 µl reaction was: 9.9 µl sdw, 2.5µl PCR buffer, 5 µl Q solution, 0.4 µl of 25 
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mM MgCl2, 2 µl of 10 mM DIG-labelled dNTPs, 1 µl primer mix, 1 µl template DNA and 
0.2 µl of 5 units/ µl Taq polymerase. PCR conditions were as in Section 3.4.7.4 above, 
with annealing temperatures specified in Table 3.3. The template DNA used in the PCR 
reaction was strain DS1813. The concentration of PCR product was measured using a 
Biophotometer (Eppendorf, UK) and stored at -20
o
C, undiluted (50-100 ng/µl).  
 
 
 
Figure 3.2: Probe generation 
Schematic showing the method used to generate DIG labelled probes for use in a macroarray dot blot 
hybridisation reaction. These DIG labelled probes were screened for specificity against a range of C. 
difficile isolates, and bacteria from other species. This can be seen later in section 3.5.6.2. 
 
3.4.8.2. Sensitivity of DIG-labelled probes 
To establish the sensitivity each DIG-labelled probe, 2 µl of probe was serially diluted in 
20 µl sdw, and 2 µl of each dilution sequentially dot blotted onto a positively charged 
nylon membrane (Roche Diagnostics, Charles Avenue, West Sussex, UK) and fixed with 
UV light (ChemiDoc, BioRad laboratories, UK) to ascertain the optimum probe 
concentration for further DNA hybridisation dot blotting experiments. 
 
 
 
Anchor Probe
Detector Probe
Hypothesised Conserved Nucleotide Sequence
The anchor and detector probe were used in a PCR 
DIG labelling reaction to amplify the hypothesised 
conserved region and create a DIG labelled probe
Dig labelled probes were tested against variety of 
C. difficile bacteria and other species for specificity 
using dot blotting macroarray technique
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3.4.8.3. Macro-arraying genomic DNA onto a positively charged nylon membrane 
To allow all of the C. difficile isolates to be examined easily via dot blot, a Macro-arraying 
technique was employed to hybridise gDNA samples onto the positively charged nylon 
membrane. The gDNA extracted from the C. difficile isolates (using Chelex 100), was 
aliquoted at 30 μl per well into a 384 well plate (ABGene, Fisher Scientific, UK) and 
printed into the positively charged membrane using a Flexys robotic workstation 
(Genomic Solutions Ltd, UK). The robot was set to blot 4 spots of DNA in a grid format 
(Figure 3.3). To orientate the membrane a single well was included, containing loading 
dye (Bromophenol blue, Sigma Aldrich, UK) and 50 ng/ μl lambda phage DNA (Promega, 
UK). After macroarraying the gDNA was fixed to the nylon membrane using a UV 
transilluminator (ChemiDoc, BioRad laboratories, UK) for 5 min. The fixed membranes 
were stored for future use between two sheets of blotting paper at room temperature.  
 
Blotting paper
Plate
Sample gridding 
from macroarray
Nylon membrane
 
 
Figure 3.3: Macroarraying experiment 
The gDNA from a range C. difficile isolates was macroarrayed onto a positively charge nylon membrane 
using a robotic machine- FLEXYS (Genomic Solutions Ltd, UK). gDNA was macroarrayed in the sample 
gridding format shown above to give four dots of DNA; thus four replicates for each isolate. After 
macroarraying the gDNA was fixed onto the membrane using a UV transilluminator (ChemiDoc, BioRad 
laboratories, UK) and stored on blotting paper in a plate for future use.  
 
 
3.4.8.4. Solutions for DNA hybridisation dot blots 
All solutions used in the dots blots were made according to instructions from Roche. The 
methods and solutions are specific for use with the DIG detection system (Roche 
Diagnostics, Charles Avenue, West Sussex, UK). These are listed in detail in the 
Appendix. 
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3.4.8.5. DNA hybridisation dot blots 
3.4.8.5.1. Pre-hybridisation of membrane 
To prepare the membrane for hybridisation the membrane was calibrated in a pre-
hybridisation step. The hybridisation tubes were washed thoroughly and the hybridisation 
oven (Fisher Scientific, UK) warmed to 50
o
C beforehand. This was checked using a 
thermometer (Fisher Scientific, UK). For pre-hybridisation, 20 ml of DIG Easy Hyb buffer 
(Roche Diagnostics, Charles Avenue, West Sussex, UK) was put in each hybridisation 
tube and left in the hybridisation oven until they reached 50
o
C. Subsequently the 
membrane was put into the hybridisation tube with DNA side facing the tube interior and 
a further 20 ml heated DIG Easy Hyb buffer was added to give 40 ml in each tube. 
 
3.4.8.5.2. Hybridisation of the probes to the membrane 
For hybridisation of the DIG labelled probes to any DNA on the membranes, another 
hybridisation step is undertaken. Each hybridisation experiment was repeated three times. 
Approximately 5-10 μl of the DIG-labelled PCR product probe (this is dependent on the 
probe concentration, as described by Roche Diagnostics) to 500 μl of DIG Easy Hyb 
buffer (Roche Diagnostics, Charles Avenue, West Sussex, UK) and boiled in a beaker on a 
hot plate (Fisher Scientific, UK) for 10 min (98
o
C) followed by chilling immediately on 
ice. The boiled probe was added to the pre-heated hybridisation tube after Prehybridisation 
stage and subsequently the tubes were rotated in the hybridisation oven (Fisher Scientific, 
UK) overnight at 50
o
C. 
 
3.4.8.5.3. Stringency Washes 
The stringency washes are employed to remove any unbound probe and is carried out at 
approximately 10
o
C above the hybridisation temperature (this is equivalent to the PCR 
annealing temperatures as described in Table 3.3). In practise the temperature should be 
60-68
o
C depending on the stringency required. The hybridisation oven was set at the 
appropriate stringency temperature specific for the probe used and the stringency solutions 
(SSC solutions) were heated manually using a microwave (GE microwave Model No. 
JE2160BF01, kW 1.65 (M/W) to 60
o
C. The hybridisation buffer was then discarded from 
the tube and the stringency washes conducted. The membrane was washed in 40 ml 2x 
SSC stringency solution twice for 15 min, and then in 40 ml 0.5x SSC stringency solution 
twice for 25 min. For high stringency the membrane was washed in 40 ml 0.1x SSC 
stringency solution twice for 15 min. 
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3.4.8.5.4. Detection of bound probe using DIG chemiluminescence 
The bound probes were detected on the membrane using an anti-DIG alkaline phosphatase 
method. The membrane was equilibrated in washing buffer for 2 min then agitated in 1% 
blocking solution for 45 min. The membrane was then agitated for 30 min in a 1:10,000 
dilution of anti-DIG alkaline phosphatase antibody (Roche Diagnostics, Charles Avenue, 
West Sussex, UK) in 1% blocking solution. To make the 1:10000 dilution of anti- DIG 
antibody, 5 μl of antibody was diluted into 50 ml of 1 % blocking solution. The antibody 
was centrifuged prior to dilution in 1% blocking solution. 
 
The membrane was then washed twice for 15 min in washing buffer to remove any 
unbound antibody from the membrane, and equilibrated in detection buffer for 2 min. In 
an eppendorf 10 μl CSPD (Roche Diagnostics, Charles Avenue, West Sussex, UK) was 
added to 1000 μl detection buffer. The membrane was placed DNA side up onto a clean 
plastic bag and the 1000 μl CSPD pipetted over the membrane. The plastic bag was folded 
so there were no bubbles and to ensure the membrane was entirely covered with CSPD. 
The membrane was incubated at 37
o
C for 15 min to this makes the light-producing 
reaction reach equilibrium. The blots were exposed overnight. 
 
3.4.8.5.5. Chemiluminescent Camera Method for detection:  
To visualise the blot a chemiluminescent camera was used, courtesy of Dr. Claire 
Hamilton and Dr. Kelly Berube in Cardiff School of Biosciences. The chemiluminescent 
camera (Biospectrum® Imaging system, UVP, UK) is sensitive enough to detect any light 
emission from the membrane. The image was visualized using the VisionWorks® LS 
analysis software (UVP, UK).  
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3.5. RESULTS 
3.5.1. Bioinformatic analysis of C. difficile sequences  
Conserved nucleotide regions within the sequences of toxins A and B were identified by 
employing Rupnik’s toxin typing method (1998). Conserved regions from different 
clinical isolates (20 from tcdA and 19 from tcdB) of C. difficile were collated from the 
Genbank database and imported into ClustalW (European Bioinformatics Institute) to 
identify common areas from which to design probes using the Jalview
TM
 MSA viewer 
(Figure 3.4). Two conserved regions within toxin A and four conserved regions within 
toxin B were identified (Table 3.5). These results confirmed that the regions defined by 
Rupnik et al. (1998) were indeed conserved within both C. difficile toxins, and these 
conserved regions were suitable for probe design for the MAMEF- based assay. 
 
 
Figure 3.4: Schematic diagram showing deduction of conserved regions 
Sequences of toxins A and B respectively obtained from the Genbank database were assessed for conserved 
regions using EBI ClustalW. The Bioedit v7.1.3 (Hall, 2001) method of viewing MSA allows conserved 
residues to be colour coded according to those used in the EBI program ClustalW. The guanine reside (G) is 
shown as black, cytosine (C) as blue, adenosine (A) as green and thymine (T) as red. 
 
 
tcdA Region 1 tcdA Region 2
Conserved Probe
tcdR tcdB tcdE tcdA tcdC
7570      7580      7590      7600      7610    
....|....|....|....|....|....|....|....|....|....|....|....|
1tcdA ACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAATACT
2tcdADove 1990    ACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAATACT
3tcdASebaihia 2006 ACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAATACT
4tcdAR20291 ACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAGTATTACTTTAATACT
5tcdACD196 ACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAGTATTACTTTAATACT
7630      7640      7650      7660      7670      7680    
....|....|....|....|....|....|....|....|....|....|....|....|
1tcdA AACACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAAT
2tcdADove 1990    AACACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAAT
3tcdASebaihia 2006 AACACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAAT
4tcdAR20291 AACACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAAT
5tcdACD196 AACACTGCTGAAGCAGCTACTGGATGGCAAACTATTGATGGTAAAAAATATTACTTTAAT
9130      9140      9150      9160      9170      9180    
....|....|....|....|....|....|....|....|....|....|....|....|
1tcdA GGAGTGTTTAAAGGGTCTAATGGATTTGAATACTTTGCACCTGCTAATACGGATGCTAAC
2tcdADove 1990    GGAGTGTTTAAAGGGTCTAATGGATTTGAATACTTTGCACCTGCTAATACGGATGCTAAC
3tcdASebaihia 2006 GGAGTGTTTAAAGGGTCTAATGGATTTGAATACTTTGCACCTGCTAATACGGATGCTAAC
4tcdAR20291 GGAGTGTTTAAAGGACCTAATGGATTTGAATACTTTGCACCTGCTAATACGGATGCTAAC
5tcdACD196 GGAGTGTTTAAAGGACCTAATGGATTTGAATACTTTGCACCTGCTAATACGGATGCTAAC
9190      9200      9210      9220      9230      9240    
....|....|....|....|....|....|....|....|....|....|....|....|
1tcdA AATATAGAAGGTCAAGCTATACGTTATCAAAATAGATTCCTACATTTACTTGGAAAAATA
2tcdADove 1990    AATATAGAAGGTCAAGCTATACGTTATCAAAATAGATTCCTACATTTACTTGGAAAAATA
3tcdASebaihia 2006 AATATAGAAGGTCAAGCTATACGTTATCAAAATAGATTCCTACATTTACTTGGAAAAATA
4tcdAR20291 AATATAGATGGTCAAGCTATACGTTATCAAAATAGATTCCTACATTTACTTGGAAAAATA
5tcdACD196 AATATAGATGGTCAAGCTATACGTTATCAAAATAGATTCCTACATTTACTTGGAAAAATA
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Table 3.5: Conserved regions of toxins identified via MSA 
Regions within toxin A and toxin B of C. difficile were identified by ClustalX and the MSA analysis 
software Jalview
TM
. The size of these regions were determined are listed above. Two regions in toxin A and 
three regions in toxin B were conserved across all the sequences collated from GenBank. 
 
 
C. difficile 
Toxin 
Region 
Length (bp) 
Final Conserved Nucleotide Regions References 
 
Toxin A: 1 
 
 
Toxin A: 2 
 
50 
 
 
76 
 
ATGGATTTGAATACTTTGCACCTGCTAATACGGATGCAA
CAACATAGAA 
 
AAAATATTACTTTAATACTAACACTGCTGTTGCAGTTACT
GGATGGCAAACTATTAATGGTAAAAAATACTACTTT 
 
Sebaihia et al., 2006 
Lemee et al., 2005 
Letournier et al., 2003 
Braun et al., 2000 
Sambol et al., 2000 
Kato et al., 1998 
Hundsberger et al., 
1997 
 
Eichel-Streiber, 1995 
Sauerborn & Eichel –
Streiber, 1990 
Dove et al., 1990 
Wren et al., 1990 
 
 
Toxin B: 1 
 
51 
 
TTGGCAAATAAGCTATCTTTTAACTTTAGTGATAAACAA
GATGTACCTGTA 
 
Toxin B: 2 
 
41 
 
CATATTCTGGTATATTAAATTTCAATAATAAAATTTACTA
T 
   
Toxin B: 3 52 TTTGAGGGAGAATCAATAAACTATACTGGTTGGTTAGAT
TTAGATGAAAAGA 
Toxin B 
extra region 
39 TCAAGACTCTATTATAG 
TAAGTGCAAATCAATATGAAGT 
 
 
 
3.5.2. Probe Design 
Probes for the MAMEF assay were designed to recognise sequences within each 
conserved region (~50 nucleotides; Table 3.5) and were configured to take account of the 
requirements of the assay as described in Section 1.7. Thus the anchor probes were 17 
nucleotides in length while the fluorescent detector probes were 22 nucleotides in length, 
and a 5 nucleotide gap between the anchor and fluorescent probes was incorporated to fit 
the MAMEF assay requirements. The potential capture and fluorescent detector probes 
designed from the regions can be seen in Tables 3.6 and 3.7.  
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Table 3.6: Conserved regions of toxins identified via MSA 
Probes regions within toxin A of C. difficile were designed to recognise nucleotide sequences within 
conserved regions of toxin A, and incorporated features needed for use in a future MAMEF assay. Regions 
were divided at natural break within the nucleotide sequence- at GC or CC points. The entire conserved 
region and the capture and detector probes designed from them is shown. The colour coding of bases 
indicates areas of probe under design.  Bases shown in purple indicate the capture probe under design and 
its corresponding detector sequence from the conserved region. Bases shown in green indicate the capture 
probe under design and its corresponding detector sequence from the conserved region. Bases shown in blue 
indicate the capture probe under design and its corresponding detector sequence from the conserved region. 
Bases shown in red indicate the capture probe under design and its corresponding detector sequence from 
the conserved region.  
 
 
Clostridium 
difficile 
Toxin 
Region 
Probe Regions 
(50 nt in total) 
 
 
Entire Conserved 
Region 
Capture Probe (17 nt) Detector Probe 
 Region (22 bp) 
Remaining 
region after  
 1 2 3 4   
1. Toxin A 
50 bp  
Region 
 
ATGGATTTGAATACT
TTGCACCTGCTAATA
CGGATGCTAACAAC
ATAGAA 
GGATTTGAAT
ACTTTGC 
TTTGAATACTT
TGCACC 
GAATACTTTGC
ACCTGC 
 
 
 
ACCTGCTAATACGGATGCT
AAC 
 
AACATA GAA 
TGCTAATACGGATGCTAAC
AAC 
 
ATAGAA 
TAATACGGATGCTAACAAC
ATA 
 
GAA 
2. Toxin A 
72 bp  
Region 
AAAATATTACTTTAA
TACTAACAC 
TGCTGTTGCAGTTAC
TGGATGGCAAACTA
TTAATGGTAAAAAA
TACTACTTT 
TACTTTAATAC
TAACAC 
TTTAATACTAA
CACTGC 
ACTAACACTGC
TGTTGC 
TGCTGTTGCA
G 
TTACTG 
TGCTGTTGCAGTTACTGGA
TGG 
 
CAAACTATTAA 
TGTTGCAGTTACTGGATGG
CAA 
 
ACTATTAATGG 
ATGGCAAACTATTAATGGT
AAA 
 
AAATACACTT 
GATGGCAAACTATTAATG
GTAA 
 
AAAATACTACT 
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Table 3.7: Conserved regions of toxins identified via MSA 
Probes regions within toxin B of C. difficile were designed to recognise nucleotide sequences within 
conserved regions of toxin B, and incorporated features needed for use in a future MAMEF assay. Regions 
were divided at natural break within the nucleotide sequence- at GC or CC points. The entire conserved 
region and the capture and detector probes designed from them is shown. The colour coding of bases 
indicates areas of probe under design. Bases shown in purple indicate the capture probe under design and its 
corresponding detector sequence from the conserved region. Bases shown in green indicate the capture 
probe under design and its corresponding detector sequence from the conserved region. Bases shown in blue 
indicate the capture probe under design and its corresponding detector sequence from the conserved region. 
Bases shown in red indicate the capture probe under design and its corresponding detector sequence from 
the conserved region.  
 
 
Clostridium 
difficile 
Toxin Region 
Probe Regions 
(50 nt in total) 
 
 
Entire 
Conserved 
Region 
Capture Probe (17 nt) 
 
Detector Probe 
 Region (22 bp) 
Remaining 
DNA Region 
1 2 3 4  
1. Toxin B 
51 bp  
Region 
 
TTGGCAAATAA
GCTATCTTTTAA
CTTTAGTGATAA
ACAAGATGTAC
CTGTA 
TTGGCAAATAA
GCTATC 
ATAAGCTATCTTT
TAAC 
TCTTTTAACTT
TAGTG 
 TTTTAACTTTAGTGATAAA
CAA 
 
GATGTACCT
GT 
TTTAGTGATAAACAAGATG
TAC 
 
CTGTA 
ATAAACAAGATGTACCTGT
A 
 
2. Toxin B 
41 bp Region 
CATATTCTGGTA
TATTAAATTTCA
ATAATAAAATTT
ACTAT 
CTGGTATATTAA
ATTTC 
   AATAATAAAATTTACTAT  
3. Toxin B 
52 bp Region 
TTTGAGGGAGA
ATCAATAAACT
ATACTGGTTGGT
TAGATTTAGAT
GAAAAGA 
AGGGAGAATCA
ATAAAC 
GAATCAATAAAC
TATAC 
TCAATAAACTA
TACTGG 
TAAACTAT
ACTGGTTG
G 
TATACTGGTTGGTTAGATT
TAG 
ATGAAAAG
A 
TGGTTGGTTAGATTTAGAT
GAA 
AAGA 
TTGGTTAGATTTAGATGAA
AAG 
A 
TTAGATTTAGATGAAAAG
A 
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3.5.3. In silico characterisation of probe properties 
The anchor and fluorescent detector probes for each toxin were analysed for GC content 
and secondary structures. Those with secondary structures were discarded from further 
use. Sequences were then imported into BLASTn and those sequences with significant hits 
to species other than C. difficile were discarded (9 tcdA sequences and 14 tcdB sequences). 
Those which showed homology to C. difficile only were selected for commercial synthesis 
(Table 3.8). 
 
Table 3.8: Final probes for commercial synthesis 
The probes above were commercially synthesised for further experiments. (Eurofins MWG Operon, 
Ebersberg, Germany). 
 
 
Clostridium difficile 
Toxin 
Anchor (Capture) Probe F Primer 
5’              3’ 
(17 nt) 
 
 
 
Detector Probe F Primer 
5’              3’ 
(22 nt) 
Toxin A Probe from 
50 bp Region 
 
TTTGAATACTTTGCACC 
 
 
 
TGCTAATACGGATGCTAACAAC 
Toxin A Probe  from 
76 bp 
 
TTTAATACTAACACTGC 
 
 
 
TGTTGCAGTTACTGGATGGCAA 
Toxin B Probe TCAAGACTCTATTATAG  TAAGTGCAAATCAATATGAAGT 
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3.5.5. PCR Thermocycle Optimisation 
The annealing temperatures of the synthetically designed probes were optimised for tcdA 
and tcdB binding and to enable the PCR DIG-labelling of the probes for subsequent use in 
genomic hybridisation macroarraying experiments. The anchor and fluorescent detector 
probes were all tested across a temperature gradient (+/- 10
o
C) corresponding to the 
annealing temperatures shown in Table 3.3. The PCR reactions revealed that the annealing 
temperatures recommended by Eurofins MWG Operon (Ebersberg, Germany) were 
optimal for each reaction (Figure 3.5; 3.6; 3.7). 
 
M    1     2     3      4     5     6     7  8     9   10    11   12   M
1000
500
100
M    1     2     3      4     5     6     7  8     9   10    11   12   M
A B
 
 
Figure 3.5: Anchor and detector gradient PCRs for tcdA 50bp probe 
(A) This gel shows the optimal temperature of PCR annealing over a temperature gradient of 55.6
o
C (+/- 
10
o
C). The gel also shows the PCR reaction for the anchor probe worked generating a product. (B) This gel 
shows the optimal temperature of PCR annealing over a temperature gradient of 63.5
o
C (+/- 10
o
C). The gel 
also shows the PCR reaction for the anchor probe worked generating a product. The optimal annealing 
temperatures for the anchor and fluorescent detector probes were determined as 55.6
o
C and 66.9
o
C. Marker 
(M) used is 1000 bp. PCR products at the optimal annealing temperatures are circled in red. 
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M    1     2     3      4     5     6     7  8     9   10    11   12   M
1000
500
100
M    1     2     3      4     5     6     7  8     9    10    11  12   M
A B
 
Figure 3.6: Anchor and detector gradient PCRs for tcdA 76 bp probe 
(A) This gel shows the optimal temperature of PCR annealing over a temperature gradient of 37.3
o
C (+/- 
10
o
C). The gel also shows the PCR reaction for the anchor probe worked generating a product. (B) This gel 
shows the optimal temperature of PCR annealing over a temperature gradient of 63.5
o
C (+/- 10
o
C). The gel 
also shows the PCR reaction for the anchor probe worked generating a product. The optimal annealing 
temperatures for the anchor and fluorescent detector probes were determined as 37.3
o
C and 66.9
o
C. Marker 
(M) used is 1000 bp. The amplicons produced from PCR at the optimal annealing temperatures are circled in 
red. 
1000
500
100
M    1     2     3     4     5     6     7  8     9   10   11   12   13  14   MM    1     2     3      4     5     6     7  8     9   10    11   12  13  M
A B
 
Figure 3.7: Anchor and detector gradient PCRs for tcdB  
(A) This gel shows the optimal temperature of PCR annealing over a temperature gradient of 55.6
o
C (+/- 
10
o
C). The gel also shows the PCR reaction for the anchor probe worked generating a product. (B) This gel 
shows the optimal temperature of PCR annealing over a temperature gradient of 63.5
o
C (+/- 10
o
C). The gel 
also shows the PCR reaction for the anchor probe worked generating a product. The optimal annealing 
temperatures for the anchor and fluorescent detector probes were determined as 55.6
o
C and 66.9
o
C. Marker 
(M) used is 1000 bp. PCR products at the optimal annealing temperatures are circled in red. 
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3.5.6. DNA Hybridisation dot blots 
DNA hybridisation was used as a rapid method to screen all isolates in our collection 
against the designed probes.  
 
3.5.6.1. Sensitivity of DIG-labelled probes 
The sensitivities of each DIG-labelled DNA probe were assessed to determine the optimal 
concentration for use in further dot blot experiments. The higher the concentration of 
probe the more vivid the blot once hybridisation has occurred. The probe with the highest 
sensitivity and strongest chemiluminescent signal was produced by the tcdA 76 bp Anchor 
probe, which gave a signal at a dilution of 10 ng/ μl (Figure 3.8). This is important for 
capturing target DNA within a future MAMEF based assay. On the basis of the sensitivity 
results (Figure 3.8) the concentration of probe used for subsequent macroarray screening 
studies was 60 ng/ μl.  
100         80 60         50        40         20        10          5         0
tcdA 50 bp Anchor
tcdA 50 bp Detector
tcdA 76 bp Anchor
tcdB Anchor
tcdA 76 bp Detector
tcdB Detector
 
 
Figure 3.8: Sensitivities of DIG-labelled Probes 
The probes (Table 3.7) were tested for sensitivity by performing a serial dilution of each probe (0-100 
ng/μl). The probe concentration which showed the strongest signal was used for further macroarraying 
experiments. On the basis of the sensitivity results (Figure 3.7) the concentration of probe used for 
subsequent macroarray screening studies was 60 ng/ μl.  
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3.5.6.2. Macro-arraying genomic DNA onto a positively charged nylon membrane of 
C. difficile isolates 
Genomic DNA from the C. difficile isolates tested were macroarrayed as shown in Table 
3.9. As expected each strain containing a copy of the toxin A and B gene sequences gave a 
positive signal, the strength of which varied between isolates, likely due to an artefact of 
experimental procedure. The results do not reflect the toxin A and B gene copy numbers 
within the C. difficile genome. Indeed Wren et al. (1990) postulated that there was a single 
copy of toxin A within the C. difficile genome.  
 
To confirm the specificity of the probes variant isolates of C. difficile (tcdA
-
tcdB
+
) lacking 
either the toxin A (ribotypes 017; 047: tcdA
-
tcdB
+
) or toxin B (Toxinotype XIa; XIb; 
DS1684: tcdA
-
tcdB
-
) gene sequences were included in the panel. The DNA from these 
isolates did not bind to the probes.  
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Table 3.9: gDNA from C. difficile isolates macroarrayed onto the nylon membrane.  
 
gDNA from the collection of C. difficile isolates tested was arrayed onto the positively 
charged membrane in the format shown above. Isolates were organised according to PCR 
ribotype. Toxin production per ribotype is shown in Table 3.1. 
 
 
 
Figure 3.9: gDNA Macroarrays of C. difficile isolates 
The macroarrays were performed against C. difficile isolates in our collection (58 isolates) using each probe 
as listed in Table 3.7. (A)  tcdA50 anchor probe vs. C. difficile isolates,  (B)  tcdA50 detector probe vs. C. 
difficile isolates, (C)  tcdA76 anchor probe vs. C. difficile isolates, (D)  tcdA76 detector probe vs. C. difficile 
isolates, (E)  tcdB anchor probe vs. C. difficile isolates, (F)  tcdB detector probe vs. C. difficile isolates.  
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- 
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3.5.6.3. Dot blot of species unrelated to and closely related to C. difficile 
To further confirm the specificity of the probes genomic DNA from other bacterial 
species, both close and distant relatives were subject to hybridisation analysis (Figure 
3.10). Dots were spotted by hand in the order listed in Table 3.2. The probes did not bind 
to the bacterial species unrelated to C. difficile further indicating that the probes were 
highly specific to toxins A and B of C. difficile. Species of the Clostridium genus, 
including species of the LCT family closely related to C. difficile (which possess toxins 
closely related to tcdB) did not shown any probe hybridisation which further validates the 
specificity of the probes.  
 
 
 
Figure 3.10: Dot blot of related and unrelated bacterial species by DNA hybridisation 
Species which were related and unrelated to C. difficile were tested against the probes for specificity. There 
was no hybridisation of the probes to the gDNA on the membrane. Positive control for all reactions is 
CD630 and a variant strain control R22680 (tcdA
-
tcdB
+
) was also included (highlighted by white square). 
(A)  tcdA50 anchor probe,  (B)  tcdA50 detector probe, (C)  tcdA76 anchor probe, (D)  tcdA76 detector 
probe, (E)  tcdB anchor probe, (F)  tcdB detector probe.  See p98 for list of all species used. 
 
3.5.6.4. Dot blot of human metagenomic gut DNA 
To further confirm the specificity of the designed probes, metagenomic DNA from human 
gut flora, from ten human volunteers were examined for hybridisation against the designed 
DNA probes (Table 3.3). Dots were spotted by hand in the order listed in Table 3.2. The 
probes did not bind any human metagenomic DNA samples giving a clear blot. Thus as a  
result of these experiments the tcdA 76bp anchor and detector probes, and the tcdB anchor 
and detector probes were used in the MAMEF- based detection assay. 
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3.6. DISCUSSION 
The underlying hypothesis for this study is that gene sequences encoding biologically 
essential protein structures are under considerable selective pressure, and are thus forced 
to conserve their primary sequences (Adhya & Patra, 2012). Indeed this is likely to be the 
case for toxins A and B, the organisms’ principle virulence factors. We also hypothesised 
that these conserved regions are unlikely to contain any of the DNA restriction sites 
specified and examined by Rupnik’s restriction enzyme toxin typing system (1998).  
 
To determine the conserved nature of the regions which were not digested by the 
restriction enzymes used by Rupnik (1998), bioinformatic analyses were performed using 
C. difficile toxin A and B sequences deposited in the Genbank database. We found 
homology, of varying degrees, between regions in toxin A and toxin B with each other. 
Indeed the homology between both toxins has been suggested to be the result of a gene 
duplication event (Von Eichel-Streiber et al., 1992) as they share ~66% sequence and 
functional homology (Voth & Ballard, 2005). This was reflected in our bioinformatic 
analyses and gives credence to the gene duplication theory postulated by Von Eichel-
Streiber et al. (1992); however it appears that toxin B is more stable than toxin A in C. 
difficile. This suggests that toxin B may have evolved in C. difficile first, and toxin A was 
duplicated later. Toxin A is absent, or truncated, within variant strains of C. difficile; thus 
arguably the detection of toxin B within the C. difficile genome is of the most import when 
considering assay design as all toxigenic C. difficile isolates possess this toxin. The role of 
the two toxins of C. difficile in disease however has been widely debated (Lyras et al., 
2009; Kuehne et al., 2010) 
 
Bioinformatic analysis of these conserved regions also revealed homology of toxin B to C. 
sordellii lethal toxin (TcsL), and to the TpeL toxin of C. perfringens, which are part of the 
LCT family. Toxin B and TcsL share a sequence homology of 85% (Voth & Ballard) and 
thus presented a challenge in defining a toxin B specific DNA probe (Von Eichel-Streiber 
et al., 1992; Green et al., 1995). In the context of evolution it is likely to be indicative of a 
common toxin ancestor within the Clostridium family and may have arisen as a result of 
divergent evolution. Toxin A did share homology to the TcsL sequences from the LCT 
family; however this homology was not as high as with toxin B (85%). 
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From bioinformatical analyses the individual structural domains of toxins A and B also 
shared homology with toxins associated with bacterial pathogens of insects, including 
Photorhabdus luminescens, and P. asymbiotica mcf (makes caterpillars floppy) toxins. 
This association of C. difficile’s primary toxins with mcf toxins are potentially indicative 
of an insect associated past, and this finding may shed light on the evolutionary path of C. 
difficile itself. Indeed the presence of other insect virulence factors and gene homologs in 
the C. difficile genome may reflect the possibility that C. difficile may have originally 
been an insect pathogen.  
 
Alternatively the toxin genes themselves may have been acquired as a result of HGT from 
insects. This hypothesis can be supported by the fact that the PaLoc of C. difficile, where 
the toxin genes are located (Section 1.4.5), is positioned between two insertion sequences, 
and as such its presence is suggestive of horizontal acquisition. However importantly the 
PaLoc is currently not mobile and appears to have lost its mobility over its evolution, 
hence it is still designated as a “pathogenicity locus” (Braun et al., 1996). Indeed the 
insect associated genes also suggest that C. difficile may have originated as a scavenging 
organism able to degrade organic matter and insects in a potential environmental niche 
habitat. This is explored further in Chapter 4. 
 
While published nucleotide sequences are a useful source of information, they only 
represent a fraction of the diversity found in nature. Thus we adopted a rigorous screening 
process to ensure the specificity of our probes; using C. difficile isolates, related 
Clostridium species and metagenomic DNA extracts of human gut flora. Indeed the probes 
designed were specific for conserved regions within the areas defined by Rupnik (1998) 
for future use in a MAMEF based toxin detection assay. In the context of the MAMEF 
assay it would be beneficial to employ anchor probes which are highly sensitive to target 
DNA to facilitate efficient capture of target DNA. The inclusion of a second specific 
probe carrying the fluorescent detection tag at the 5’ end further enhanced the specificity 
of the assay (Section 1.7.1).  
 
Probes were firstly tested for specificity against a comprehensive panel of 58 C. difficile 
clinical isolates, representing a range of differing toxinotypes. We observed differences in 
the binding efficiency of our probes to target DNA, with the most sensitive probe being 
the tcdA (76 bp) anchor probe. Probes were further screened for specificity against isolates 
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from near neighbours within the Clostridium family, including those which possessed 
LCT genes. Finally they were subjected to a more stringent analysis by running them 
against 10 metagenomic DNA extracts from human gut flora which represents 
approximately 10
12
 per gram wet weight bacteria (Shoemaker et al., 2001). 
 
In conclusion, the ability of the resulting designed probes to bind specifically to toxins A 
and B confirms their suitability for inclusion in an assay able to detect the presence of 
pathogens in human faeces (as described in Chapter 5). Probes were designed using the 
above method were unique to toxigenic C. difficile and conserved within toxigenic 
isolates. Moreover the potential association of C. difficile toxins to insect associated 
pathogenic toxins is a link which will be explored further in Chapter 4. Indeed if the 
evolution of C. difficile and its toxins can be traced we can better understand the organism 
and explore methods to prevent the severe disease caused by its toxins. 
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CHAPTER 4 
EVOLUTION OF CLOSTRIDIUM 
DIFFICILE AND INVERTEBRATE 
ASSOCIATION 
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4.1. ABSTRACT 
Bioinformatic analysis of the genome of C. difficile revealed the presence of genes 
encoding proteins homologous to known insect virulence factors. These genes included a 
binary toxin, a putative chitinase gene and a set of genes from Photorhabdus luminescens 
and P. asymbiotica linked to virulence. Further analysis of the genes encoding C. difficile 
tcdA and tcdB revealed the presence of mcf 1 & 2 proteins which is known play a role in 
insect pathogenicity. 
 
The presence of these homologs suggests that at some stage in its evolution C. difficile 
may have been an insect pathogen. To determine if the bacterium has the ability to infect 
insects, we employed an insect model in collaboration with the University of Bath. We 
attempted to infect the tobacco hawk moth caterpillar Manduca sexta with the spore and 
vegetative forms of C. difficile. At 25
o
C there appeared to be no adverse effects upon the 
insects after injection and feeding. However at 37
o
C an effect was observed on the 
injected insects at pupation. The injection of spores and vegetative cells appeared to assist 
more insects to pupate, whereas injection of the controls (water and sodium taurocholate) 
resulted in insect mortality. The insects fed spores and vegetative cells did not show any 
signs of infection. Furthermore when the vegetative and spore forms of C. difficile were 
tested with haemolymph obtained from M. sexta there was evidence of antimicrobial 
activity. To understand whether temperature affected the ability of C. difficile spores to 
germinate, we assessed the germination of C. difficile spores at 25
o
C, 30
o
C and 37
o
C. 
Results suggest 37
o
C is optimal for germination.
 
 
In addition to screening for insect pathology we also determined the ability of C. difficile 
to degrade chitinase. A commercially available chitinase assay kit was used to ascertain 
the ability of C. difficile to produce chitinase, revealing that chitinase appears to be 
released from spore preparations when spore germination is initiated. The bioinformatic 
and in vivo experimental analysis of C. difficile has revealed that while there are genes 
within the C. difficile genome that appear to encode proteins associated with insect 
pathogenicity, they may not be biologically active. Moreover this inactivity may in fact 
suggest that although these genes may have originated from invertebrate associated 
ancestors, they may have lost biological function throughout C. difficile’s evolution.  
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4.2. INTRODUCTION 
Biological evolution has created millions of diverse species on this planet due primarily to 
repeated differentiation of existing species (Bourtzis & Miller, 2003). At its fundamental 
level an organism evolves by altering its genetic make up. This can be achieved through 
the loss, modification or acquisition of genes (horizontal gene transfer) which in turn is 
driven by natural selection. Genetic adaptations such as the acquisition of virulence factors 
allow bacteria to access and survive in new environments (Shames et al., 2009). To do so 
they must overcome physical, cellular and molecular barriers presented by the host, they 
must grow and replicate and avoid the defence mechanisms of the host. This interaction 
can be harmful, benign or even beneficial to the host (Ochman & Moran, 2001). 
 
Bacteria which have adapted to infect humans are often opportunistic pathogens that have 
“host-jumped” from another species. There are numerous examples of human pathogens 
which have evolved from diseases of insects and domestic animals including B. anthracis 
and Y. pestis (Waterfield et al., 2004; Scully & Bidochka, 2006). As a result of evolution, 
mammals and insects have developed similar immune response mechanisms to pathogens.  
 
The mammalian and insect innate immune systems have comparable structural and 
functional homology; however their adaptive immune systems are different. The innate 
immune system includes cellular and humoral defences. As part of the cellular immune 
system insects display phagocytosis, nodulisation and encapsulation. This response 
comprises haemocytes which phagocytose invading bacteria (similar to mammalian 
macrophages) and produce antibacterial reactive oxygen species (ROS) which kill the 
invaders in a similar manner to human neutrophils. Thus it is not surprising that insects 
and humans possess homologous proteins involved in superoxide production (Bergin et 
al., 2005).  
 
Processes of the humoral system  include melanisation, haemolymph (insect blood 
system) clotting and antimicrobial peptide production such as cecropins, defensins, 
attacins, lysozymes and heat shock proteins (Salzet, 2001; Seed & Dennis, 2008). 
Similarities between the insect and human immune systems supports the argument that 
pathogenicity mechanisms developed to enable bacteria to infect insects may also 
contribute to virulence in humans. An example of an insect pathogen which evolved to 
infect humans is B. anthracis. This pathogen, similar to C. difficile, is a Gram positive 
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spore forming bacillus which, unlike C. difficile, is able to grow aerobically. Examination 
of the genome of B. anthracis reveals evidence of loss of gene function which is thought 
to have occurred during its evolution from an entomopathogenic ancestor of the B. cereus 
group into a mammalian pathogen (Ivanova et al., 2003).  
  
The B. cereus group share a high degree of genetically similar genes (80-100% sequence 
identity) and comprise B. cereus (primarily a soil commensal), B. anthracis (a mammalian 
pathogen) and B. thuringiensis (an insect pathogen). Some scientists have proposed that 
these should be classified as a single species; however due to the distinct pathogenic 
behaviour between species they have all maintained their individual status (Helgason et 
al., 2000).  
 
B. anthracis is the causative agent of anthrax. The plasmids of B. anthracis pXO1 and 
pXO2 confer toxin production. pXO1 carries the anthrax toxin genes pagA, lef and cya, 
and pXO2 carries the cap genes encoding antiphagocytic factors (Read et al., 2003). Both 
B. cereus and B. anthracis possess 14 or 15 genes functioning as degraders of chitin, 
chitosan, starch and glycogen which are all associated with insects. Common virulence 
factors of B. anthracis and B. cereus include homologs of viral enhancin genes and an 
immune inhibitor gene (inhA) which selectively cleaves insect antimicrobial peptides 
(Read et al., 2003). 
 
The presence of plasmids encoding insecticidal toxins is the principal means of 
differentiating B. thuringiensis from other members of the group (Helgason et al., 2000). 
B. thuringiensis is mainly an insect pathogen which produces crystal protein toxins (cry) 
at the sporulation stage of growth. These insecticidal toxins are used as a method of 
biocontrol and cause breakdown of the insect gut (Hofte & Whiteley, 1989). Vegetative 
insecticidal toxins (VIP) are produced at the vegetative stage of growth, however not all 
strains of B. thuringiensis produce this toxin. The VIP genes of B. cereus- specifically B. 
thuringiensis - are of interest as they are directly associated with insects. VIP genes do not 
show any homology to the δ- endotoxins of B. thuringiensis, but they do target insects 
which are not susceptible to the δ- endotoxins (Bhalla et al., 2005). All these factors 
suggest a common insect associated ancestor for the bacillus group through virulence 
factor-containing plasmid acquisition.  
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Gram negative Photorhabdus species also produce insecticidal toxins. The Photorhabdus 
genus includes P. luminescens, P. temperata and P. asymbiotica. The latter is associated 
with human wounds and is not opportunistic but has links to soft tissue disease and has 
been thought to be transmitted via an invertebrate vector (spiders) (Gerrard et al., 2004). 
The two former however are associated with nematodes. Nematodes contain P. 
luminescens and P. temperata within their gut. When they encounter an insect host in the 
soil, they bite the insect injecting the bacteria into the gut. In order to survive the 
Photorhabdus multiplies within the insect blood system (haemolymph) and feeds on the 
insect tissue, releasing toxins and proteases into the corpse (Ffrench-Constant et al., 2003; 
Waterfield et al., 2004).  
 
Mcf 1 (Makes Caterpillars Floppy) toxin is released by P. luminescens. When expressed in 
a recombinant E. coli vector and injected into caterpillars, mcf 1 causes rapid degradation 
of the insect gut making the insect “floppy” (Daborn et al., 2002). Mcf1 is an 8.8 kb gene 
encoding a predicted protein 2929 aa long and has 20% homology to residues in the 
membrane translocation domain of C. difficile toxin B (Daborn et al., 2002). Mcf 1 is also 
encoded adjacent to a pheV-tRNA gene located on the same site as the viral enhancin gene 
in Y. pestis suggesting conserved mechanisms of HGT (Waterfield et al., 2004). Mcf 2 is 
encoded within P. asymbiotica and is 2993 aa in length.  
 
Insecticidal toxin complexes (Tc) are produced by Photorhabdus after host death and are 
delivered directly into the insect gut (haemocoel) by nematodes. The toxins are produced 
in four forms; Tca, Tcb, Tcc and Tcd (Bowen et al., 1998; Heerman and Fuchs, 2008). 
Other toxin complexes similar to the insecticidal toxin complexes include Serratia 
entomophilia’s sepABC genes that cause “amber disease” in larvae of New Zealand grass 
grubs (Hurst et al., 2000). The sep genes are encoded on a 120 kb plasmid pADAP which 
also encodes a prophage-like locus for an “anti-feeding effect”. Prophage–like loci are 
also present in the genomes of P. luminescens and P. asymbiotica ATCC 43949, each 
encoding effector proteins. Some of these proteins display sequence similarity to the Mcf 
toxins of Photorhabdus, TcdA of C. difficile and YopT from Yersinia enterocolitica 
(Dove et al., 1990; Yang et al., 2006). These acquired virulence factors are classed as 
Photorhabdus virulence cassettes. 
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P. asymbiotica is an emerging human pathogen which, unlike the other Photorhabdus 
species, carries plasmids. Plasmids include pPAU1 of the North American strain and 
pPAA1 and pPAA2 of other strains which have yet to be fully sequenced. Within the P. 
asymbiotica ATCC 43949 genome there is a low copy number of the insecticidal toxin 
complexes in the Tca and Tcd encoding gene islands. This gene loss has been suggested as 
the reason for the absence of oral toxicity to model insects (Wilkinson et al., 2009).  
 
A rapid virulence annotation (RVA) technique has been utilised to screen the cosmid 
library of P. asymbiotica ATCC43949 against a range of vertebrate and invertebrate 
targets. The P. asymbiotica cosmid library (40000 bp insert size) was cloned into E. coli 
and screened against a murine macrophage cell line, the nematode Caenorhabditis 
elegans, the protozoan Acanthamoeba polyphaga and the caterpillars of the tobacco horn 
worm (M. sexta) and the greater wax moth (Galleria mellonella). From the screen 21 P. 
asymbiotica gene regions displayed toxicity factors common to one or more of the test 
models (Waterfield et al., 2008). Any regions associated with human pathogenesis were 
determined by comparison with the insect pathogen P. luminescens. Interestingly the 
cellular immune response of insects is also inhibited by P. asymbiotica, all of which 
indicates that P. asymbiotica may have very recently evolved from a Photorhabdus 
ancestor to be capable of infecting both insects and humans (Waterfield et al., 2008). 
 
Insects also possess physical barriers as a defence from pathogenic bacteria. Their hard 
exoskeleton and gut lining is made from chitin (Kramer & Muthukrishnan, 1998). Chitin 
is a polymer of N-acetylglucosamine with similarities to cellulose (Bowen et al., 1991). 
Indeed some pathogenic bacteria possess an enzymatic gene called a chitinase which 
“melts” the exoskeleton of insects through degradation of chitin to a lower molecular 
weight. Insects periodically shed their chitin layers using such chitinase enzymes, and 
some bacteria have acquired such enzymes through evolution to be able to combat insect 
defences. It is highly probable that these bacteria have co-evolved within an insect vector. 
Interestingly C. difficile possesses a putative chitinase gene which is biologically 
functional in its spore form, but not in its vegetative form. This chitinase is thought to be 
associated with the spore coat protein CotE (Lawley et al., 2009; Permpoonpattna et al., 
2011). 
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To determine if C. difficile contains homologs to genes known to play a role in insect 
virulence we probed the NCBI database of published C. difficile genomes for homologs of 
the enhancin genes, VIP genes, mcf 1, TC toxins, RVA genes and the chitinase genes 
described above. We also determined the ability of clinical isolates of C. difficile to infect 
a live insect model. 
 
4.2.1. Model Insects 
Model systems are often used to study human infectious diseases. Most mammalian 
research uses primates, rodents and felines as hosts for microbial diseases; however there 
are many ethical concerns over the suffering endured by these animals (Scully & 
Bidochka, 2006). This has led some researchers to evaluate insects as an alternative model 
for the study of human pathogenic bacteria. There are many benefits to using insects as 
model hosts. They can be easily maintained, used in large numbers and do not require 
legal permission for experimental use which leads to reduced costs and labour time 
(Scully & Bidochka, 2006).  
 
An example of a successful infection model is the fruit fly Drosophila melanogaster 
which has been used extensively to characterise the pathogenicity of a range of bacterial 
species including Penicillium, P. aeruginosa, P. entomophila, Wolbachia species, Erwinia 
carotovora and Serratia marcescens (Vallet-Gely et al., 2008). The wax moth G. 
mellonella is also increasingly being used as a bacterial infection model (Seed & Dennis, 
2008). The moth is a pest of bee hives, feeding upon pollen and destroying combs. 
Bacteria studied using this model include B. cereus, P. aeruginosa, Proteus mirabilis and 
fungal pathogens such as Aspergillus (Kavanagh and Reeves, 2004). 
 
A further bacterial infection model, and the one used in this study, is the tobacco horn 
worm M. sexta the life cycle of which is shown in Figure 4.1 (Manduca project, 2001). 
The large size of the Manduca allows for easy dissection, bacterial recovery and general 
handling (Silva et al., 2002; Daborn et al., 2002). It is possible to infect these insects via 
direct injection into the hemocoel and by feeding which has led to it being employed as 
the primary model with which to study Photorhabdus species (Silva et al., 2002). For 
these reasons we utilized this model to test our clinical isolates of C. difficile, supplied 
courtesy of Dr. N. Waterfield at the University of Bath.  
 
     CHAPTER 4 
 
127 
 
 
 
 
 
Figure 4.1: Lifecycle of Manduca sexta caterpillar 
The larvae of the Manduca undergo several stages in their lifecycle.  
 Image taken from [insected.arizona.edu/manduca/PDFs/Posters.pdf @2001 Manduca Project] 
 
4.2.2. M. Sexta Biology 
Insects have three body parts: the head, the thorax and the abdomen. The insect M. sexta 
has a lifecycle as shown in Figure 4.2. The eggs of the insect are spherical and are 
approximately 1.5 mm in diameter for 3-5 days (Villenueva, 2007). The hatched 
larvae/caterpillars are cylindrical and have five pairs of legs (Figure 4.2). The main feature 
of the larvae is the red horn at the dorsal end segment from which the M. sexta derives its 
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name as the “tobacco hornworm”. Each stage of growth is known as an instar and there 
are five instars in total. In the environment Manduca larvae live 9-15 inches deep 
underground in loose soil or leaf litter. After fifth instar stage the larvae pupate for 3-5 
days and then hatch to form adult tobacco horn moths (Manduca Project, 2001). 
 
Thorax
Prolegs Spiracle
Horn
Legs
Chewing 
mouthparts
Head
 
 
Figure 4.2: Larvae of Manduca sexta 
The sections and major parts of the M. sexta larvae are shown here. The red horn and the characteristic 
lateral white stripes can be seen. The larvae have six legs, and prolegs which allow it to stay on the tobacco 
leaf. 
 
4.2.3. M. sexta gut biology 
The midgut of M. sexta is a simple tube running through the body of the insect allowing 
rapid passage and processing of large quantities of plant material (Brinkman et al., 2008). 
The midgut itself is highly alkaline (pH 9) which enables the insect to extract nutrients 
from its food; however this environment may only allow for certain bacterial communities 
to survive. The bacterial composition of the M. sexta gut has been characterised. 
Commensal bacteria of the M. sexta include Staphylococcus, Micrococcus, 
Corynebacterium, Bacillus and Paenibacillus species (Van der Hoeven et al., 2008). 
Often, breeding colonies of M. sexta are susceptible to epidemic infections thus antibiotics 
are added to suppress infection (Hoffman et al., 1966). 
 
4.2.4. M. sexta haemolymph 
The haemolymph of M. sexta contains hemolin, peptidoglycan recognition proteins and C- 
type lectins (Jiang, 2008). Challenge of Manduca with bacteria induces synthesis of 
effector proteins and antimicrobial peptides which are secreted into the insect plasma. The 
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hemolin is a 48 kDa protein containing four immunoglobulin domains, and is unregulated 
in response to bacterial challenge. The C- type (calcium dependent) lectins are involved in 
binding bacteria and haemocyte aggregation (Rolf & Reynolds, 2009). The haemolymph 
also comprises a blue biliprotein known as insecticyanin (Holden et al., 1987). The 
insecticyanin holoprotein is produced during the larval stage of growth and confers 
camouflage of the Manduca. 
 
4.3. RESEARCH AIMS 
The aims of this chapter are to: 
 
 Analyse the genome of  C. difficile for the presence of homologs to  genes known  to 
express insect virulence factors 
 Determine the feasibility of infecting an insect model with C. difficile with a view to use 
the model to test the ability of our probes to detect C. difficile. 
 Determine the ability of C. difficile to produce biologically active chitinase 
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4.4. MATERIALS & METHODS 
4.4.1. Bioinformatic analysis of C. difficile virulence gene sequences using BLASTp 
The amino acid (protein) sequences of Toxin A and B individual structural domains 
(glucosyltransferase domain, cysteine protease domain, transmembrane domain, receptor 
binding domain) were analysed to determine if they shared any sequence identity with 
amino acid sequences from other organisms stored within the GenBank sequence database 
[www. ncbi.nlm.nih.gov/Protein]. Amino acid sequence identity was determined using the 
Basic Local Alignment Search Tool protein homology search facility: BLASTp 
[http://blast.ncbi.nlm.nih.gov/Blast.cgi]. Sequences showing over 80% query coverage, 
and in >50% sequence identity, were considered to have significant homology (Altschul et 
al., 1997). The query coverage shows how long the query sequence inputted into BLAST 
is covered by the one found (subject) by BLAST. The maximum identity refers to the 
percentage alignment of the Blast input (query) sequence to its matched (subject) 
sequence and indicates the maximum percentage of identical nucleotides or amino acids 
within the noted alignment length (http://blast.ncbi.nlm.nih.gov). 
 
4.4.2. Bioinformatic analysis of the C. difficile genome for homologs to genes known 
to play a role in insect virulence 
A total of 5 independent C. difficile genomes were analysed for the presence of homologs 
to the following virulence factors: 
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Table 4.1: Table of genes examined in this study 
Genes were accessed and obtained from the NCBI Genbank database. The protein sequences were subjected 
to protein BLAST analysis and nucleotide sequences were examined via BLASTN against the non 
redundant NCBI database. 
Bacterium Species Gene 
Examined 
Bioinformatic BLAST 
Sequence Analysis 
Performed 
C. difficile tcdA: 
glucosyltransferase domain, cysteine 
protease domain, transmembrane domain 
and receptor binding domain 
PROTEIN 
C. difficile tcdB: 
glucosyltransferase domain, cysteine 
protease domain, transmembrane domain 
and receptor binding domain 
PROTEIN 
C. difficile cdtA 
cdtB 
PROTEIN 
C. difficile Putative chitinase/peroxiredoxin PROTEIN 
B. cereus ATCC 14579 
C. botulinum B1 str. Okra, 
C. perfringens D str. JGS1721 
Enhancin PROTEIN 
P. asymbiotica ATCC 43949 RVA 1- 21 
(Waterfield et al., 2008) 
PROTEIN 
P. luminescens mcf 1 
mcf 2 
Insecticidal Toxin genes 
NUCLEOTIDE 
 
4.4.3. Multiple sequence Alignments 
To identify regions common to mcf, TC toxins, toxin A and toxin B individual nucleotide 
sequences were analysed using ClustalW Multiple Sequence Alignment (MSA) program 
provided by European Bioinformatics Institute (Larkin et al., 2007). The results of this 
analysis were displayed using Bioedit v7.1.3 (Hall, 2001) MSA viewer in which bases are 
colour coded to highlight conserved regions. 
 
4.4.4. Insect infection studies 
To determine if C. difficile is capable of infecting an insect host we exposed the tobacco 
hornworm M. sexta to a series of bacterial challenges using either spores or vegetative 
organisms. 
 
4.4.4.1. Manduca sexta  
The tobacco hornworms (M. sexta) used in this study were supplied by Dr. N. Waterfield 
of the University of Bath (Figure 4.3). The M. sexta larvae were at fifth instar growth 
stage fed on an artificial wheat-germ diet (Reynolds & Nottingham, 1985) and one feeding 
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block (1cm
2
) was used per insect. Unless otherwise stated the media was supplemented 
with the antibiotic chloramphenicol and formaldehyde to prevent decomposition. The 
insects were kept individually in a transparent plastic sealed container punctured with air 
holes to allow ventilation and maintained at 25
o
C, in a DEFRA approved facility at the 
University of Bath. 
 
 
Figure 4.3: Live Manduca sexta used in this study 
The Manduca at fifth instar growth stage. Before experiments were performed they were wiped with 70% 
ethanol and handled using gloves. 
 
4.4.4.2. Bacterial Strains & Growth conditions 
The two isolates of C. difficile selected for the insect infection studies were DS1813, a 
hypervirulent 027 ribotype and DS1748 a non epidemic 002 ribotype. Spores and 
vegetative forms of each isolate were produced as previously described (Chapter 2). 
 
4.4.4.3. Preliminary Oral Infection of M. sexta with C. difficile spores 
A total of 90 Manduca at 2
nd
 instar were used in this preliminary study. 45 M. sexta 
previously fed on antibiotic-containing wheat germ were divided into three groups of 15. 
Each individual Manduca was fed a 1 cm
2
 food block inoculated with 100 μl C. difficile 
spores of strain DS1813 at a concentration of 1 x 10
7
 cfu/ml. For the second group each 
insect was fed a 1 cm
2
 food block inoculated with 100 μl C. difficile spores of strain 
DS1748 at a concentration of 1 x 10
7
 cfu/ml. As a control 15 Manduca were also fed food 
with sterile deionised water. Manduca were allowed to feed on the spore-containing 
antibiotic food for the next 3 days. This experiment was repeated using antibiotic free food 
disks. To determine if the presence of Sodium taurocholate enhanced the pathogenicity of 
C. difficile spores for Manduca, 100 μl of the bile salt sodium taurocholate (0.1%) was 
added to the 1 cm
2
 antibiotic free food blocks. As a control M. sexta were fed food with 
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sdw. Following feeding the insects were examined for signs of infection/morbidity after 3 
days. 
 
4.4.4.4. Direct Injection of Manduca sexta with C. difficile at 25 
o
C 
4.4.4.4.1 Spore challenge 
Fifth-instar M. sexta larvae were injected with 50 μl of a stock spore concentration of 1.33 
x 10
9 
/ ml spores of DS1813 and DS1748. This is a total of 6.65 x 10
7
 spores. Replicates of 
10 were used in this study. Injections were performed directly into the insect midgut using 
a 100 μl disposable syringe needle (Fisher Scientific, UK). Post injection, larvae were fed 
with wheat-germ and were monitored for symptoms of toxicity over time. This approach 
was repeated using DS1748 spores, and with sdw as a control. 
   
4.4.4.4.2. Vegetative challenge 
Experiment conducted as per above. Vegetative cultures of C. difficile strains DS1813, 
and DS1748 were grown anaerobically for 18 h, and larvae were injected with a total of 50 
μl of a vegetative cell concentration of 2 x 109 cfu/ml cells. This is a total of 1 x 107 cfu 
injected into each insect. 
 
4.4.4.5. Direct Injection of M. sexta with C. difficile at 37
o
C 
Experiments were performed as above however, insects were incubated at 37
o
C. 
 
4.4.4.6. Oral Infection of M. sexta with C. difficile spores 
A total of 100 M. sexta 2
nd
 instar larvae were divided into five groups of 20 fed on wheat-
germ with no antibiotics. This experiment was repeated using antibiotic containing food 
discs. Each individual Manduca was fed a 1 cm
2
 food block inoculated with 100 μl C. 
difficile spores of strain DS1813 at a concentration of 1 x 10
6
 cfu/ml. For the second group 
each insect was fed a 1 cm
2
 food block inoculated with 100 μl C. difficile spores of strain 
DS1748 at a concentration of 1 x 10
6
 cfu/ml (Figure 5.4). The final group of 20 insects 
served as control and were fed a 1 cm
2
 food block inoculated with 100 μl sdw.  
 
The insects were monitored each morning for 5 days for symptoms of toxicity and faecal 
matter was collected from each insect and retained for analysis. Signs of infection 
included abnormal colouring of the larvae from blue-green to brown, unusual faecal 
matter production and death. At the end of the experiment all insects were killed by 
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freezing at -20
o
C, subsequently dissected and the midgut was homogenized in sdw using a 
VortexGenie (Fisher Scientific, UK). To determine the number of recoverable bacteria a 
dilution series of faecal samples from each day was prepared with sdw and serial dilutions 
were then plated in duplicate onto CDMN agar. Plates were incubated for 48 h at 37°C 
anaerobically and individual colonies counted. 
 
 
Figure 4.4: Manduca sexta feeding on wheat-germ based food block 
Manduca were placed into individual containers with the wheat germ food block as the food source. Lids 
were applied to the containers to secure the insects, and each lid had ventilation holes. 
 
4.4.4.7. The effect of temperature on the ability of C. difficile spores to germinate 
All of the infection studies undertaken above with M. sexta were performed at 25
o
C. To 
determine the ability of the C. difficile isolates used in our infection studies to germinate 
and replicate at this and other temperatures we incubated individual strains at 25
o
C, 30
o
C 
and 37
o
C degrees. Spore germination was assessed by adding a 1 ml spore suspension (1 x 
10
7
 spores/ ml) to 9 ml BHI broth in a 15 ml heat resistant falcon tube (Fisher Scientific, 
UK) and incubated at the relevant temperature. At 1 h intervals 1 ml of spores were 
removed from broth culture and the optical density (OD450) was determined (Ultrospec 
1100 pro UV/Visible spectrophotometer). The number of viable vegetative organisms and 
spores in each sample was determined by plating serial dilutions of heat shocked (80
o
C for 
10 min) and unheated samples onto BHI agar containing 0.1% sodium taurocholate. The 
plates were then incubated at the relevant germination temperature.  
 
Experiments conducted at 37
o
C were performed using a Bug Box Plus anaerobic cabinet 
(Ruskinn Technology Ltd, Bridgend, Wales). For experiments undertaken at 25
o
C and 
30
o
C we employed a 3.4L anaerobic jar (Oxoid, Basingstoke, Hampshire, UK) with an 
anaerobic gas generating kit (Oxoid, Basingstoke, Hampshire, UK). The anaerobic jar was 
then placed into the incubator at the relevant temperature. 
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4.4.4.8. Effect of Manduca haemolymph on C. difficile spores and vegetative cells 
Fifth instar M. sexta were killed by chilling on ice for 20 min, the head subsequently 
removed and haemolymph extracted. Each experiment was performed in triplicate. C. 
difficile spores of strains DS1813 (7 x 10
5
 cfu/ml) and DS1748 (8.33 x 10
5
 cfu/ml) were 
inoculated into individual Eppendorfs containing 200 μl of M. sexta haemolymph. A 
single colony C. difficile (strains DS1813 and DS1748) was inoculated into an Eppendorf 
containing 200 μl haemolymph. The inoculated haemolymph was incubated anaerobically 
for 48 h. Viable counts of vegetative cells and spores were conducted after incubation as 
described in Chapter 2 using CDMN selective agar. 
 
4.4.4.9. Detection of Chitinase activity in spores and vegetative cells of C. difficile 
Chitinase activity was determined as per Permpoonpattna et al. (2011). A pre-supplied 
Chitinase assay kit (Sigma CS0980) was used and the reactions performed (n =6) in a 
microtitre plate (Fisher Scientific, UK). The concentration of C. difficile vegetative cells 
used was 1.33 x 10
6
 cfu/ml, and for the spore suspensions 2.67 x 10
6
 cfu/ml were used in 
the reactions and C. difficile strains DS1813 and DS1748 were tested for chitinase activity. 
Spores of C. difficile were tested for chitinase activity following germination with sodium 
taurocholate (ST) at a range of concentrations- 0%, 3% and 5%. Spores were added to ST 
mixed with PBS and incubated anaerobically for 30 min. The chitinase activity was 
assessed following this.  
 
The Substrate solution comprised 4-Nitrophenyl N-acetyl-β-D-glucosaminide (1 mg/ml) 
which was dissolved in 1 ml Assay buffer (A4855). Subsequently the Substrate and 
Standard solutions were calibrated to 37
o
C. The positive control used was the chitinase 
control enzyme (chitinase from Trichoderma viride), which was mixed with Substrate 
solution. For each subsequent test 90 μl of substrate solution was mixed in with 10 μl C. 
difficile sample. Reaction time was 30 min at 37°C. After the reaction was stopped (200μl 
of 0.04g/ml sodium carbonate) and then the OD405 of supernatants was measured using a 
plate reader (Dynex, Worthing, West Sussex, UK).  
 
4.4.4.10. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 5.04 for Windows, 
(GraphPad Software, La Jolla California USA, www.graphpad.com). Statistical significant 
differences were tested for using one way analysis of variance (ANOVA) at the 95% 
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confidence interval in conjunction with Dunnett’s post test. A P value of <0.05 was 
considered significant (Bowker & Randerson, 2006). 
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4.5. RESULTS 
4.5.1. Bioinformatic analysis of known C. difficile virulence genes using BLAST 
4.5.1.1. Toxin A Analysis 
BLAST comparisons of the four individual structural protein domains of toxin A revealed 
significant query coverage (99-100%) and maximum sequence identity of >41% to 
domains within bacteria of the LCT family. These included C. difficile tcdB, C. sordellii 
tcsL, C. novyi tcnA and C. perfringens toxins tpeL and tcpA (Table 4.2). Hits with species 
other than those in the LCT family include Vibrio parahaemolyticus and P. fluorescens 
putative toxin A within the glucosyltransferase domain. In the cysteine protease domain, 
maximum sequence identity to Vibrio cholerae RTX toxin was found to be 24%. The 
receptor binding domain of tcdA has homology to Streptococcus sobrinus, S. oralis and C. 
perfringens cell wall binding proteins. Interestingly only the membrane translocation 
domain of tcdA had identity (98%) to an insect associated bacterium- P. luminescens 
subsp. laumondii. 
 
Table 4.2: Table depicting homology hits to structural domains of toxin A 
The homology hits against each individual structural domain of C. difficile toxin A were deduced by protein 
BLAST. The percentage of sequence query coverage, and the percentage of maximum identity of each 
bacterial gene is displayed in correlation to each structural domain (*query coverage/maximum identity). 
Hits of > 50% sequence identity were considered significant. The full alignments from the protein BLAST 
[http://blast.ncbi.nlm.nih.gov/Blast.cgi] are detailed in the Appendix (p227). 
 
Bacterial gene screened 
for homology 
Homology with  C. difficile Toxin A domain   
(*query coverage/maximum sequence identity) (%) 
Glucosyl-
transferase  
(GT) domain 
Cysteine 
protease 
domain 
Membrane 
Translocation 
domain 
Receptor 
Binding 
Domain 
C. difficile tcdB  *100/49 99/59 100/60 99/42 
C. sordellii tcsL  100/52 99/57 100/60 99/41 
C. perfringens tpeL 100/45 99/52 99/46 - 
C. novyi α toxin 99/33 98/34 96/38 99/50 
C. perfringens tcpA 99/45 99/52 99/46 - 
Citrobacter rodentium lymphocyte inhibitory factor 81/24 - - - 
Pseudomonas fluorescens Putative toxin A 81/25 - - - 
P. luminescens subsp. laumondii Hypothetical protein - - 98/22 - 
Yersinia mollaretii Chemotaxis protein - 99/25 98/25 - 
Yersinia mollaretii RTX toxin - 83/27 88/27 - 
Vibrio cholerae RTX toxin - 83/24 - - 
Streptococcus salivarius Hypothetical protein - - - 99/24 
S. oralis cell wall binding repeat domain protein - - - 99/31 
C. perfringens cell wall binding repeat domain protein - - - 99/29 
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4.5.1.2. Toxin B Analysis 
BLAST comparisons of the four individual structural protein domains of toxin B revealed 
significant query coverage (99-100%) and maximum sequence identity of >40% to 
domains within bacteria of the LCT family. These included C. difficile tcdA, C. sordellii 
tcsL, and C. perfringens toxins tpeL and tcpA (Table 4.3). The GT domain of tcdB had 
sequence identity of 21% to P. fluorescens toxin A and mcf toxins, while the cysteine 
protease domain had sequence identity of 25% to the insect pathogen P. luminescens 
subsp. laumondii hypothetical protein. There was 27% homology of the cysteine protease 
domain to Y. mollaretii RTX toxin, P. asymbiotica RTX toxin and Vibrio cholerae RTX 
toxin. Interestingly the membrane translocation domain of tcdB had sequence identity (24-
33%) to the mcf toxins of P. luminescens subsp. laumondii, P. asymbiotica, P. 
luminescens, and Xenorhabdus bovienii. The receptor binding domain, however, was 
dramatically different showing 31% and 29% sequence identity to Ruminococcus albus 
and S. oralis. 
Table 4.3: Table depicting homology hits to structural domains of toxin B 
The homology hits against each individual structural domain of C. difficile toxin B were deduced by protein 
BLAST. The percentage of sequence query coverage, and the percentage of maximum identity of each 
bacterial gene is displayed in correlation to each structural domain (*query coverage/maximum identity). 
Hits of > 50% sequence identity were considered significant. The full alignments from the protein BLAST 
[http://blast.ncbi.nlm.nih.gov/Blast.cgi] are detailed in the Appendix (p227). 
 
Bacterial gene screened 
for homology 
Homology with  C. difficile Toxin B (% Homology) 
Glucosyl- 
transferase  
(GT) domain 
Cysteine 
protease 
domain 
Membrane 
Translocation 
domain 
Receptor 
Binding 
Domain 
C. difficile tcdA  *100/51 100/57 100/60 99/42 
C. sordellii tcsL  100/75 100/74 100/92 100/74 
C. perfringens tpeL 100/44 100/51 100/44 - 
C. novyi α toxin 99/34 98/36 96/37 99/34 
C. perfringens tcpA 96/44 100/51 100/44 - 
Pseudomonas fluorescens Putative toxin A 82/21 - - - 
P. luminescens subsp. laumondii (hyp. Protein)/ mcf  toxin - 92/25 100/24 - 
P. asymbiotica  mcf toxin - - 100/24  
Yersinia mollaretii  RTX toxin - 93/27 88/33 - 
P. asymbiotica subsp. asymbiotica RTX toxin - 83/27 - - 
Xenorhabdus bovienii Putative mcf toxin - - 98/24 - 
P. luminescens mcf2  toxin - - 98/23 - 
Vibrio cholerae RTX toxin - 84/27 - - 
Pseudomonas fluorescens mcf toxin 82/21 - - - 
Pseudomonas fluorescens fitD - - 98/26 - 
Ruminococcus albus cell wall binding repeat domain protein - - - 99/31 
S. oralis cell wall binding repeat domain protein - - - 100/29 
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4.5.2. Bioinformatic analysis of the C. difficile genome for homologs to genes known 
to play a role in insect virulence 
The genome of C. difficile has potential links to genes associated with insect virulence. 
Genes in C. difficile were screened for insect associated gene homologs using protein 
BLAST (Altschul et al., 1997). These genes included the binary toxin and the putative 
chitinase/peroxiredoxin gene. The genome of C. difficile was also screened for homologs 
to the enhancin genes from B. anthracis, B. cereus, C. botulinum and C. perfringens, 
which would further potentiate an evolutionary link with insects.  
 
4.5.3. Bioinformatic analysis of binary toxin 
The binary toxin of C. difficile is related to other ADP-ribosylating binary toxins of 
species that are directly linked to insect pathogenicity. These bacteria include the VIP2 
toxin of Bacillus thuringiensis and, to a lesser extent, C. perfringens Iota toxin and C. 
spiroforme. BLAST (protein) analysis of the C. difficile binary toxins revealed links to the 
ADP-ribosylating toxins from other species, as expected (Figure 4.5). Links to the ISP2a 
protein of bacteria Brevibacillus laterosporus were found, which is known to cause 
toxicity to nematodes and beetles (Oliveiera et al., 2004). There were no links to species 
associated with insects other than to the VIP genes of B. thuringiensis. 
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Figure 4.5: Protein BLAST homology hits to C. difficile Binary Toxin 
The bacterial genes with high homology to C. difficile binary toxin are displayed as per BLAST format. The 
accession number directly links to the Genbank Accession for the bacterial gene, and the gene description is 
displayed. The maximum score is defined by the score of the highest scoring pair homology and is similar to 
the E- value. The E- value is defined as the Expect value and the lower the E value the more significant the 
homology hit. The total score corresponds to the total scores of the high scoring pair from the database 
sequence. Query coverage directly relates to the percentage length coverage of the query. The higher the 
percentage coverage, the higher the homology (Altschul et al., 1997). Hits of > 80% query coverage were 
considered significant. 
 
 
4.5.4. Bioinformatic analysis of putative C. difficile chitinase gene 
The putative chitinase gene of C. difficile belongs to a family of chitinases known as the 
GH18 glycosylhydrolases, which hydrolyse chitin and have been identified in bacteria, 
fungi and insects. BLASTp analysis of the chitinase gene revealed high (100%) query 
coverage homology hits to peroxiredoxin/chitinase genes within other C. difficile strains, 
suggesting that this gene may be conserved (Figure 4.6). This gene however has links to 
Clostridium bartletti, an organism which can be isolated from human faeces (sequence 
query coverage 83%). 
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Figure 4.6: Protein BLAST homology hits to C. difficile putative peroxiredoxin/chitinase 
The bacterial genes with high homology to C. difficile the putative peroxiredoxin/ chitinase are displayed as 
per BLAST format. The accession number directly links to the Genbank Accession for the bacterial gene, 
and the gene description is displayed. The maximum score is defined by the score of the highest scoring pair 
homology and is similar to the E- value. The E- value is defined as the Expect value and the lower the E 
value the more significant the homology hit. The total score corresponds to the total scores of the high 
scoring pair from the database sequence. Query coverage directly relates to the percentage length coverage 
of the query. The higher the percentage coverage, the higher the homology (Altschul et al., 1997). Hits of > 
80% query coverage were considered significant. 
 
4.5.5. Bioinformatic analysis of enhancin genes 
To establish if genes within the C. difficile genome are homologous to the enhancin genes 
commonly associated with insects, the enhancin gene sequences from B. cereus, C. 
botulinum subsp. Okra, C. perfringens, and B. anthracis were inputted into BLASTp. The 
enhancin gene from B. cereus had no homology to C. difficile, but had 100% query 
coverage to the enhancin proteins within B. thuringiensis (Figure 4.7). The enhancin 
protein from C. botulinum, however, had 100% homology to other C. botulinum 
subspecies, and 90% to Y. pestis enhancing factors. C. perfringens D str. JGS1721 has 
100% homology to enhancin from C. botulinum species, B. cereus species and the 
enhancin from B. anthracis strain Ames.  
 
     CHAPTER 4 
 
142 
 
 
(a) 
(b) 
(c) 
(d) 
 
 
Figure 4.7: Protein BLAST homology hits to enhancin genes 
(a) B. cereus ATCC 14579 (b) C. botulinum B1 str. Okra (c) C. perfringens D str. JGS1721 (d) B. 
anthracis Ames. A range of bacteria known to possess expressed enhancin genes were analysed for 
homologs to C. difficile. Results are displayed as per BLAST format. The accession number directly links to 
the Genbank Accession for the bacterial gene, and the gene description is displayed. The maximum score is 
defined by the score of the highest scoring pair homology and is similar to the E- value. The E- value is 
defined as the Expect value and the lower the E value the more significant the homology hit. The total score 
corresponds to the total scores of the high scoring pair from the database sequence. Query coverage directly 
relates to the percentage length coverage of the query. The higher the percentage coverage, the higher the 
homology hit (Altschul et al., 1997). Hits of > 80% query coverage were considered significant. 
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4.5.6. Bioinformatical analysis of invertebrate associated virulence factors 
4.5.6.1. Screening for homology with Mcf toxin genes against C. difficile toxin genes 
From Table 4.2 and 4.3 it was revealed that the membrane translocation domains of TcdA 
and TcdB had high (99-100%) homology to P. luminescens and P. asymbiotica Mcf 
genes. Hence the amino acid sequences of these toxins were inputted into Bioedit v7.1.3 
(Hall, 2001) and analysed using an MSA viewer using colour codes equivalent to those 
used in ClustalW (Thompson et al., 1997; Figure 4.8). Mcf 1 from P. luminescens had 18-
19% sequence identity to TcdA and TcdB respectively. BLAST analysis revealed 17-18% 
sequence identity of TcdB to the mcf from P. asymbiotica. This was expected as 20% 
sequence identity of the mcf toxins to TcdB has been described previously (Dove et al., 
1990).  
                                        450       460       470       480    
                                ....|....|....|....|....|....|....|....| 
1. Photorhabdus luminescens (g  TCTGAGAGAGAACGCGGCAGGCAAGCAGGTTAAGCTGGAT  
2. Photorhabdus asymbiotica mc  TCCAGGCGGCTTAAAGACCCTGAATGAGGCGCCCCTGAAT  
3. C. difficile toxin B (gi|26  ATCAGCAACAAATGATACACTTGAATCATTTAGAGAAAAC  
4. C. difficile toxin A (gi|26  TTCTACCACTGAAGCATTACAGCTACTAGAGGAAGAGATT  
 
                                        490       500       510       520    
                                ....|....|....|....|....|....|....|....| 
1. Photorhabdus luminescens (g  ATCAAGATCAAACGTCTGGAACAGCAACTGACTATGCAGG  
2. Photorhabdus asymbiotica mc  GTGGAGACGGCGACCCTGAAGGAGGTGACCTCGAAGGAGA  
3. C. difficile toxin B (gi|26  TTAAATGACCCTAGATTTGACTATAATAAATTTTACAGAA  
4. C. difficile toxin A (gi|26  CAAAATCCTCAATTTGATAATATGAAATTTTACAAAAAAA  
 
                                        530       540       550       560    
                                ....|....|....|....|....|....|....|....| 
1. Photorhabdus luminescens (g  TGGCTGCCTCCACGTTGTTCGGCCCAAAATACGTGATGCT  
2. Photorhabdus asymbiotica mc  TGATTCTGAAGGAGGATAAGGTGAACAAGCGGGCTAAGCT  
3. C. difficile toxin B (gi|26  AACGTATGGAGATAATCTATGATAAGCAGAAAAATTTCAT  
4. C. difficile toxin A (gi|26  GGATGGAATTTATATATGATAGACAAAAAAGGTTTATAAA  
 
                                        570       580       590       600    
                                ....|....|....|....|....|....|....|....| 
1. Photorhabdus luminescens (g  GTTTTCCGAATTACAGGCCTACAAGGAGGTCAATGCTCGC  
2. Photorhabdus asymbiotica mc  GGATGCCGAGATTAAGCGTTTGGAACAGCAACTGACCGTA  
3. C. difficile toxin B (gi|26  AAATTACTATAAAACTCAAAGAGAAGAAAATCCTGACCTT  
4. C. difficile toxin A (gi|26  TTATTATAAATCTCAAATCAATAAACCTACAGTACCTACA  
 
Figure 4.8: MSA of mcf toxin of P. luminescens and P. asymbiotica against toxins A and B of C. 
difficile 
The nucleotide sequences of tcdA and tcdB of C. difficile, and the mcf toxin of P. luminescens and P. 
asymbiotica, were imported into EBI ClustalW for alignments. The Bioedit v7.1.3 (Hall, 2001) method of 
viewing MSA allows conserved residues to be colour coded according to those used in the EBI program 
ClustalW. The guanine reside (G) is shown as black, cytosine (C) as blue, adenosine (A) as green and 
thymine (T) as red.  
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4.5.6.2. Screening for homology with Insecticidal toxin genes against C. difficile toxin 
genes 
As the mcf toxins from P. luminescens shared 20% homology with tcdB of C. difficile, it 
was of interest to screen the insecticidal toxins from P. luminescens for homology to TcdA 
or TcdB. Hence the nucleotide sequences of the insecticidal toxins TccA, TccB, TccC, 
TcaC, and TcdA of P. luminescens and P. asymbiotica TccC were inputted into ClustalW 
and analysed using an MSA viewer (Figure 4.9). Bioinformatic analysis of the insecticidal 
toxins revealed no significant homology to any C. difficile toxins. Significant homology at 
the genome level is considered to be 20% or above.  
 
                                        6330      6340      6350      6360   
                                ....|....|....|....|....|....|....|....| 
TcaC Photorhabdus luminescens   CCGGTCAATCGGAAG--TCACACTAGAAAAGCCCAC--GT  
TccB1 Photorhabdus luminescens  CCAGCTATGCCATCACATTGCAACAACAGGCGTTGG--AT  
TccC Photorhabdus luminescens   ACAGAGTAATAGGTG--GCGGATTCTTGGGGAGGTT--AT  
TccA Photorhabdus luminescens   GCACAGAGCCAGACTGGCCTTGGCGTTACACAGCAACAGC  
TcdA1 Photorhabdus luminescens  TATTGACTAACCTGAGCATTCAGGACAAAACCATTG--AA  
TcdA C. difficile (gi|26068537  GTGTTTTAGCAATAA--ATATGTCATTATCTATAGC--TG  
TcdB C. difficile gi|260685375  GTATAATGGCAGTAA--ATTTAACAGCAGCTACAAC--TG  
TccC Phototrhabdus asymbiotica  CAAAAAAACTGATCG--GTTGATTATCAGGCCCCCT--GA  
 
                                        6370      6380      6390      6400   
                                ....|....|....|....|....|....|....|....| 
TcaC Photorhabdus luminescens   TACA-GGCGCTGGTAGCGTTTCAAGAAACCGCCATGATGG  
TccB1 Photorhabdus luminescens  GGATTGGCGGCGGATCGTCTGGCGCTGTTGGCT-AGTCAG  
TccC Photorhabdus luminescens   TAGGCCGGGCTGTCAGCCCATATGCCGCCGGTTTAGCCAG  
TccA Photorhabdus luminescens   AAGGCTATGTCCTGAGCCGTGATAGTGATTATACCCTTTG  
TcdA1 Photorhabdus luminescens  GAATTGGATGTCGAGAAAACCGTGCTGGAAAAA-TCCAAA  
TcdA C. difficile (gi|26068537  CAACGGTAGCTTCAATTGTTGGAATAGGTGCTGAAGTTAC  
TcdB C. difficile gi|260685375  CAATCATTACTTCATCTTTAGGAATAGCTAGTGGATTTAG  
TccC Phototrhabdus asymbiotica  AAGACGGTAG------------------------------  
 
                                        6410      6420      6430      6440   
                                ....|....|....|....|....|....|....|....| 
TcaC Photorhabdus luminescens   ACGAT------ACCTCATTACAGGCGT-ATGAAGGGGTGA  
TccB1 Photorhabdus luminescens  GCGACGGCGCAACAGCGTCATGACCATTATTACACGCTGT  
TccC Photorhabdus luminescens   ACAATTAGTGCATTTCAGTATAGCCAG-ACCTGTCTTTGA  
TccA Photorhabdus luminescens   GCAAAGCACCGGTCAGGCGATGGTGGCTGGCGTATCTCAT  
TcdA1 Photorhabdus luminescens  GCGGGAGCCCAATCGCGCTTTGATAGCTATAGCAAGTTGT  
TcdA C. difficile (gi|26068537  TATTTTCTTATTACCTATAGCTGGTAT-ATCTGCGGGAAT  
TcdB C. difficile gi|260685375  TATACTTTTAGTTCCTTTAGCAGGAAT-TTCAGCAGGTAT  
 
 
Figure 4.9: MSA of Insecticidal Toxin Complexes of P. luminescens and P. asymbiotica against toxins 
A and B of C. difficile The nucleotide sequences of tcdA and tcdB of C. difficile, tccA, tccB1, tccC, tcaC, 
and tcdA1 of P. luminescens and P. asymbiotica tccC were imported into EBI ClustalW for alignments. The 
Bioedit v7.1.3 (Hall, 2001) method of viewing MSA allows conserved residues to be colour coded according 
to those used in the EBI program ClustalW. The guanine reside (G) is shown as black, cytosine (C) as blue, 
adenosine (A) as green and thymine (T) as red. 
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4.5.6.3. Screening for homology with RVA genes from P. asymbiotica 
To determine of there were genes within C. difficile that were linked to the Photorhabdus 
virulence gene set, the 21 RVA genes from the cosmid library of P. asymbiotica 
ATCC43949 (associated with cross-species virulence) were inputted into BLAST for 
potential homology hits to genes in the C. difficile genome. BLAST analysis revealed no 
homology to any known C. difficile toxins. 
 
4.5.7. Insect infection studies 
To determine if C. difficile is capable of infecting an insect host, we exposed the tobacco 
hornworm M. sexta to a series of bacterial challenges using either spores or vegetative 
organisms. 
 
4.5.7.1. Direct injection of Manduca sexta with C. difficile at 25
o
C 
Attempts to infect M. sexta with C. difficile spores were unsuccessful. Injected spores 
administered in combination with the germinant sodium taurocholate had no obvious 
effect on the health of the M. sexta. Indeed the M. sexta also survived challenge with 
vegetative cells showing no symptoms of toxicity or morbidity. 
 
4.5.7.2. Direct Injection of M. sexta with C. difficile at 37
o
C 
Further attempts to infect M. sexta with C. difficile spores were unsuccessful at a higher 
temperature of 37
o
C. There was no rapid acute infection and thus the Manduca followed 
their normal life cycle (Figure 4.1) and as expected started to pupate after 5 d at 5
th
 instar. 
Furthermore we employed sodium taurocholate as a germinant in conjunction with spores; 
however no infection manifested. Interestingly Manduca which only received sodium 
taurocholate or water were unable to pupate correctly at 37
o
C (Figure 4.10). Indeed the M. 
sexta also survived challenge using vegetative cells and showed no symptoms of toxicity 
or morbidity.  
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Figure 4.10: Results of direct injection of C. difficile in M. sexta 
Insects were directly injected with C. difficile vegetative cells and spores of strains DS1813 and DS1748. 
Spores were injected in combination with ST to attempt to elicit an infective response. Controls used were 
ST and sterile water. In total 20 Manduca were tested in each sample group. The number of Manduca which 
died after injection with ST is shown in blue, the number of Manduca which survived and showed a 
subsequent delay in pupation; and thus their normal lifecycle are show in purple and finally those which 
were able to pupate normally after 5 days are shown in red. As these values are percentages of Manduca 
statistical analysis of the values was not conducted. 
 
 
 
4.5.7.3. Effect of Manduca haemolymph on C. difficile spores and vegetative cells 
C. difficile was tested against M. sexta haemolymph to determine if the response to direct 
injection with C. difficile was influenced by compounds within the insect haemolymph. 
Spores of strains DS1813 (7 x 10
5
 cfu/ml) and DS1748 (8.33 x 10
5
 cfu/ml) were 
inoculated into haemolymph and recovered on CDMN selective agar. In response to 
haemolymph 2.17 x 10
3
 cfu/ml of strain DS1813 and 3.58 x 10
4
 cfu/ml of strain DS1748 
were recovered. Indeed this is indicative of potential antimicrobial compounds present 
with the haemolymph of M. sexta. Furthermore, there was no recovery of vegetative C. 
difficile from the inoculated haemolymph after incubation.  
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4.5.7.4. Oral Infection of M. sexta with C. difficile spores 
To determine the feasibility of infecting Manduca via feeding, insects were fed spores 
with and without sodium taurocholate upon antibiotic containing and antibiotic-free wheat 
germ. After 3 d we saw no evidence of morbidity in any of our feeding studies suggesting 
that oral uptake does not initiate infection. 
 
4.5.7.5. Potential for gastrointestinal colonisation of M. sexta 
We tested M. sexta as a possible model to study the ability of C. difficile to colonise the 
gut. To determine if these differences in hydrophobicity affected the ability of the spores 
to adhere to the insect midgut and subsequently cause infection, Manduca were fed spores 
and the numbers recovered over a 5 d period. Two strains with different hydrophobic 
characteristics were used; DS1813 spores which are highly hydrophobic (77% RH) and 
DS1748 spores which are hydrophilic (14%). 
 
In a subsequent series of experiments spores of each strain of C. difficile were fed to 
Manduca on antibiotic containing or antibiotic-free wheat germ with and without 
taurocholate. Faecal matter was cultured to ascertain the number of spores that passed 
through the insect, or remained within the insect. The expectation was that successful 
infection would result in an increase in the number of cells recovered. Upon the fifth day 
of the study the Manduca were killed and dissected to remove the mid gut. This was then 
cultured to ascertain the number of bacteria remaining within the gut. Infection of the 
Manduca was unsuccessful as the number of bacteria recovered decreased over time and 
there was no evidence of an increase in the total number of C. difficile, suggesting that the 
organism had simply passed through the gut. Culture of the gut contents at 5 days revealed 
no difference in the numbers of bacteria recovered from each test group as shown in 
Figure 4.11. This was confirmed by use of one way ANOVA revealed no significant 
difference between the mean results from each test group (P = 0.0769) (Figure 4.11). The 
mean results for each test group were further compared to each other using Dunnett’s 
multiple comparison post-hoc test, also revealing no significant difference in recovery. 
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Figure 4.11: Average final recovery of C. difficile per Manduca sexta test group 
The average recovery was determined by adding up the number of spores recovered and divided per insect 
(20). The final number of spores recovered appears to be equivalent to the number of spores initially fed (1 x 
10
6
) to the insects. The final recovered DS1748 spores on antibiotic containing wheat germ is shown in blue, 
final recovered DS1748 spores on antibiotic-free wheat germ is shown in red, final recovered DS1813 
spores on antibiotic containing wheat germ is shown in green, and final recovered DS1748 spores on 
antibiotic free wheat germ is shown in purple. There is no statistical significance between the mean values, 
determined by use of one way ANOVA (P = 0.0769). 
 
4.5.8. The effect of temperature on the ability of C. difficile spores to germinate 
To determine if the temperature at which the insects were stored (25
o
C) had an effect on 
the ability of C. difficile spores to germinate; we looked at the ability of spores to 
germinate at 25
o
C, 30
o
C and 37
o
C. Results suggest C. difficile spore of strains DS1813 
and DS1748 germinate better at 37
o
C (Figure 4.12). At 25
o
C there was a significant 
reduction in germination for DS1813, which appears to only germinate well at 37
o
C. 
DS1748 appears to be able to germinate with varying ability across 25
o
C, 30
o
C and 37
o
C.  
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Figure 4.12: Germination graphs of DS1813 spores and DS1748 spores  
Spores were subjected to three different temperatures and germination monitored. The optical density (450 
nm) of the spores was measured each hour over a period of 8 hours. An increase in optical density indicates 
germination has occurred. The optical density of DS1813 was determined at 25
o
C blue, 30
o
C red and 37
o
C 
green. The optical density of DS1748 was determined at 25
o
C blue, 30
o
C red and 37
o
C green. One way 
ANOVA revealed highly significant differences in DS1813 germination at 37
o
C. Analysis of DS1748 
revealed a significant differences in the germination abilities of spores at different temperatures (P = 0.002). 
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Statistical analysis via one way ANOVA revealed that there were highly significant 
differences in the germination ability of DS1813 spores between temperatures (P < 0.001). 
The most significant was at 37
oC as deduced via Dunnett’s multiple comparison post hoc 
test. Analysis of DS1748 germination revealed significant differences between the test 
temperatures (P = 0.002).  
 
4.5.9. Detection of Chitinase activity in spores of DS1813 & DS1748 
To determine if the peroxiredoxin/chitinase gene in C. difficile was biologically 
functional, the chitinase activity of germinating and ungerminated spores of C. difficile 
strains DS1813 and DS1748 and their vegetative cells were assessed using the Chitinase 
Assay kit (Sigma Aldrich, Dorset, UK). Vegetative cells of both strains failed to 
demonstrate chitinase activity. The same was true for ungerminated spores (Figure 4.13). 
However germinating spores (treated with the germinant sodium taurocholate) showed 
evidence of chitinase activity similar to that recently reported by (Permpoonpattna et al., 
2011). Statistical analysis using one way ANOVA (P <0.0001) revealed a significant 
difference when comparing the mean results between each strain with and without 
addition of taurocholate. When comparing the effect of sodium taurocholate on the strains, 
the most significant results were from spores of strains DS1813 and DS1748 when 
germinating with 3% ST, and spores of strain DS1813 germinating with 5% ST when 
compared to the blank in a Dunnetts multiple comparison post-hoc test. 
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Figure 4.13: Chitinase activity of C. difficile   
Vegetative cells and spores of C. difficile strains DS1813 and DS1748 were tested for chitinase activity 
using a chitinase assay kit (Sigma Aldrich). A blank solution was used to calibrate the assay, and a Standard 
marker for significant chitinase activity. The Positive control (Chitinase from Trichoderma viride) was also 
used to determine if the reaction was viable. Vegetative cells of both strains did not demonstrate chitinase 
activity upon testing. Untreated spores did not exhibit chitinase activity; however spores treated with the 
germinant ST appeared to show a marked increase in chitinase activity. 
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4.6. DISCUSSION 
Bioinformatic analysis of the genome of C. difficile revealed the presence of genes 
encoding proteins homologous to known insect virulence factors. Analysis of the genes 
encoding C. difficile tcdA and tcdB revealed homology to the mcf proteins which are 
known play a role in insect pathogenicity. Furthermore individual structural protein 
domains of each toxin revealed significant structural homology to proteins associated with 
insect infection. For toxin A this included P. fluorescens putative toxin A and a P. 
luminescens subsp. laumondii hypothetical protein. The structure of toxin B also has 
significant association with P. fluorescens putative toxin A and the mcf toxins of P. 
luminescens and P. asymbiotica.  
 
The putative chitinase/peroxiredoxin gene within the C. difficile genome has been 
suggested to be associated with the spore coat proteins and the ability of the spore to 
germinate (Permpoonpattna et al., 2011). Thus the ability of selected C. difficile 
vegetative cells and germinating and ungerminating spores to produce a biologically 
functional chitinase was assessed. As expected we found that chitinase was released from 
germinating spores of both strains. This suggests that the spores may be releasing 
chitinase during germination to potentially enable macromolecular degradation of soil 
elements, such as fungi and dead insects, and thus allow nutrient uptake. Spores from 
other members of the clostridial family are usually saprophytic, residing in soil so it may 
be the case that the chitinase release from germinating spores is a relic of C. difficile’s 
evolutionary history. Hence it could also be assumed that C. difficile may have divergently 
evolved alongside a saprophytic Clostridium into a human pathogen (Figure 1.11). 
 
To establish whether C. difficile is able to infect insects we employed the M. sexta 
infection model host system. We found that C. difficile spores and vegetative cells were 
unable to elicit symptoms of infection upon either injected or oral delivery at 25
o
C and 
37
o
C. While challenge at 37
o
C with C. difficile had no obvious effects on the health of the 
insect, we did observe that the majority of insects followed their normal life cycle at this 
temperature in that they pupated after 5 days in contrast to unchallenged controls which 
were unable to pupate correctly. The presence of the bile salt germinant sodium 
taurocholate had no affect on infectivity.  
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This suggests that immune specific priming leading to developmental changes may have 
occurred following exposure to spores (Alberea & Schaub, 2008). In order to defend 
against infection, insects possess an innate immune system capable of pathogen 
recognition and elimination, releasing small effector molecules and antimicrobial peptides 
(Waterfield et al., 2004). This may have occurred upon direct injection of C. difficile into 
the Manduca haemocoel, inducing an adaptive immune response. It would be of interest to 
examine which immune defence molecules are expressed in Manduca upon challenge with 
C. difficile. 
 
Interestingly experiments using the haemolymph of the Manduca revealed that 
compounds within the haemolymph reduced the viability of C. difficile vegetative cells 
and spores after inoculation. Thus as there was a reduction in spore viability, and no 
vegetative C. difficile survived, credence can be given to the theory that potential 
antimicrobial peptides within the haemolymph are active. There was no neutralisation step 
involved in the experiment as the potential antimicrobial compounds have not been 
pinpointed. Indeed a further explanation of the lack of pathology is that C. difficile toxin A 
and B receptors are not present within the insect.  
 
To determine if the incubation temperatures at which the experiments were performed 
influenced the ability of the spores to germinate, we assessed spore germination at the 
following range of temperatures: 25
o
C, 30
o
C and 37
o
C. There appeared to be a significant 
increase in germination ability for both DS1813 (P < 0.001) and DS1748 strains (P 
=0.002) at 37
o
C. Thus incubation of the Manduca at 37
o
C should have elicited an 
infection; however as infection did not occur we can conclude that temperature had no 
effect on the ability of C. difficile to infect the Manduca.  
 
We also attempted utilise M. sexta as a potential model for the colonisation of C. difficile. 
Two strains with differing hydrophobic characteristics were tested; the highly 
hydrophobic DS1813 and hydrophilic DS1748. We established that there was no 
difference in the passage or adherence ability of either strain through the Manduca. Indeed 
there was also no difference between antibiotic treated and non-antibiotic treated food 
upon the colonisation abilities of C. difficile. There was no replication of C. difficile in the 
Manduca, and thus we have concluded that it is a poor model with which to study C. 
difficile colonisation. 
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Thus we have analysed the genome of C. difficile for insect associated genes and 
homologs, and have found genes which are similar to known insect virulence factors. We 
have attempted to establish an insect infection model for C. difficile but were 
unsuccessful. The origins of C. difficile and its evolution have yet to be established. While 
we cannot comment upon the evolutionary origins of the bacterium itself, we have found 
that toxin B of C. difficile is structurally similar to the insect associated mcf toxins. 
 
Toxin A does not share this homology. This may suggest that toxin B may have originated 
as the first infective toxin from an insect associated ancestor, and thus the variant toxin A 
may have arisen as a duplication event. In contrast to toxin B which is structurally stable, 
toxin A has variations within its gene coding sequences and thus this structural instability 
is also indicative of gene duplication (Rupnik et al., 1999). 
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RAPID METHODS OF DETECTING 
TOXIN A AND TOXIN B  
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5.1. ABSTRACT 
To enable the development of a rapid sensor, DNA probes specific for conserved regions 
within toxins A and B were identified as described in Chapter 3. The probes with the 
highest sensitivity were incorporated into a rapid MAMEF based assay and were 
subsequently assessed for their ability to detect C. difficile (vegetative and spores) in a 
range of organic matrices which included milk and faecal matter. Using this platform we 
were able to detect as few as 100 spores in a 500 μl suspension of faecal matter within 40 
seconds. This prototype biosensor had the potential to be developed into a real time beside 
diagnostic assay. 
 
5.2. INTRODUCTION  
Microwave accelerated metal enhanced fluorescence (MAMEF) is a technique which 
utilises low power microwave heating and a phenomenon known as metal enhanced 
fluorescence (MEF). The underlying principal of the technology is based on the selective 
heating of water, whereby the aqueous medium used in the assay is heated via microwave 
power to a higher temperature than plasmonic particles (electrons) within the metal 
surface. In this case silver is used as plasmons can be easily excited using this metal 
(plasmon resonance effect). Therefore a temperature gradient between the cold metal 
surface and the warm aqueous solution is formed, which allows DNA or other biomarkers 
to be recognised, bound and subsequently for fluorescence to occur (Geddes, 2010). Non 
radiative energy transfer occurs between fluorophores and plasmon electrons in a non 
continuous film. The metal surface becomes a mirror which intensifies the fluorophore 
signal (Geddes & Lakowicz, 2002; Das et al., 2002). The assay does not require prior 
purification of organic material and so it highly rapid and is able to detect targets with 
organic material without quenching of the signal. This means a signal can be detected 
easily in raw organic material. 
 
Conventional methods currently used to detect C. difficile infection as described in Section 
1.6. Although these methods require long turnover times and are laborious they are used 
because of their sensitivity and specificity. It is important to develop a rapid detection 
method for C. difficile to prevent transfer of micro-organisms between patients and to 
enable healthcare professionals to provide an efficient treatment regimen for the patient. 
The prevention of cross infection between patients would reduce treatment times and costs 
to the NHS.  
     CHAPTER 5 
 
157 
 
Currently it costs approximately £400 per day for each infected patient, with the estimated 
length of stay for patients with C. difficile being between 14-27 days. Thus the estimated 
cost of  treating  a patient with C. difficile in Wales would be  £8 613, and given  that over 
800 patients with C. difficile-related infections are seen per year by the University 
Hospital Wales, Cardiff, this represents a considerable avoidable cost burden (Cardiff & 
Vale NHS Trust, 2010). 
 
The laboratory tests currently used to detect C. difficile include toxinogenic assays, PCR 
methods, antigen detection (GDH) and ELISA based assays as described in Section 1.6. 
The challenges when using these methods include the time taken to conduct the tests, and 
their lack of sensitivity. Symptoms of C. difficile infection normally manifest within 24- 
48 hours of infection (as described Section 1.2), and thus there is a pressing need to 
diagnose C. difficile during the early, subclinical phase of infection to enable treatment 
and to minimise cross transmission within the hospital environment.     
     
A biosensor capable of detecting the presence of C. difficile in clinical samples in <60 
seconds without the need for complex pre-processing would dramatically reduce the time  
required to obtain confirmation of the presence of the organism compared to current 
laboratory assays. Ideally such an assay would be able to detect C. difficile with high 
sensitivity and specificity, whilst being inexpensive to run and low maintenance. 
 
A technology approach which offers the potential to develop such a rapid sensor is 
MAMEF. The approach has previously been employed to detect a range of pathogens 
including B. anthracis, Salmonella typhimurium and C. trachomatis (Aslan et al., 2008; 
Zhang et al., 2011, Tennant et al., 2011). The technology breaks open vegetative bacteria 
and spores releasing target DNA which is rapidly detected by pathogen specific probes. In 
the case of B. anthracis, a Gram positive spore former similar to C. difficile, pathogen 
specific DNA targets were detected within 60 seconds of the start of the assay. 
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5.3. RESEARCH AIMS 
The aims of this chapter are to: 
 
 To determine the ability of conserved probes identified from C. difficile Toxin A and 
Toxin B (as per Chapter 3) to detect target DNA using a MAMEF detector platform 
 To determine microwave conditions which optimise the release of target DNA from C. 
difficile spores and  vegetative bacteria 
 Determine the ability of the sensor platform to identify C. difficile target DNA within a 
range of organic matrices 
 Determine the sensitivity of the assay using known concentrations of C. difficile spores 
and vegetative cells spiked into organic matrices 
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5.4. MATERIALS & METHODS 
5.4.1. Bacterial Strains, biological fluids and genomic DNA 
Genomic DNA was isolated from C. difficile strain CD630 (supplied by NTCC, HPA, 
UK) using Chelex 100 resin (BioRad Laboratories, UK) as detailed in Chapter 3. Whole 
milk (3.5g fat content) was purchased from Whole Foods (Harbour East, Baltimore, MD, 
USA). PBS (0.01 M phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium 
chloride) was made by dissolving 1 tablet in 200 ml diH2O (Sigma Aldrich, USA). Human 
faecal matter was provided by a healthy volunteer. 
 
5.4.2. Anchor and Fluorescent Probes and target DNA 
Probes specific for conserved regions of toxin A and toxin B of C. difficile were designed 
and validated as described in Chapter 3. Probes were modified as follows to enable 
incorporation into the MAMEF detection platform (Figure 5.1); a thiol group was added to 
the 5’ region of the anchor probe to enable binding of the DNA to the surface of the silver 
island film (SiF) while the capture probe was labelled with an Alexa® (Invitrogen, USA) 
fluorophore (Aslan et al., 2008; Zhang et al., 2011). The Alexa fluorophore 488 (green) 
was used to label toxin A and the Alexa fluorophore 594 (red) was used to label toxin B. 
These fluorophores were chosen as their emissions were at wider ends of the fluorescent 
spectrum and thus would yield two different colours upon excitation. 
 
 Toxin A Toxin B 
Anchor Probe Thiol-TTTTT-
TTTAATACTAACACTGC 
Thiol- TTTTTT- 
CAAGACTCTATTATAG 
Capture Probe Alexa-488 – 
TGTTGCAGTTACTGGATGGCAA 
Alexa-594- 
TAAGTGCAAATCAATATGAAG 
Synthetic 
oligonucleotides 
AAATTATGATTGTGACGTAATCCCA 
ATACAACGTCAATGACCTACCGTT 
AGTTCTGAGATAATATCTAATCCC
AAT 
ATTCACGTTTAGTTATACTTG 
 
Table 5.1: Table of Oligonucleotides 
The anchor probes for both toxins have a run of 5 consecutive Ts (thymine bases) included to increase the 
flexibility of the probes in detecting target DNA once bound to the silver surface. The capture probes have 
an Alexa ® group added to aid fluorescent detection. The target region negative strand was also synthesised 
to aid assay development. 
 
     CHAPTER 5 
 
160 
 
The nucleotide sequences of the anchor and capture probes from each toxin are shown in 
Table 5.1. The common regions in anchor probes were preceded by a run of 5 consecutive 
Ts (thymine bases) included to increase the flexibility of the probe design once bound to 
the silver surface, and enhanced by the inclusion of a C at the terminal of the probe to 
which a thiol group was subsequently added (Aslan et al., 2008). The negative strand of 
the target region was also synthesised to bind to the capture and anchor probes 
(Invitrogen, USA) (Table 5.1). 
 
Alexa Fluor®
Synthetic
Target
43 nt
Glass
Fluorescent 
Capture
Probe 
22 nt
Silver
Anchor
Probe 
17 nt
5 nt
Thiol
group
 
 
Figure 5.1: Configuration of 3 piece DNA detection assay 
This configuration as used for the design of both toxin A and toxin B probes. The anchor probe is fixed to 
the SiF by the addition of the thiol group and is 17 oligonucleotides in length. The fluorescent probe is 22 
oligonucleotides in length and has the Alexa® attached to the 3’ end. When a target DNA strand binds to the 
anchor DNA, it should also bind to the fluorescent probe causing release of plasmons which under laser light 
induce fluorescence. Inadequate binding does not induce fluorescence. The 5 nucleotide spacer region is 
included to aid the fluorescent reaction to occur. 
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5.4.3. Formation of gold lysing triangles to microwave C. difficile   
To focus the microwave power in the microwave, gold lysing triangles were used. Gold 
lysing triangles were provided by the Institute of Fluorescence (University of Maryland). 
Glass microscope slides (Starfrost®, LightLabs, USA) were covered with a paper mask 
(12.5 mm  in size and 1 mm gap size) leaving a triangle bow-tie region exposed. Gold was 
deposited onto the glass microscope slides using a BOC Edwards 306 Auto vacuum E-
beam evaporation deposition unit, in equilateral gold triangles of 12.5 mm and 100 nm 
thick at 3.0 x 10
-6
 Torr (Tennant et al., 2011). Two layers of self-adhesive silicon isolators 
(Sigma Aldrich, USA) (diameter = 2.5 mm) were placed on top of the bow-tie regions, 
creating a lysing chamber (Zhang et al., 2011) as shown in Figure 5.2. 
 
5.4.4. The release of C. difficile DNA from vegetative cells and spores using 
microwave irradiation 
To optimise DNA release the following approaches were investigated: 
(i) Boiling C. difficile (1 x 10
5
 cfu/ml) was suspended into PBS buffer into 15 ml Falcon 
tubes (Fisher Scientific, USA) and boiled in a water bath on a hot plate (Fisher Scientific, 
USA) for 3 h. After each 30 min, a 100 μl sample was taken from the boiling spores and 
cooled on ice. The DNA released from C. difficile was examined using gel 
electrophoresis. 
 
(ii) Gold Triangles C. difficile (1 x 10
5
 cfu/ml) was suspended into PBS buffer and 
pipetted at a volume of 500 μl into the gold tie lysing chamber and exposed to a 15 s 
microwave pulse at 80% power in a GE microwave Model No. JE2160BF01, kW 1.65 
(M/W). The microwaved solution was examined for the presence of viable organisms. 
Further experiments involved spiking milk and human faecal matter (both diluted with 
PBS buffer) with varying concentrations of C. difficile and then performing microwave 
radiation. Each experiment was conducted in triplicate. 
 
5.4.5. Bacterial quantification after focussed microwave irradiation 
(i) Vegetative cells: The control samples (4 x 10
6
 cfu/ml) were serially diluted using 
Miles Misra (1938) drop count method (as described in Chapter 2). Briefly 20 μl of 
bacterial sample was serially diluted in 1:10 ratio in 180 μl BHI broth and drop counts 
performed on BHI agar and incubated at 37
o
C in a 3.4L anaerobic jar (Oxoid, 
Basingstoke, Hampshire, UK) with an anaerobic gas generating kit (Oxoid, Basingstoke, 
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Hampshire, UK). Post lysis the number of remaining viable bacteria (cfu/ml) was 
enumerated using the Miles Misra method as above (1938). 
 
(ii) Spores: The control samples (1.33 x 10
7
 cfu/ml) were serially diluted using Miles 
Misra (1938) drop count method as described in Chapter 2. Briefly 20 μl of the spore 
sample was serially diluted in 1:10 ratio in 180 μl BHI broth and drop counts performed 
on BHI agar supplemented with the spore germinant sodium taurocholate (0.1% ). Plates 
were incubated at 37
o
C in a 3.4L anaerobic jar (Oxoid, Basingstoke, Hampshire, UK) with 
an anaerobic gas generating kit (Oxoid, Basingstoke, Hampshire, UK). Before DNA 
release the sample was heated at 80
o
C for 10 min to ensure removal of any vegetative 
cells. After lysis the number of remaining viable spores (cfu/ml) was enumerated using the 
Miles- Misra method as above (1938). 
  
5.4.6. Gel electrophoresis of samples 
Post microwave irradiation the sample was centrifuged at 3000 g for 15 min (Heraeus 
Primo R; Fisher Scientiﬁc, Waltham, MA, USA) and the supernatant resuspended in a 
ratio of 1:2 ethanol (Sigma Aldrich, USA). The supernatant was removed and resuspended 
in 100 μl sdw.  The samples separated on 2% (w/v) agarose (Sigma Aldrich, USA) gels 
prepared in 1 X TAE buffer (Sigma Aldrich, USA) with 5 μl Ethidium Bromide (Sigma 
Aldrich, USA) and were run at 70 V using a BioRad electrophoresis Power Pac (Bio Rad 
Laboratories). Pre-lysis samples were included as a control.  
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5.4.7. Silver Island Film formation on glass substrate 
Silver island Films (SiFs) were prepared on Silane-prep 
TM
 glass slides (Sigma Aldrich, 
USA) to enable silver adhesion, as follows. A solution of silver nitrate was made by 
adding 0.5 g in 60 ml dH2O to 200 ml of freshly prepared 5% (w/v) sodium hydroxide 
solution and 2 ml ammonium hydroxide. The solution was continuously stirred at RT, and 
then cooled to 5
o
C in an ice bath. The slides were soaked in the solution and 15 ml of 
fresh D-glucose was added (0.72 g in 15 ml dH2O). The temperature of the solution was 
raised to 40 
o
C and as the colour of the mixture turned from yellow/green to yellow-
brown, the slides were removed from the mixture, washed with dH2O, and sonicated using 
an MSE Soniprep 150 sonicator (Sanyo) for 1 min at RT (Tennant et al., 2011). SiFs used 
in this study were between an OD450 of 0.4 - 0.5 (Figure 5.2). 
 
5.4.8. Preparation of MAMEF assay platform for detection of C. difficile DNA 
Glass slides with SiFs deposited were coated with self-adhesive silicon isolators 
containing oval wells (2.0 mm=diameter, 632 mm=length, 619 mm=width) (Sigma 
Aldrich, USA). The thiolated anchor probe was decapped to remove the thiol groups and 
enable binding to the SiF. This was achieved by diluting 40 μM anchor probe into 100 μl 
of 1 M Tris- EDTA (TE) buffer and adding 9 μl to 250 mM of 20 μl dithiothreitol (DTT) 
(38.5 mg DTT into 1 ml TE buffer). The mixture was incubated at RT for 60 min. The 
decapped anchor probe (1 μM) was diluted into 4 ml TE buffer and 100 μl of anchor probe 
was added to and incubated in each oval well of the SiF for 75 min. After incubation the 
anchor was removed and 50 μl of 1 μM Alexa-Fluor® probe was added to 50 μl of DNA 
from the target organism. The SiFs containing the bound probes and DNA was then 
incubated using MAMEF for 25 s in a microwave cavity at 20% microwave power, GE 
microwave Model No. JE2160BF01, 1.65 kiloWatts. In the presence of target DNA the 
three piece assay is complete and enhanced fluorescence can be observed. The sample was 
then removed from the well after MAMEF and the well washed with 100 μl TE buffer 3 
times. Each experiment was conducted in triplicate. 
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A B
 
 
Figure 5.2: Gold lysing triangle on Starfrost ® slide and Silver island Film 
(A) Gold triangle with silicone isolators added to create lysing chamber. In this lysing chamber 500 μl 
volume can be added and irradiated. (B) The SiF here is at an OD450 of 0.43 and has multi-well silicone 
isolators added. Each well can hold an individual DNA assay reaction; hence multiple repeats can be 
conducted. The SiF must be kept moist to prevent the silver from being oxidised. 
 
5.4.9. Detection and fluorescence spectroscopy 
The presence of target DNA was confirmed by the generation of a fluorescent signal 
following excitation with laser light. The following fluorophores were employed (details 
in Table 5.2). Fluorescence was emitted by the DNA MAMEF capture assay and 
measured using a diode laser (Figure 5.3) and a Fibre Optic Spectrometer (HD2000) 
(Ocean Optics, Inc) by collecting the emission intensity (I) through a notch filter. 
 
Alexa 
Fluor® Dye 
Absorption 
(nm) 
Emission 
(nm) 
Fluorescent 
Colour 
C. difficile 
Toxin 
Laser 
Notch Filter 
(nm) 
Alexa 488 495 519 GREEN Toxin A 473 
Alexa 594 590 617 RED Toxin B 610 
 
Table 5.2: Table of fluorescence characteristics 
Alexa Fluor dyes used to detect C. difficile toxins A and B. The absorbance and their fluorescence emission 
(nm) coupled with the laser filter is used to give the fluorescence intensity measurement. 
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Figure 5.3: Laser platform used to excite the samples 
The laser beam is directed into each well using glass prisms, and fluorescence is detected using a notch filter 
and a Fibre optic spectrometer. 
 
 
5.4.10. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 5.04 for Windows, 
(GraphPad Software, La Jolla California USA, www.graphpad.com). Three replicates 
(n=3) were performed for each detection experiment. Statistical significant differences 
were tested for using one way analysis of variance (ANOVA) at the 95% confidence 
interval in conjunction with a Kruskall-Wallis test. Dunnett’s post test was employed to 
compare sample data to control data. A P value of <0.05 was considered significant 
(Bowker & Randerson, 2006).  
 
 
 
 
 
 
Fibre optic 
spectrometer 
SiF with isolator 
Laser Beam 
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5.5. RESULTS 
5.5.1. Detection of synthetic DNA targets by MAMEF 
The ability of the toxin A and B probes to detect synthetic target DNA (43 nucleotides in 
length) was determined. Target DNA was diluted in TE buffer to give the following range 
of concentrations; 1 nM, 10 nM, 100 nM, 500 nM, 1000 nM and 100 μM with TE buffer 
serving as a control. The lowest concentration of DNA detected by each probe was 1 nM 
(Figure 5.4 A & C). Targets were readily detected by MAMEF as can be seen in Figure 
5.4 (B & D). As the concentration of the synthetic target increases the fluorescent intensity 
increases. Taking the concentration of 10 nM as an example, the intensity for Toxin A is 
20 AU and Toxin B is 45 AU. For toxin A probes the excitation is 495 nm, and emission: 
519 nm, and toxin B excitation is 590 nm and emission is 617 nm. 
 
The difference in signal intensity seen between toxin A and toxin B  may be due to several 
factors; including the optical density of the SiF used, the concentration and specificity of 
the anchor and capture probes and the excitation wavelength of the laser used to produce 
fluorescent emission. For example the concentration of anchor probe to toxin B in this 
experiment was ten-fold higher that for toxin A. 
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1000 nM 500 nM 100 nM
10 nM 1 nM Control
Control1 nM10 n M
100 nM500 nM1000 nM
A B
C D
 
 
Figure 5.4: Detection of various concentrations of synthetic oligonucleotides in TE buffer by MAMEF 
(A) This graph shows detection of toxin A synthetic oligonucleotide. There is an increase in fluorescent 
intensity as the concentration of the oligonucleotide increases. (B) The fluorescent signal produced at each 
concentration. Excitation: 495 nm, Emission: 519 nm. (C) The graph shows detection of toxin B synthetic 
oligonucleotide. There is an increase in fluorescent intensity as the concentration of the oligonucleotide 
increases. (D) The fluorescent signal produced at each concentration. Excitation: 590 nm, Emission: 617 nm. 
 
5.5.2. Detection of synthetic DNA in whole milk by MAMEF 
To determine the ability of these probes to detect toxins A and B in the presence of 
biological material, target DNA was mixed with whole milk. The whole milk was diluted 
by 10% with PBS and the synthetic target DNA was diluted in the milk to final 
concentrations of 1 nM, 10 nM, 100 nM, 500 nM and 1000 nM. As can be seen in Figure 
5.5 (B & D) the limit of sensitivity was similar to that seen with PBS at 1nM for both 
Toxin A and B. Interestingly reducing the concentration of Toxin B anchor probe from 10 
     CHAPTER 5 
 
168 
 
μM to 1 μM did not affect the sensitivity of the assay. As before there was an increase in 
fluorescent intensity as the concentration of the target oligonucleotide increased although 
the intensity of the signal was less (~5 AU) than that seen in the presence of PBS when 
comparing the results from experiments using 1 μM anchor (Figure 5.4 A; Figure 5.5 A & 
C). At the concentration of 10 nM the intensity in the presence of milk for Toxin A is ~20 
AU and Toxin B is 25 AU. 
 
1000 nM 500 nM 100 nM
10 nM 1 nM Control
1000 nM 500 nM 100 nM
10 nM 1 nM Control
A
C
B
D
 
 
Figure 5.5: Detection of various concentrations of synthetic oligonucleotides in whole milk by 
MAMEF 
(A) This graph shows detection of toxin A synthetic oligonucleotide in whole milk. There is an increase in 
fluorescent intensity as the concentration of the oligonucleotide increases. The signal has not been quenched 
by the milk. (B) The fluorescent signal produced at each concentration. Excitation: 495 nm, Emission: 519 
nm. (C) The graph shows detection of toxin B synthetic oligonucleotide in the presence of whole milk. 
There is an increase in fluorescent intensity as the concentration of the oligonucleotide increases. The signal 
is strong with no evidence of quenching. (D) The fluorescent signal produced at each concentration. 
Excitation: 590 nm, Emission: 617 nm. 
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5.5.3. Detection of synthetic DNA in human faecal matter by MAMEF 
The aim of this study is to detect C. difficile directly from human faecal samples. 
Therefore experiments were performed where target DNA was mixed with human faecal 
matter. Faecal matter was diluted by 50% with PBS and the synthetic target DNA was 
then added to give the following range of concentrations; 1 nM, 10 nM, 100 nM, 500 nM 
and 1000 nM. The limit of sensitivity was 1 nM for toxin A and 1 nM for toxin B. As 
expected an increase in fluorescent intensity was observed as the concentration of target 
oligonucleotide increased (Figure 5.6 A & B). The signal intensity however was less than 
observed in the presence of PBS and whole milk for both toxins A and B (Figure 5.4 A; 
Figure 5.5 A & C; Figure 5.6 A & B). At the concentration of 10 nM the intensity in the 
presence of milk for Toxin A is ~10 AU and Toxin B is 12 AU which are similar. 
 
 
BA
 
 
Figure 5.6: Detection of various concentrations of synthetic oligonucleotides in faecal matter by 
MAMEF 
(A) This graph shows detection of toxin A synthetic oligonucleotide in the presence of human faecal matter. 
It can be seen that there is still a strong signal. There is an increase in fluorescent intensity as the 
concentration of the oligonucleotide increases. (B) The first graph shows detection of toxin B synthetic 
oligonucleotide. There is an increase in fluorescent intensity as the concentration of the oligonucleotide 
increases. 
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5.5.4. Statistical analysis of synthetic DNA detection within organic matrices 
Statistical analysis of differences in synthetic target DNA detection of toxin A was 
performed using one way ANOVA, which revealed a P value of 0.0534. Thus as P > 0.05, 
this indicates there is no significant difference between the organic matrices used (TE 
buffer, Milk and faecal matter). This was further confirmed using the Kruskall-Wallis test 
where P = 0.2588. 
 
One way ANOVA results of toxin B synthetic target DNA detection revealed a P value of 
0.107. As P > 0.05 there is no significant difference between the organic matrices used 
(TE buffer, milk and faecal matter). This was further confirmed using the Kruskall-Wallis 
test where P = 0.158. Also there was a significant difference between the control sample 
of toxin A and B and the test concentrations as determined by Dunnetts multiple 
comparison of variance test (Graphpad Prism 5). 
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5.5.5. Detection of genomic DNA from C. difficile Strain 630  
To establish if the toxin A and B probes could detect targets within gDNA, we employed 
DNA from C. difficile strain CD630. Genomic DNA from CD630 was microwaved in 
PBS buffer for a shorter time of 8 seconds at 70% power to determine if target DNA could 
be detected. A control of unmicrowaved gDNA in PBS was employed. The toxin probes 
were able to detect gDNA at concentrations of 0.010 μg before microwave treatment, and 
0.010 μg and 0.005 μg after microwave treatment (Figure 5.7 A & B). The limit of 
sensitivity was 0.005 μg gDNA for both toxin A and toxin B. There is an increase in 
fluorescent intensity as the concentration of the oligonucleotide increases (Figure 5.7 A & 
B). The signal intensity however was similar to synthetic target intensity observed in the 
presence of PBS, and greater than that observed when the synthetic targets were tested in 
the presence of whole milk and faecal matter (Figure 5.4 A; Figure 5.5 A & C; Figure 5.6 
A & B; Figure 5.6).  
 
BA
 
 
Figure 5.7: Detection of target DNA within various concentrations of genomic DNA by MAMEF 
(A) This graph shows detection of toxin A synthetic oligonucleotide in the presence of human faecal matter. 
It can be seen that there is still a strong signal. There is an increase in fluorescent intensity as the 
concentration of the oligonucleotide increases. (B) The first graph shows detection of toxin B synthetic 
oligonucleotide. There is an increase in fluorescent intensity as the concentration of the oligonucleotide 
increases. 
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5.5.6. Release of target DNA from a C. difficile spore preparation via boiling 
A boiling based method was developed to release DNA from C. difficile. The release of   
DNA from spores was assessed by mixing spores from a ~80% preparation with either 
PBS or diH20, followed by boiling for 3 hours with samples removed every 30 min to 
determine if DNA has been released using gel electrophoresis. As can be seen in Figure 
5.8, there appeared to be no DNA release from water-treated spores. However in contrast, 
spores suspended in PBS produced a smear upon gel electrophoresis which was thought to 
represent fragmented DNA. Therefore PBS was used as the diluent for samples used in 
further experiments. 
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Figure 5.8: Gel electrophoresis of boiled C. difficile spores and vegetative cell mixed spore preparation 
C. difficile spores and vegetative cells at a concentration of 1 x 10
5
 cfu/ml were boiled in water and PBS 
buffer to ascertain DNA release. A sample was taken every half an hour for 3 h. Lanes 1-7: Boiling in PBS: 
Lane 1: shows the control sample of spores without boiling or centrifugation, Lane 2: Spore DNA release 
after 30 min boiling, Lane 3: Spore DNA release after 60 min boiling, Lane 4: Spore DNA release after 90 
min boiling, Lane 5: Spore DNA release after 120 min boiling, Lane 6: Spore DNA release after 1500 min 
boiling, Lane 7: S Spore DNA release after 180 min boiling. Lanes 5-14: Boiling in Water: Lane 8: shows 
the control sample of spores without boiling or centrifugation, Lane 9: Spore DNA release after 30 min 
boiling, Lane 10: Spore DNA release after 60 min boiling, Lane 11: Spore DNA release after 90 min 
boiling; Lane 12: Spore DNA release after 120 min boiling; Lane 13: Spore DNA release after 150 min 
boiling, Lane 14: Spore DNA release after 180 min boiling. 
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5.5.7. Release of DNA from a C. difficile spore preparation using focussed microwave 
irradiation  
We sought to develop a method which would rapidly release target DNA using microwave 
radiation. Gold triangles were used to assist in breaking open bacteria when exposed to 
microwave irradiation. This method has previously been used with B. anthracis to release 
DNA from spores (Aslan et al., 2008). Rapid heating occurs at the 1 mm gap between two 
adjacent triangles where the microwaves are focussed thus reducing the need for complex 
DNA extraction methods. A total of 500 μl of vegetative bacteria and spores were tested at 
a range of microwave powers and times until an optimal period of irradiation was 
identified (15 s in the microwave cavity at 80% power). Each sample was run under gel 
electrophoresis to establish DNA release (Figure 5.9).  
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Figure 5.9: Gel electrophoresis of C. difficile spores and vegetative cell mixed preparations 
C. difficile spores and vegetative cells at a concentration of 1 x 10
5
 cfu/ml were lysed using the gold lysing 
triangles. The power used was 80% microwave power. The 1 kb marker (M) was used. Lane 1 represents the 
control which was not lysed. Lane 2: lysis at 8 s, Lane 3: 9 s, Lane 4: 10 s, Lane 5:  11 s, Lane 6: 12 s, Lane 
7: 13 s, Lane 8: 14 s, Lane 9: 15 s and Lane 10: 16 s. The lane which showed the best lysis with the strongest 
banding (between 50 -200 bp) was Lane 9 (15 seconds). This means that the DNA had not been broken 
down to a level where it could not be detected via MAMEF, unlike in Lane 10. 
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5.5.8. Bacterial quantification following focussed microwave irradiation 
The number of viable vegetative bacteria and spores in our spore preparations pre- and 
post- microwave treatment were determined (Figure 5.10). We observed a 4 x 10
3
 cfu/ml 
log reduction in vegetative counts following microwave treatment. The corresponding 
reduction in viable spores was 1.33 x 10
4
 cfu/ml.  
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Figure 5.10: Viable counts of C. difficile spores and vegetative cells before and after lysis in PBS. 
(A) C. difficile vegetative cells were lysed by microwave irradiation at a concentration of 4 x 10
6
 cfu/ml (B) 
After lysis the concentration of vegetative cells was 6.67 x 10
2
 cfu/ml. (C) Spores were lysed at a 
concentration of 1.33 x 10
7
 cfu/ml. (D) After lysis 3.67 x 10
3
 were left. 
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5.5.9. Detection of C. difficile target DNA in PBS 
Using the conditions described above (80% microwave power) spores and vegetative cells 
of C. difficile CD630 were suspended in PBS and microwaved for 15 s. Following 
treatment, vegetative bacteria were diluted to give the following range of final 
concentrations in each assay well; 1000 cfu, 100 cfu and 10 cfu of vegetative bacteria. 
Following treatment, spores were diluted to give the following range of final 
concentrations in each assay well; 10000 cfu, 1000 cfu, 100 cfu and 10 cfu. PBS buffer 
was used as a control (Figure 5.11 A & B). 
 
The probes readily detected DNA released from vegetative cells in PBS, yielding a signal 
of approximately 20 Intensity units at 1000 cfu. The limit of sensitivity was 10 cfu for 
both toxin A and toxin B. There is an increase in fluorescent intensity as the concentration 
of vegetative cells increases (Figure 5.11 A). However the signal intensity was higher for 
the toxin B probe at 60 Intensity Units at 1000 cfu (Figure 5.11 B). As mentioned 
previously this may be due to a range of factors including anchor concentration, optical 
density of the SiF and efficiency of the fluorophore emission upon binding to target DNA.  
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Figure 5.11: Detection of DNA from microwaved vegetative C. difficile in PBS using MAMEF 
(A) Detection of toxin A from vegetative C. difficile lysed in PBS. (B) Detection of toxin B from vegetative 
C. difficile lysed in PBS. As the concentration of cfu increases the fluorescent intensity also increases. 
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The probes readily detected DNA released from the spore preparation in PBS, yielding a 
strong signal of approximately 15 Intensity units at 1000 cfu. The limit of sensitivity was 
10 cfu for both toxin A and toxin B. There is an increase in fluorescent intensity as the 
concentration of spore preparation increases (Figure 5.12 A). The signal intensity is 
similar for the toxin B probe at 18 Intensity Units at 1000 cfu (Figure 5.12 B).  
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Figure 5.12: Detection of DNA from microwaved C. difficile spore preparation in PBS using MAMEF 
(A) Detection of toxin A from spores of C. difficile lysed in PBS. A concentration of 10000 cfu of spores 
were used for toxin and B studies. (B) Detection of toxin B from spores of C. difficile lysed in PBS. As the 
concentration of cfu increases the fluorescent intensity also increases.  
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5.5.10: Detection of C. difficile target DNA in whole milk  
Spores of C. difficile CD630 were suspended in milk and microwaved for 15s using 80% 
microwave power. Following treatment, spores were diluted to give the following range of 
final concentrations in each assay well; 1000 cfu, 100 cfu and 10 cfu (Figure 5.13). The 
probes readily detected DNA released from spores in milk and the intensities appear to be 
similar as can be seen in Figure 5.13 A & B. The limit of sensitivity was 10 cfu for both 
toxin A and toxin B. For the concentration of 1000 cfu the signal intensity was ~ 5AU less 
than in the presence of PBS for both toxins A and B (Figure 5.13 A & B). However the 
signal is higher for the toxin B probe when detecting the spores (25 Intensity Units at 1000 
cfu) in Figure 5.13 B compared to the same concentration in toxin A.  
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Figure 5.13: Detection of DNA from microwaved C. difficile in whole milk using MAMEF 
(A) Detection of toxin A from spores of C. difficile lysed in whole milk. (B) Detection of toxin B from 
spores of C. difficile lysed in whole milk. As the concentration of cfu increases the fluorescent intensity also 
increases 
 
5.5.11. Detection of C. difficile target DNA in Human faecal matter 
Spores of C. difficile CD630 were suspended in human faecal matter and microwaved for 
15s using 80% microwave power. Following treatment, spores were diluted to give the 
following range of final concentrations in each assay well; 1000 cfu, 100 cfu and 10 cfu 
(Figure 5.14). The probes readily detected DNA released from spores in faeces as can be 
seen in Figure 5.14 A & B. The limit of sensitivity was 10 cfu for both toxin A and toxin 
B. The signal intensity was slightly higher than observed in the presence of PBS and milk 
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at 25 AU for toxin A and 20 AU for toxin B (Figure 5.13 A & B; Figure 5.14 A & B). In 
this experiment toxin A emitted a higher fluorescent signal than toxin B in response to the 
target. 
 
G
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Figure 5.14: Detection of DNA from lysed C. difficile in varying biological media using MAMEF 
(A) Detection of toxin A from spores of C. difficile microwaved in human faecal matter. (B) Detection of 
toxin B from spores of C. difficile microwaved in human faecal matter. For each assay it is clear that as the 
cfu increases the fluorescent intensity increases. 
 
5.5.12. Statistical analysis of C. difficile DNA detection within organic matrices 
Statistical analysis of toxin A target DNA detection was performed using one way 
ANOVA, in conjunction with a Kruskall-Wallis test revealing a P value of 0.069. Thus as 
P >0.05, this indicates there is no significant difference between the organic matrices used 
(TE buffer, Milk and faecal matter). One way ANOVA of toxin B target DNA detection 
revealed a P value of 0.008. As P < 0.05 there is a significant difference in detection 
between the organic matrices used (TE buffer, Milk and faecal matter). This was further 
confirmed using the Kruskall-Wallis test where P = 0.018. There is no significant 
difference in detection between spore concentrations used; however there was a significant 
difference between the control samples of tcdA and B and the test concentrations as 
determined by Dunnetts multiple comparison of variance test (Graphpad Prism 5). 
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5.6. DISCUSSION 
We have developed a MAMEF-based assay capable of detecting conserved regions of the 
genes encoding toxins A and B of C. difficile. We were able to detect as few as 10 cfu of 
C. difficile in a faecal suspension within 40 seconds. To put this into context, this 
represents a high level of sensitivity as in human infection approximately 10
6
- 10
8
 spores 
are released. This level of sensitivity and speed compares favourably with all of the 
currently available C. difficile detection methods as described in Section 1.6. Indeed, there 
is presently no assay capable of directly detecting the presence of C. difficile within faecal 
samples. As far as we are aware, our assay is also the only system capable of detecting 
both toxins A and B. 
 
At present C. difficile assays which employ a DNA based detection system utilise PCR to 
amplify specific DNA targets within 2- 8 hours (Zheng et al., 2004; Sloan et al., 2008; 
Goldenberg et al., 2009). This reaction is enzyme-based, and thus requires prior 
purification to remove enzyme inhibitors which prevent the amplification of target DNA. 
This can result in false negative reactions as described in Section 1.6.2 (Bickley & 
Hopkins, 1999). Other factors leading to false negative results include poor DNA 
extraction methods and the presence of exogenous DNases and RNases within a reaction 
(Ballagi-Pordany & Belak, 1996; Woodford & Johnson, 2004). False positive reactions 
can occur due to carry over contamination from previously amplified targets and 
exogenous target DNA present in reagents and sterile culture material (Kwok & Higuchi, 
1989). Thus it would not be possible to directly detect target DNA from a faecal sample 
without prior purification when using PCR.  
 
In contrast the MAMEF DNA detection system does not require purification and is 
sensitive enough to detect DNA without the need for an amplification step, further 
reducing the time required to achieve a result. An advantage of this assay is the 
construction of the hybridisation platform which allows efficient binding of target DNA 
through the incorporation of a flexible region within the anchor DNA. This comprises of a 
region of 5 thymidines which do not bind to target DNA, but instead facilitate the 
flexibility of the anchor enhancing its ability to capture target DNA in the solution (Aslan 
et al., 2010). DNA targets can be detected rapidly and efficiently within biological 
matrices such as blood (Aslan et al., 2010; Tennant et al., 2011). This study however is 
the first report of MAMEF based DNA target detection directly from milk and faeces. 
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A further advantage of the prototype assays we have developed is its ability to detect the 
genes encoding both toxins A and B. Current methods for diagnosis of CDAD are 
described in Section 1.6. Strains of C. difficile with an intact toxin B encoding gene but 
variations in the genes encoding toxin A also exist. Hence PCR and RT-PCR DNA based 
assays such as BD Gene Ohm and Xpert Cepheid are configured to detect only toxin B 
(Deshpande et al., 2011). However the role of toxins A and B in disease has been widely 
debated, with some suggesting only toxin B is essential for virulence and other suggesting 
both toxins are capable of causing fulminant disease (Lyras et al., 2009; Kuehne et al., 
2010). This highlights the importance of a diagnostic system able to detect both toxins A 
and B in an infected patient. 
 
The principle component of any nucleic acid based detection system is DNA. Thus it is 
essential that any DNA based approach includes a method to liberate DNA from the target 
microorganism. We developed a microwave based method which released DNA from a 
mixture of C. difficile vegetative bacteria and spores. The mechanism by which DNA is 
released is currently unclear; it has been proposed that spores of bacteria release DNA and 
biological components upon exposure to the electric fields generated by focussed 
microwaves (Kim et al., 2009). A further possibility is that internal pressure generated by 
the microwave irradiation of water in the spore core results in the disruption of the spore 
the release of biological components (Vaid & Bishop, 1998). 
 
We found that microorganisms suspended in PBS yielded DNA while those suspended in 
water did not. This may be attributed to the presence of salts within the PBS aiding the 
potential disruption of vegetative bacteria and spores by elevating the boiling point of the 
solution (Joffe, 1945). Indeed the release of ionic components such as Ca
2+
DPA may also 
contribute to this phenomenon. Previous analysis of DPA release from microwaved spores 
has indicated that stable complexes are formed between DPA and other ionic components 
which may affect the boiling point of the solution (Celandroni et al., 2004). The exact 
mechanism of microwave heating has yet to be determined; it is thought that microwaves 
can cause ions to accelerate and collide with other molecules causing dipoles and thus an 
electric field by which disruption of protein structure of microorganisms can occur (Banik 
et al., 2003). 
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Our assay is able to detect DNA targets within genomic DNA derived from C. difficile. In 
these preliminary experiments we used preparations containing both vegetative cells and 
spores as a model of human infection (Section 1.2). It is thus likely that the probes are 
detecting DNA derived from vegetative cells, rather than DNA liberated from broken 
spores. Given that the MAMEF technology has the ability to detect a single copy number 
of the target DNA, future studies will focus on the production of ultra pure spore 
preparations to determine whether spore DNA or vegetative cell DNA is being detected 
(Aslan et al., 2008; Lawley et al., 2009).  
 
With regards the sensitivity and specificity of our assay we determined the ability of our 
probes to detect synthetic and genomic DNA in a variety of organic matrices. Each probe 
detected 1 nM target DNA (the lowest concentration tested) in PBS, milk, and human 
faecal matter. We also examined the ability of our probes to detect DNA from 
microwaved spore and vegetative cell preparations in PBS, milk and faecal matter. Our 
preliminary findings indicate a limit of sensitivity of 10 cfu, the lowest concentration of 
cfu tested. To further improve this assay the lower limit of detection below a concentration 
of 10 cfu should be ascertained using pure spore preparations. Target DNA from 
unmicrowaved spore preparations was also detected. This suggests DNA from vegetative 
cells in the preparation, or genomic DNA on the surface of the spores, is being detected by 
the probes. 
 
To realise the potential of our promising preliminary data, future studies must focus on 
optimisation of the MAMEF platform. Thus the microwaves and laser platform would 
need to be incorporated into a hand held device capable of being used at the bedside. Also 
the SiFs used in the majority of experiments varied in their optical densities (between 0.4-
0.5) due to the silver adhering unevenly to the silicone glass surface (Aslan et al., 2010). 
Thus an improvement of the system would be to use SiFs with the exact same optical 
densities across the silicone glass slide surface. This would allow an even fluorescence 
intensity to be emitted when a target is detected. Furthermore, optimisation of the amount 
of anchor DNA bound to the SiF upon the fluorescent intensity would increase the 
sensitivity of the assay. 
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We anticipate that a future assay will be multiplexed and thus able to detect the presence 
of both toxins A and B in a sample. Further studies would involve examining a wide range 
infected C. difficile patient samples and carrying out clinical trials. 
 
We believe our prototype C. difficile detection assay has the potential to be developed into 
a real-time assay capable of identifying individuals infected with C. difficile within 40 
seconds. Such an assay would fulfil the pressing need for a rapid and sensitive detection 
system able to detect both toxin A and B encoding genes of C. difficile. In the future we 
believe this assay would be used as a means of screening patients upon admission to 
hospital to enable appropriate treatment regimens and clinical management decisions to be 
made.
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6.1. GENERAL DISCUSSION 
The aim of this research was to examine the virulence factors which contributed to the 
prevalence of the hospital bacterium C. difficile. It was also important to better understand 
the organism for which this assay was designed by not only exploring its genetic 
characteristics, but by further exploring its physical characteristics to enable a future assay 
to be designed optimally. We also designed probes specifically able to detect C. difficile 
toxins A and B within human faecal matter using a MAMEF based technological assay.  
 
The resistant spore form of C. difficile facilitates its persistence in the hospital 
environment, and enables it to initiate infection by mechanisms which have yet to be 
elucidated. As part of our research we sought to determine which characteristics of the C. 
difficile spore contributed to the organisms’ virulence. To determine if spore structure 
contributed to surface binding we characterised the abilities of spores representing a range 
of clinical isolates of differing ribotypes to adhere to organic and inorganic surfaces. 
Using the MATH hydrophobicity assay of Rosenberg et al. (1980) we identified an 
association between ribotype and spore hydrophobicity in that spores which demonstrated 
the highest percentage hydrophobicity were predominantly of hypervirulent and epidemic 
ribotypes.  
 
We then demonstrated that spores of different clinical ribotypes were better able to adhere 
to stainless steel, a material common to the hospital environment. This provided potential 
clues as to how hypervirulent isolates are transmitted, survive and spread within the 
hospital environment. Spores which exhibited high hydrophilic and hydrophobic 
properties were further investigated for adherence to organic material in the form of 
human adenocarcinoma cells (Caco 2 and HT 29). It was observed that spores with high 
hydrophobicity were better able to adhere to the adenocarcinoma cells in contrast to spores 
with hydrophilic characteristics. Thus we found that the surface hydrophobicity of spores 
influenced their ability to adhere to organic and inorganic surfaces.  
 
To determine if variations in spore adherence were associated with spore structure we 
characterised the architecture of selected spores by electron microscopy. Spores of the 
isolate DS1813, with the greatest hydrophobicity, were found to possess a distinct 
exosporium similar to that shown surrounding spores of strain CD630 (Lawley et al., 
2009). The presence, or absence, of this layer is thought to contribute to the degree with 
  GENERAL DISCUSSION 
 
185 
 
which spores of Bacillus spp adhere to surfaces (Koshikawa et al., 1989). The exosporium 
of C. difficile appears to plays an essential role in the attachment of the spore to the gut 
lining and thus is an important step in the process of bacterial colonisation (Panessa-
Warren et al., 1997). We also observed that the exosporial layer did not surround spores of 
every isolate examined, suggesting that there is no direct correlation between spore 
hydrophobicity and the presence of an exosporium. Another reason for examining spore 
adherence was to establish whether C. difficile spores could adhere to materials used 
within the context of a MAMEF based technological detection assay.  
 
Following attachment to the cells lining the gut, the spore form of C. difficile must 
germinate to initiate infection. In the context of this study we observed that certain strains, 
such as R20291 (BI/NAP1/027), exhibited varying germination ability when grown in 
different  laboratory culture media which suggests that strains differ with regards to the 
factors which trigger their germination. Indeed we isolated a variant of 027 capable of 
significant germination in the absence of the co-germinant sodium taurocholate. While the 
basis of these differences in relative germination in synthetic laboratory media are 
intriguing, their relevance to in vivo conditions has yet to be determined. Overall our data 
supports the current hypotheses that spores of C. difficile regulate their germination by 
sensing ideal locations to attach and germinate within the gut. This may be a result of bile 
salts, such as sodium taurocholate which has a positive effect on germination, and 
chenodeoxycholate which has an inhibitory effect on germination (Sorg & Sonenshein, 
2008; Giel et al., 2010).  
 
The key virulence factors of C. difficile which are expressed following attachment and 
germination are its two toxins. Toxin A and toxin B gene sequences of C. difficile were 
examined using bioinformatic analysis for conserved areas to understand the organism’s 
evolution as well as to determine regions suitable for probe design. Bioinformatic analysis 
of both toxins revealed significant homology to each others’ structural domains, which 
supports the theory that the toxins may have originally evolved as a duplication of the 
other (Von Eichel-Streiber, 1992). The original toxin ancestor has yet to be elucidated, 
and there is some debate as to which toxin was duplicated. Even so from our studies we 
hypothesise that the tcdA gene, which is more susceptible to HGT and had less areas of 
conservation, may have been a duplication of the more stable tcdB. 
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We also identified homology with virulence genes associated with insect pathogenicity. 
The majority of the structural domains of toxin B shared significant homology with the 
mcf toxin from P. luminescens and a number of other proteins associated with insect 
infection. Indeed this homology suggests that toxin B may have originated as a toxin from 
an insect associated ancestor. 
 
To better understand if C. difficile has an association with insects, we employed the insect 
Manduca sexta as a model infection system. C. difficile spores and vegetative cells were 
unable to elicit symptoms of infection upon either injected or oral delivery at 25
o
C and 
37
o
C. An interesting observation was that while injection with spores at 37
o
C had no 
obvious effects on the health of the insects they did pupate in contrast to the unchallenged 
controls, suggesting that exposure to spores had an effect on insect development (Alberea 
& Schaub, 2008).  
 
The failure of spores to initiate infection could be due to the fact that the insect lacks the 
necessary germination triggers. In an attempt to trigger germination we exposed insects to 
a mixture of spores supplemented with the bile salt sodium taurocholate; however no 
germination or subsequent infection manifested. This result may be an artefact of the 
insect system whereby the anaerobic environments (haemolymph/haemocoel; Wyatt & 
Meyer, 1956) were not able to sustain C. difficile. Further to this it may be likely that the 
insects do not possess the toxin receptors needed for pathology. Indeed the insect 
haemocoel may also contain antimicrobial factors which could account for the failure to 
initiate infection in the M. sexta. 
 
To determine if this indeed the case the vegetative and spore forms of C. difficile were 
suspended in M. sexta haemolymph. A reduction in the number of viable spores was 
observed supporting the hypothesis that the haemolymph is antimicrobial, possibly as a 
consequence of the production of antimicrobial peptides (Waterfield et al., 2004). 
Attempts to develop a gut colonisation model were also unsuccessful due to the fact that 
there was no difference in the passage or adherence ability of either strain tested. On the 
basis of these results, we have concluded that M. sexta is a poor model with which to 
study C. difficile pathogenicity and colonisation. 
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C. difficile has also been found to possess chitinase/ peroxiredoxin genes within its spore 
coat proteins which are associated spore germination (Permpoonpattna et al., 2011). To 
determine if this chitinase was indeed a relic of an insect infective past, we analysed 
spores of the widest differing hydrophobicity and found that chitinase was indeed released 
from germinating spores of both strains. This suggests that spores may be releasing 
chitinase during germination to potentially enable macromolecular degradation of soil 
elements, such as fungi and dead insects, and thus allow nutrient uptake, but also indicates 
that the presence of insect associated genes within the C. difficile genome may be 
associated with the evolution of the whole genome of C. difficile. Hence the common 
ancestor to C. difficile may indeed be an insect associated pathogen. 
 
Conserved sequences within the gene encoding regions of C. difficile toxins A and B were 
identified to design probes for use in the MAMEF assay. Candidate probes specific to 
conserved regions within toxins A and toxin B were synthesised and examined for 
specificity using a rigorous screening process against 58 clinical isolates of C. difficile, 
unrelated species, species from the LCT family and 10 human metagenomic gut DNA 
extracts. The probes used in this study were highly specific, gave no false positives or 
negatives and were incorporated into a prototype MAMEF based detection system. Using 
this system we were able to detect 10 cfu of C. difficile in a faecal suspension within 40 
seconds. Indeed as described previously (Section 1.6) there are currently no assays 
available which are able to rapidly detect tcdA and tcdB within human faecal suspensions 
near to this time frame. We have also proven that C. difficile can be directly detected in 
other complex organic matrices such as milk. This prototype biosensor has the potential to 
be developed into a real time beside diagnostic assay. 
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6.2. CONCLUSIONS 
The aim of this thesis was to determine the contribution of C. difficile’s virulence factors 
to its pathogenicity, while simultaneously designing an assay capable of detecting C. 
difficile toxins A and B using the MAMEF technological platform. The ability of C. 
difficile spores to germinate in the presence of different laboratory culture media was 
examined and we suggested that strains differed with regards to their germination triggers. 
Furthermore we observed that spores produced from a range of clinical isolates varied in 
their ability to adhere to organic and inorganic surfaces. This adherence ability was 
associated with spore surface hydrophobicity, with the most hydrophobic spores being 
amongst the most virulent ribotypes. These results suggest that spore adherence is closely 
associated with the spread and virulence of certain strains.  
 
From bioinformatic analysis it appears that the toxin genes of C. difficile appear to have 
evolved as a duplication of each other, with toxin A being a duplicate of toxin B. There 
was also homology of the C. difficile toxin genes to genes linked to insect pathogenicity, 
suggesting that C. difficile may have associated with insects throughout its evolution. 
Whether the genome acquired the toxins through HGT or evolved from an insect toxin 
ancestor is still the subject of debate.  
 
Finally conserved DNA signatures within toxins A and B of C. difficile were identified 
and analysed for specificity and sensitivity to C. difficile. Probes were engineered into the 
MAMEF platform and the assay was able to detect C. difficile at a lower detection limit of 
10 cfu in human faecal suspensions within 40 seconds. 
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6.3. FUTURE WORK 
To build on the research described above we propose that the following studies be 
considered: 
 
1. Examine the abilities of a larger collection of C. difficile clinical isolates to germinate in 
different laboratory culture media to establish if there is an association between ribotype 
and germination ability.  
 
2. Characterise the ability of spores of a representative collection of C. difficile clinical 
isolates to adhere to human adenocarcinoma cells to determine if there is a definitive 
association between virulence and adherence.  
 
3. Determine the role of the exosporium in the pathogenicity of C. difficile.  
 
4. Determine the basis of the antimicrobial activity of M. sexta haemolymph.  
 
5. Determine if direct injection of C. difficile into the haemolymph of other insects, such 
as cockroaches or Galleria, elicits a similar response. Indeed this would add support to our 
hypothesis that C. difficile evolved from an insect associated ancestor. 
 
6. Determine if the toxins of C. difficile had an effect upon the insect gut. This study can 
be conducted by adding the toxins to insect gut tissue culture. Any resulting pathology 
would indicate the presence of C. difficile toxin receptors on the surface of these cells. 
 
7. Currently the MAMEF assay detects two individual toxins in separate reactions; thus 
the assay would be benefit to be made into a single assay. 
 
8. Develop the prototype MAMEF based C. difficile detection assay.  
 
9. File a patent for the toxin A and B probe sequences and explore the commercialisation 
of this assay. 
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6.4. FUTURE BENEFITS AND APPLICATIONS 
The potential benefits of an assay capable of detecting both toxins of C. difficile in faecal 
suspensions are numerous. Indeed current assays are designed to detect only one of the 
two C. difficile toxins, have low sensitivities and often take hours to yield a result (Section 
1.6). In the context of hospital diagnosis, a variety of tests are used for CDI diagnosis, and 
there is currently no universal standard assay capable of rapidly (<60 mins) and accurately 
detecting the presence of both toxins. Thus an assay capable of specifically detecting both 
toxins A and B, without the need for prior purification or amplification, within raw human 
faecal samples in 40 seconds would be of tremendous benefit to the healthcare industry.  
 
Indeed such an assay would negate the need for the use of multiple non-specific, non-rapid 
assays, and has the potential to provide results at the patient bedside. This rapid diagnosis 
would allow the treatment regimen for patients to be tailored accordingly, preventing cross 
infection and further disease transmission. Currently within the NHS (UK) it takes 
approximately three days to diagnose a person with suspected toxigenic C. difficile, and it 
costs ~ £600 to keep a person in hospital; hence it would cost £1800 per patient. Patients 
with infection can expect to spend up to 27 days in hospital and in Wales it currently costs 
£8 000 to treat each individual case of C. difficile (Cardiff & Vale NHS Trusts, 2011). 
Thus any measure which would reduce the costs incurred by the NHS with regards to 
diagnosing C. difficile infection, and save lives in the process, would be of use. 
 
Another benefit of the C. difficile detection assay is its use of conserved sequences which 
are unlikely to change as a result of selective pressure. Indeed these conserved sequences 
are likely to remain conserved within toxigenic C. difficile and thus these probe sequences 
could potentially be applied to any platform technology- not only the MAMEF 
technological platform. 
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8.1. Bacterial Staining 
8.1.1. Gram Staining 
Colonies of C. difficile were spread onto a microscope slide using a sterile loop and 
emulsified using water. Slides were fixed under Bunsen flame and subsequently stained 
with crystal violet (Oxoid Ltd, Basingstoke, UK) for sixty seconds, washed with water and 
then flooded with Gram’s iodine (Oxoid Ltd, Basingstoke, UK) for sixty seconds. These 
were then washed with water and flooded with 95% ethanol (Fisher Scientific, UK) for ten 
seconds, washed with water and counterstained with safranin (Oxoid Ltd, Basingstoke, 
UK) for thirty seconds, rinsed, blotted and allowed to air dry. The samples were viewed 
under light microscope under oil immersion at 1000x TM 
 
8.1.2. Spore Staining  
Spores from C. difficile were spread onto a glass microscope slide using a sterile cool 
loop. Once this was air dried the slide was fixed by passing it briefly through a Bunsen 
flame two or three times without exposing the dried film directly to the flame. The slides 
were placed over a screened boiling water bath and flooded with Malachite Green (Oxoid 
Ltd, Basingstoke, UK). Slides were then washed with water and counterstained with 
Safranin (Sigma Aldrich, UK) for 30 seconds and washed with water (Oxoid Ltd, 
Basingstoke, UK). The samples were viewed under light microscope under oil immersion 
at 1000x TM. Spores strained green and vegetative cells red. 
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8.2. Statistics 
To enable interpretation of data statistical analyses were conducted. Statistical tests used 
in this thesis are described. 
 
8.2.1. One way ANOVA: 
One way analysis of variance (ANOVA) tests are performed on groups of variables and 
each group should represent separate responses to, or effects of, one factor. Thus the null 
hypothesis should be that the groups have the same mean (Bowker & Randerson, 2006). 
 
8.2.2. Kruskall-Wallis test 
This is a non- parametric test equivalent to one way ANOVA. The tests each group to 
determine if there is a different median. This is used as a final test post one way ANOVA 
if the assumptions of ANOVA are violated (Bowker & Randerson, 2006)  
 
8.2.3. T- Test 
A two sample t-test is used to compare the mean value of two independent random 
samples of normalised data (Bowker & Randerson, 2006). The non-parametric equivalent 
of a t test is the Wilcoxon’s rank test to discern if the difference between two median 
values is not significantly different from zero (Bowker & Randerson, 2006). 
 
8.2.4. P- values 
The P value is a measure of probability of the likeliness of a hypothesis being true or the 
significance of certain data. The P value statistic ranges between 0 - 1. Thus if P = 0 then 
the biological event is impossible and if P = 1 then it is certain (Bowker & Randerson, 
2006). 
 
8.2.5. Multiple comparison tests 
The Dunnett’s multiple comparison test is used to compare samples with the control group 
(GraphPad Software, La Jolla California USA, www.graphpad.com). A Tukey-Kramer 
test is also used test if significant differences between means of pairs of data are 
unexpected after ANOVA is performed. 
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8.3. Solutions for Southern Hybridisation 
8.3.1. Dig Easy Hyb Buffer  
For the hybridisation of the DIG probe to the membrane, DIG Easy Hyb buffer (Roche 
Diagnostics, Charles Avenue, West Sussex, UK) was obtained from (Roche Diagnostics, 
Charles Avenue, West Sussex, UK). It is specially designed for use with DIG detection 
methods. 
 
8.3.2. Maleic Acid Buffer 
Maleic acid buffer is used as the basic buffer for mixing further solutions needed for dot 
blots. Maleic acid buffer was prepared by adding 0.1 M maleic acid (Sigma Aldrich, UK) 
to 0.15 M sodium chloride - NaCl (Sigma Aldrich, UK) with polished H2O in a 1000 ml 
Duran bottle. The pH of the solution was calibrated to pH= 7.5 by adding Sodium 
hydroxide pellets (Sigma Aldrich, UK) (NaOH). The solution was mixed thoroughly and 
autoclaved at 121
 o
C, and left to cool before use. 
 
8.3.3. Stock solution of 20x Saline-Sodium citrate buffer (SSC) 
To wash the nylon membrane after hybridisation a stock solution of SSC buffer was made. 
SSC buffer  at 20x concentration was prepared by adding 0.3 M tri-sodium citrate (Sigma 
Aldrich, UK) at pH =7 to 3 M NaCl (Sigma Aldrich, UK) with polished H2O in a 1000 ml 
Duran bottle. The solution was mixed thoroughly before use. 
 
8.3.4. SSC X 2 
This low stringency wash solution was used to remove unspecifically bound probes from 
the membrane via washing. This has a high salt content and is washed at a low 
temperature (Roche Diagnostics, Charles Avenue, West Sussex, UK). This thus allows for 
a more efficient dot to be observed. SSC buffer at 2x concentration was prepared by 
adding 50 ml 20x SSC and 5 ml 10% SDS (Sodium Dodecyl sulphate, Sigma Aldrich, 
UK) to 500 ml polished H2O. The solution was mixed thoroughly before use. 
 
8.3.5. SSC X 0.5 
This high stringency wash solution is used to remove any undesired binding with low 
homology. This has a low salt content and is washed at a high temperature (Roche 
Diagnostics, Charles Avenue, West Sussex, UK). SSC buffer at 0.5x concentration was 
prepared by adding 12.5 ml 20x SSC and 5 ml 10% SDS (Sodium Dodecyl Sulphate, 
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Sigma Aldrich, UK) to 500 ml polished H2O. The solution was mixed thoroughly before 
use. 
 
8.3.6. SSC X 0.1 
This high stringency wash solution is also used to further remove any undesired binding 
with low homology in conjunction with 0.5x SSC buffer. This has a low salt content and is 
washed at a high temperature (Roche Diagnostics, Charles Avenue, West Sussex, UK). 
SSC buffer at 0.1x concentration was prepared by adding 2.5 ml 20x SSC and 5 ml 10% 
SDS (Sodium Dodecyl sulphate, Sigma Aldrich, UK) to 500 ml polished H2O. The 
solution was mixed thoroughly before use. 
 
8.3.7. Washing buffer 
Washing buffer is used to assist in detection of any probe bound to the DNA and was 
prepared by adding 0.3% Tween® 20 (Sigma Aldrich, UK) to 1 L pre-prepared maleic 
acid buffer in a 1000 ml Duran bottle. The solution was mixed thoroughly before use. 
 
8.3.8. Stock 10% Blocking solution 
The blocking solution is used to minimise the background on the membrane during 
detection of the bound probe. Blocking solution was obtained from Roche (Roche 
Diagnostics, Charles Avenue, West Sussex, UK) and mixed in maleic acid buffer to a 
concentration of 10% (w/v) in a 500 ml Duran bottle. The powder was dissolved by 
microwaving 5x for 30 seconds each with 10 minutes mixing in between. The final stock 
solution was autoclaved at 121
 o
C, and left to cool. Aliquots of the stock solution were 
frozen at -20
o
C until needed. This solution has to be used immediately after preparation to 
avoid spoiling. 
 
8.3.9. 1% Blocking solution 
The 1% blocking solution was made from 10% blocking solution by mixing into maleic 
acid buffer. The final solution was autoclaved at 121
 o
C, left to cool and used immediately. 
 
8.3.10. Detection Buffer 
To detect the bound probe on the membrane detection buffer was prepared by adding 100 
mM Tris-HCl (pH 9.5) (Sigma Aldrich, UK) to 100 mM NaCl (Sigma Aldrich, UK) in a 
500 ml Duran bottle. The solution was autoclaved at 121
 o
C and left to cool. 
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8.4. Bioinformatic analysis of known C. difficile virulence genes using BLAST 
8.4.1. Toxin A protein BLAST alignments 
[http://blast.ncbi.nlm.nih.gov/Blast.cgi] 
 
8.4.1.1. Glucosyltransferase domain: 
Analysis of the glucosyltransferase domain of C. difficile toxin A using protein BLAST 
revealed the following alignment: 
 
Query length= 546 amino acids. 
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Alignment information for genes shown in Table 4.2: 
C. difficile tcdB 
 
 
C. sordellii tcsL 
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C. perfringens tpeL 
 
 
C. novyi α toxin 
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C. perfringens tcpA 
 
 
 
 
Citrobacter rodentium lymphocyte inhibitory factor 
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Pseudomonas fluorescens Putative toxin A 
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8.4.1.2. Cysteine Protease domain: 
Analysis of the cysteine protease domain of C. difficile toxin A revealed the following 
alignments: 
Query length=221 amino acids. 
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Alignment information for genes shown in Table 4.2: 
C. difficile tcdB  
 
 
C. sordellii tcsL 
 
 
C. perfringens tpeL 
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C. novyi tcnα 
 
 
C. perfringens tcpA 
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Yersinia mollaretii  
Methyl accepting chemotaxis protein & RTX protein 
 
 
Vibrio cholerae RTX protein 
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8.4.1.3. Membrane translocation domain 
Analysis of the membrane translocation domain of C. difficile toxin A revealed the 
following alignments: 
Query length=172 amino acids. 
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Alignment information for genes shown in Table 4.2: 
C. difficile tcdB  
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C. sordellii tcsL 
 
 
C. perfringens tpeL 
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C. novyi tcnα 
 
 
C. perfringens tcpA 
 
 
Photorhabdus luminescens subsp. laumondii hypothetical protein 
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Yersinia mollaretii  
Methyl accepting chemotaxis protein & RTX protein 
 
 
 
8.4.1.4. Receptor binding domain 
Analysis of the receptor binding domain of C. difficile toxin A revealed the following 
alignments: 
Query coverage= 859 amino acids. 
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Alignment information for genes shown in Table 4.2: 
C. difficile tcdB 
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C. sordellii tcsL 
 
 
 
 
C. novyi α toxin 
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C. perfringens tcpA 
 
 
Streptococcus salivarius hypothetical protein 
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C. perfringens cell wall binding repeat domain protein  
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8.4.2. Toxin B protein BLAST alignments 
[http://blast.ncbi.nlm.nih.gov/Blast.cgi] 
 
8.4.2.1. Glucosyltransferase domain: 
Analysis of the glucosyltransferase domain of C. difficile toxin B using protein BLAST 
revealed the following alignment: 
Query coverage= 545 amino acids. 
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Alignment information for genes shown in Table 4.2: 
C. difficile tcdA 
 
 
 
C. sordellii tcsL 
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C. perfringens tpeL 
 
 
C. novyi α toxin 
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C. perfringens tcpA 
 
 
Pseudomonas fluorescens Putative toxin A  
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Pseudomonas fluorescens mcf cytotoxin A  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   APPENDIX 
 
257 
 
8.4.2.2. Cysteine Protease domain: 
Analysis of the cysteine protease domain of C. difficile toxin B revealed the following 
alignments: 
Query coverage= 221 amino acids. 
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Alignment information for genes shown in Table 4.2: 
C. difficile tcdA 
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C. sordellii tcsL 
 
 
 
C. perfringens tpeL 
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C. novyi α toxin 
 
 
 
 
C. perfringens tcpA 
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Photorhabdus luminescens subsp. laumondii  hypothetical protein 
 
 
Yersinia mollaretii  RTX toxin 
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P. asymbiotica subsp. asymbiotica RTX toxin 
 
Vibrio cholerae RTX toxin 
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8.4.2.3. Membrane translocation domain 
Analysis of the membrane translocation domain of C. difficile toxin B revealed the 
following alignments: 
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Alignment information for genes shown in Table 4.3: 
C. difficile tcdA 
 
 
C. sordellii tcsL 
 
 
C. perfringens tpeL 
 
 
C. novyi α toxin 
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C. perfringens tcpA 
 
 
Photorhabdus luminescens subsp. laumondii  hypothetical protein 
 
 
Photorhabdus luminescens subsp. laumondii  hypothetical protein 
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P. asymbiotica subsp. asymbiotica RTX toxin 
 
 
Yersinia mollaretii  RTX toxin 
 
 
Xenorhabdus bovienii mcf protein 
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Photorhabdus luminescens subsp. laumondii  mcf2 
 
 
P. fluorescens  FitD cytotoxin 
 
 
P. asymbiotica subsp. asymbiotica RTX toxin 
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Vibrio cholerae RTX toxin 
 
 
 
8.4.2.4. Receptor binding domain 
Analysis of the receptor binding domain of C. difficile toxin B revealed the following 
alignments: 
Query Coverage = 515 amino acids. 
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Alignment information for genes shown in Table 4.3: 
C. difficile tcdA 
 
 
 
 
C. sordellii tcsL 
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C. novyi α toxin 
 
 
 
 
Ruminococcus albus cell wall binding repeat domain protein 
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S. oralis cell wall binding repeat domain protein 
 
 
 
 
 
 
 
 
 
 
 
 
 
